簡介
本頁面提供了有關 Felix Baker 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。
平均交易盈利能力
「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。
如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。
更新頻率:每日
報告內部持倉的公司
SEC文件顯示Felix Baker已報告在以下公司擁有持倉或進行了交易:
如何解讀這些圖表
以下圖表顯示了在Felix Baker進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。
最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。
然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。
最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。
ACAD / ACADIA Pharmaceuticals Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
ACAD / ACADIA Pharmaceuticals Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
BCRX / BioCryst Pharmaceuticals, Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
BCRX / BioCryst Pharmaceuticals, Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
CELC / Celcuity Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
CELC / Celcuity Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
KALA / KALA BIO, Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
KALA / KALA BIO, Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
KNSA / Kiniksa Pharmaceuticals International, plc內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
KNSA / Kiniksa Pharmaceuticals International, plc內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
KOD / Kodiak Sciences Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
KOD / Kodiak Sciences Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
KYMR / Kymera Therapeutics, Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
KYMR / Kymera Therapeutics, Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
MDGL / Madrigal Pharmaceuticals, Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
MDGL / Madrigal Pharmaceuticals, Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
NTLA / Intellia Therapeutics, Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
NTLA / Intellia Therapeutics, Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
PRLD / Prelude Therapeutics Incorporated內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
PRLD / Prelude Therapeutics Incorporated內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
REPL / Replimune Group, Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
REPL / Replimune Group, Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
RYTM / Rhythm Pharmaceuticals, Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
RYTM / Rhythm Pharmaceuticals, Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
SERA / Sera Prognostics, Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
SERA / Sera Prognostics, Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
SYRE / Spyre Therapeutics, Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
SYRE / Spyre Therapeutics, Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
TCRX / TScan Therapeutics, Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
TCRX / TScan Therapeutics, Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
TRDA / Entrada Therapeutics, Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
TRDA / Entrada Therapeutics, Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
VTVT / vTv Therapeutics Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
VTVT / vTv Therapeutics Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
XOMAO / XOMA Royalty Corporation - Preferred Stock內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
XOMAO / XOMA Royalty Corporation - Preferred Stock內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。經調整股數 已按拆股調整。
ZYME / Zymeworks Inc.內部人士買入 - 短期收益分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值。
ZYME / Zymeworks Inc.內部人士賣出 - 短期虧損分析
在這一部分,我們分析了在 ACAD / ACADIA Pharmaceuticals Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,
歷史內部人交易
該表格顯示了由 Felix Baker 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。
| 呈報日期 | 交易日期 | 表格 | 證券代碼 | 證券 | 代碼 | 股份 | 剩餘股份 | % 變化 |
每股 股價 |
交易 金額 |
剩餘 金額 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 6,408 | 3,422,366 | 0.19 | ||||
| 2026-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 6,408 | 343,275 | 1.90 | ||||
| 2026-06-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 6,078 | 2,744,894 | 0.22 | ||||
| 2026-06-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 6,078 | 143,277 | 4.43 | ||||
| 2026-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18,622 | 39,384,587 | 0.05 | ||||
| 2026-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18,622 | 3,677,357 | 0.51 | ||||
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2,756 | 142,570 | -1.90 | 23.79 | -65,567 | 3,391,812 | |
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2,756 | 142,566 | -1.90 | 23.79 | -65,567 | 3,391,716 | |
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2,743 | 145,326 | -1.85 | 23.85 | -65,424 | 3,466,199 | |
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2,743 | 145,322 | -1.85 | 23.85 | -65,424 | 3,466,104 | |
| 2026-05-11 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15,000 | 28,203,718 | 0.05 | 84.53 | 1,267,950 | 2,384,060,283 | |
| 2026-05-11 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15,000 | 2,833,039 | 0.53 | 84.53 | 1,267,950 | 239,476,787 | |
| 2026-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 421 | 28,188,718 | 0.00 | ||||
| 2026-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 421 | 2,818,039 | 0.01 | ||||
| 2026-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 19,000 | 10,018,674 | 0.19 | ||||
| 2026-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 19,000 | 10,018,674 | 0.19 | ||||
| 2026-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 328 | 28,188,297 | 0.00 | ||||
| 2026-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 328 | 28,188,297 | 0.00 | ||||
| 2025-12-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,391,268 | 18,358,772 | 14.98 | 23.00 | 54,999,164 | 422,251,756 | |
| 2025-12-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 217,428 | 1,560,414 | 16.19 | 23.00 | 5,000,844 | 35,889,522 | |
| 2025-12-11 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 1,838,621 | 7,955,916 | 30.06 | 86.00 | 158,121,406 | 684,208,776 | |
| 2025-12-11 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 167,192 | 701,326 | 31.30 | 86.00 | 14,378,512 | 60,314,036 | |
| 2025-11-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 13,082 | 4,691,392 | 0.28 | 9.07 | 118,690 | 42,564,061 | |
| 2025-11-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1,186 | 381,338 | 0.31 | 9.07 | 10,760 | 3,459,803 | |
| 2025-11-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 13,386 | 4,678,310 | 0.29 | 9.07 | 121,395 | 42,426,658 | |
| 2025-11-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1,213 | 380,152 | 0.32 | 9.07 | 11,000 | 3,447,522 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 11,494 | 4,664,924 | 0.25 | 7.95 | 91,431 | 37,108,071 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1,040 | 378,939 | 0.28 | 7.95 | 8,273 | 3,014,346 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 80,881 | 4,653,430 | 1.77 | 7.73 | 625,331 | 35,977,994 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,321 | 377,899 | 1.98 | 7.73 | 56,602 | 2,921,726 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 30,879 | 4,572,549 | 0.68 | 7.54 | 232,812 | 34,474,733 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,795 | 370,578 | 0.76 | 7.54 | 21,073 | 2,793,973 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 11,701 | 4,541,670 | 0.26 | 7.39 | 86,481 | 33,567,029 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1,059 | 367,783 | 0.29 | 7.39 | 7,827 | 2,718,247 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,947 | 4,529,969 | 0.07 | 7.22 | 21,290 | 32,726,308 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 267 | 366,724 | 0.07 | 7.22 | 1,929 | 2,649,361 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 25,364 | 4,527,022 | 0.56 | 7.21 | 182,973 | 32,657,484 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,296 | 366,457 | 0.63 | 7.21 | 16,563 | 2,643,584 | |
| 2025-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 388 | 28,187,969 | 0.00 | ||||
| 2025-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 388 | 2,817,290 | 0.01 | ||||
| 2025-10-02 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
S - Sale | -462,967 | 425,006 | -52.14 | 1.38 | -640,654 | 588,123 | |
| 2025-10-02 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
S - Sale | -50,640 | 46,480 | -52.14 | 1.38 | -70,076 | 64,319 | |
| 2025-10-02 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
S - Sale | -195,425 | 887,973 | -18.04 | 1.60 | -311,879 | 1,417,116 | |
| 2025-10-02 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
S - Sale | -21,376 | 97,120 | -18.04 | 1.60 | -34,114 | 154,994 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 4,212 | 7,211,484 | 0.06 | 58.02 | 244,395 | 418,436,263 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 388 | 704,308 | 0.06 | 58.02 | 22,513 | 40,866,486 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 151,524 | 7,207,272 | 2.15 | 56.22 | 8,518,679 | 405,192,832 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 13,976 | 703,920 | 2.03 | 56.22 | 785,731 | 39,574,382 | |
| 2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 46,692 | 135,946 | 52.31 | ||||
| 2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 4,308 | 12,368 | 53.45 | ||||
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,128 | 1,859,091 | 0.55 | 372.16 | 3,769,209 | 691,874,287 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 933 | 194,625 | 0.48 | 372.16 | 347,223 | 72,431,115 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,494 | 1,848,963 | 0.30 | 371.00 | 2,038,301 | 685,974,518 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 506 | 193,692 | 0.26 | 371.00 | 187,729 | 71,860,700 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,747 | 1,843,469 | 0.15 | 369.34 | 1,014,563 | 680,857,623 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 253 | 193,186 | 0.13 | 369.34 | 93,442 | 71,350,351 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,419 | 1,840,722 | 0.08 | 368.84 | 523,384 | 678,931,902 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 131 | 192,933 | 0.07 | 368.84 | 48,318 | 71,161,408 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,798 | 1,839,303 | 0.26 | 367.77 | 1,764,565 | 676,442,304 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 442 | 192,802 | 0.23 | 367.77 | 162,555 | 70,906,984 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,289 | 1,834,505 | 0.12 | 366.30 | 838,459 | 671,977,714 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 211 | 192,360 | 0.11 | 366.30 | 77,289 | 70,461,314 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,772 | 1,832,216 | 0.15 | 363.75 | 1,008,308 | 666,463,806 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 255 | 192,149 | 0.13 | 363.75 | 92,756 | 69,893,699 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,587 | 1,829,444 | 0.31 | 362.39 | 2,024,662 | 662,968,735 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 191,894 | 0.27 | 362.39 | 186,630 | 69,540,102 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,443 | 1,823,857 | 0.30 | 361.37 | 1,966,957 | 659,093,770 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 502 | 191,379 | 0.26 | 361.37 | 181,410 | 69,159,318 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,514 | 1,818,414 | 0.47 | 359.39 | 3,059,873 | 653,525,445 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 784 | 190,877 | 0.41 | 359.39 | 281,764 | 68,599,877 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,472 | 1,809,900 | 0.14 | 358.21 | 885,495 | 648,324,279 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 228 | 190,093 | 0.12 | 358.21 | 81,672 | 68,093,214 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,328 | 1,807,428 | 0.46 | 357.02 | 2,973,289 | 645,293,728 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 767 | 189,865 | 0.41 | 357.02 | 273,837 | 67,786,210 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 916 | 1,799,100 | 0.05 | 355.00 | 325,180 | 638,680,500 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 84 | 189,098 | 0.04 | 355.00 | 29,820 | 67,129,790 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,923 | 1,798,184 | 0.11 | 353.88 | 680,503 | 636,333,262 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 177 | 189,014 | 0.09 | 353.88 | 62,636 | 66,887,424 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9,362 | 1,947,968 | 0.48 | 392.24 | 3,672,178 | 764,076,617 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 862 | 202,813 | 0.43 | 392.24 | 338,113 | 79,551,959 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,506 | 1,938,606 | 0.13 | 389.89 | 977,059 | 755,838,828 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 231 | 201,951 | 0.11 | 389.89 | 90,064 | 78,738,231 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 366 | 1,936,100 | 0.02 | 389.00 | 142,374 | 753,142,900 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 34 | 201,720 | 0.02 | 389.00 | 13,226 | 78,469,080 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,441 | 1,935,734 | 0.23 | 387.07 | 1,718,969 | 749,260,688 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 409 | 201,686 | 0.20 | 387.07 | 158,311 | 78,066,197 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,545 | 1,931,293 | 0.71 | 385.06 | 5,215,601 | 743,658,468 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,248 | 201,277 | 0.62 | 385.06 | 480,552 | 77,503,178 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,049 | 1,917,748 | 0.21 | 383.79 | 1,553,954 | 736,007,135 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 373 | 200,029 | 0.19 | 383.79 | 143,153 | 76,768,570 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,838 | 1,913,699 | 0.15 | 382.82 | 1,086,447 | 732,604,739 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 262 | 199,656 | 0.13 | 382.82 | 100,299 | 76,432,569 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,136 | 1,910,861 | 0.06 | 382.29 | 434,280 | 730,501,332 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 105 | 199,394 | 0.05 | 382.29 | 40,140 | 76,226,153 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9,477 | 1,909,725 | 0.50 | 381.12 | 3,611,889 | 727,837,448 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 873 | 199,289 | 0.44 | 381.12 | 332,719 | 75,953,343 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,919 | 1,900,248 | 0.10 | 380.78 | 730,717 | 723,576,433 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 198,416 | 0.09 | 380.78 | 67,017 | 75,552,844 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,209 | 1,898,329 | 0.28 | 380.44 | 1,981,694 | 722,193,641 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 480 | 198,240 | 0.24 | 380.44 | 182,610 | 75,417,732 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,325 | 1,893,120 | 0.39 | 374.43 | 2,742,728 | 708,848,115 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 675 | 197,760 | 0.34 | 374.43 | 252,743 | 74,048,028 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26,704 | 1,885,795 | 1.44 | 372.87 | 9,957,102 | 703,155,062 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,460 | 197,085 | 1.26 | 372.87 | 917,258 | 73,486,946 | |
| 2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -3,763,362 | 0 | -100.00 | ||||
| 2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -357,048 | 0 | -100.00 | ||||
| 2025-08-01 | 3 | CELC |
Celcuity Inc.
Common Stock |
689,944 | ||||||||
| 2025-08-01 | 3 | CELC |
Celcuity Inc.
Common Stock |
7,055,748 | ||||||||
| 2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28,187,581 | 0.00 | ||||
| 2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28,187,581 | 0.00 | ||||
| 2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3,763,362 | 0.03 | ||||
| 2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3,763,362 | 0.03 | ||||
| 2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 600,309 | 6,117,295 | 10.88 | 44.00 | 26,413,596 | 269,160,980 | |
| 2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 55,191 | 534,134 | 11.52 | 44.00 | 2,428,404 | 23,501,896 | |
| 2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,430 | 1,796,261 | 0.08 | ||||
| 2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,430 | 1,796,261 | 0.08 | ||||
| 2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,518 | 28,187,089 | 0.01 | ||||
| 2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,518 | 28,187,089 | 0.01 | ||||
| 2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
326,302 | ||||||||
| 2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
3,405,393 | ||||||||
| 2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10,565 | 3,415,958 | 0.31 | ||||
| 2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10,565 | 3,415,958 | 0.31 | ||||
| 2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8,397 | 2,738,816 | 0.31 | ||||
| 2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8,397 | 2,738,816 | 0.31 | ||||
| 2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16,214 | 39,365,965 | 0.04 | ||||
| 2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16,214 | 39,365,965 | 0.04 | ||||
| 2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21,970 | 148,069 | 17.42 | ||||
| 2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21,970 | 148,065 | 17.42 | ||||
| 2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 28,184,571 | 0.00 | ||||
| 2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 2,813,892 | 0.02 | ||||
| 2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3,762,409 | 0.03 | ||||
| 2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 356,095 | 0.27 | ||||
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 92,349 | 2,144,060 | 4.50 | 29.56 | 2,729,864 | 63,379,057 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 8,589 | 178,596 | 5.05 | 29.56 | 253,893 | 5,279,351 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 646,290 | 2,051,711 | 45.99 | 29.74 | 19,221,699 | 61,021,168 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 60,110 | 170,007 | 54.70 | 29.74 | 1,787,768 | 5,056,280 | |
| 2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
929,241 | ||||||||
| 2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
10,116,095 | ||||||||
| 2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -671,976 | 8,068,411 | -7.69 | 260.00 | -174,713,760 | 2,097,786,860 | |
| 2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -60,851 | 730,642 | -7.69 | 260.00 | -15,821,260 | 189,966,920 | |
| 2025-02-14 | 3 | SERA |
SERA PROGNOSTICS, INC.
Common Stock |
432,434 | ||||||||
| 2025-02-14 | 3 | SERA |
SERA PROGNOSTICS, INC.
Common Stock |
5,065,736 | ||||||||
| 2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4,400 | 9,999,674 | 0.04 | ||||
| 2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4,400 | 918,483 | 0.48 | ||||
| 2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28,184,084 | 0.00 | ||||
| 2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28,184,084 | 0.00 | ||||
| 2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,761,456 | 0.05 | ||||
| 2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 355,142 | 0.56 | ||||
| 2024-12-31 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
P - Purchase | 279,939 | 1,083,398 | 34.84 | 6.44 | 1,802,807 | 6,977,083 | |
| 2024-12-31 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
P - Purchase | 30,620 | 118,496 | 34.84 | 6.44 | 197,193 | 763,114 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 457,631 | 9,995,274 | 4.80 | 15.34 | 7,020,883 | 153,345,495 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 42,369 | 914,083 | 4.86 | 15.34 | 650,017 | 14,023,679 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 566,814 | 9,537,643 | 6.32 | 13.80 | 7,824,300 | 131,657,624 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 52,656 | 871,714 | 6.43 | 13.80 | 726,863 | 12,033,140 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 244,587 | 8,970,829 | 2.80 | 13.72 | 3,356,761 | 123,117,451 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 22,722 | 819,058 | 2.85 | 13.72 | 311,841 | 11,240,916 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 59,995 | 8,726,242 | 0.69 | 13.63 | 817,660 | 118,928,207 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 5,573 | 796,336 | 0.70 | 13.63 | 75,953 | 10,853,104 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 30,241 | 8,666,247 | 0.35 | 13.50 | 408,190 | 116,976,135 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 2,809 | 790,763 | 0.36 | 13.50 | 37,916 | 10,673,640 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -916,964 | 8,740,387 | -9.49 | 186.50 | -171,013,786 | 1,630,082,176 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -83,036 | 791,493 | -9.49 | 186.50 | -15,486,214 | 147,613,444 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -33,943 | 9,657,351 | -0.35 | 208.01 | -7,060,609 | 2,008,861,314 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -3,074 | 874,529 | -0.35 | 208.01 | -639,434 | 181,914,013 | |
| 2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4,730 | 2,730,419 | 0.17 | ||||
| 2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4,730 | 2,730,419 | 0.17 | ||||
| 2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 28,183,638 | 0.00 | ||||
| 2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 2,812,959 | 0.02 | ||||
| 2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,759,462 | 0.05 | ||||
| 2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 353,148 | 0.57 | ||||
| 2024-08-22 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 1 | 5,516,986 | 0.00 | 46.41 | 46 | 256,043,320 | |
| 2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28,183,142 | 0.00 | ||||
| 2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28,183,142 | 0.00 | ||||
| 2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,757,468 | 0.05 | ||||
| 2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,757,468 | 0.05 | ||||
| 2024-06-28 | 3 | KALA |
KALA BIO, Inc.
Common Stock |
87,876 | ||||||||
| 2024-06-28 | 3 | KALA |
KALA BIO, Inc.
Common Stock |
803,459 | ||||||||
| 2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,428 | 1,794,831 | 0.08 | ||||
| 2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,428 | 1,794,831 | 0.08 | ||||
| 2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 2,186,686 | 8,636,006 | 33.91 | ||||
| 2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 196,098 | 787,954 | 33.13 | ||||
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -5,283,206 | 28,182,605 | -15.79 | 60.00 | -316,992,360 | 1,690,956,300 | |
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -175,977 | 2,811,926 | -5.89 | 60.00 | -10,558,620 | 168,715,560 | |
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,830 | 33,465,811 | 0.01 | ||||
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,830 | 33,465,811 | 0.01 | ||||
| 2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32,682 | 126,099 | 34.99 | ||||
| 2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32,682 | 126,099 | 34.99 | ||||
| 2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6,346 | 2,725,689 | 0.23 | ||||
| 2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6,346 | 2,725,689 | 0.23 | ||||
| 2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18,774 | 39,349,751 | 0.05 | ||||
| 2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18,774 | 39,349,751 | 0.05 | ||||
| 2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
109,897 | ||||||||
| 2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
1,405,421 | ||||||||
| 2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15,000 | 33,462,981 | 0.04 | 49.01 | 735,150 | 1,640,020,699 | |
| 2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15,000 | 2,985,073 | 0.51 | 49.01 | 735,150 | 146,298,428 | |
| 2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12,000 | 6,449,320 | 0.19 | ||||
| 2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12,000 | 6,449,320 | 0.19 | ||||
| 2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
579,856 | ||||||||
| 2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
6,437,320 | ||||||||
| 2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,755,474 | 0.05 | ||||
| 2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,755,474 | 0.05 | ||||
| 2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 33,447,981 | 0.00 | ||||
| 2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 2,970,073 | 0.02 | ||||
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 89,407 | 3,753,480 | 2.44 | 9.62 | 860,042 | 36,106,226 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8,066 | 347,166 | 2.38 | 9.62 | 77,590 | 3,339,529 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8,439 | 3,664,073 | 0.23 | 9.27 | 78,207 | 33,956,064 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 761 | 339,100 | 0.22 | 9.27 | 7,052 | 3,142,541 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17,101 | 3,655,634 | 0.47 | 9.22 | 157,683 | 33,707,504 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 1,543 | 338,339 | 0.46 | 9.22 | 14,228 | 3,119,722 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 247,656 | 3,638,533 | 7.30 | 8.26 | 2,046,159 | 30,061,923 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 22,344 | 336,796 | 7.11 | 8.26 | 184,608 | 2,782,642 | |
| 2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
12,836 | ||||||||
| 2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
142,135 | ||||||||
| 2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -52,881 | 89,254 | -37.20 | ||||
| 2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -4,776 | 8,060 | -37.21 | ||||
| 2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33,447,438 | 0.00 | ||||
| 2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33,447,438 | 0.00 | ||||
| 2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3,390,877 | 0.02 | ||||
| 2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3,390,877 | 0.02 | ||||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -42,977,301 | 0 | -100.00 | 229.00 | -9,841,801,929 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -1,731,202 | 0 | -100.00 | 229.00 | -396,445,258 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23,277 | 0 | -100.00 | 229.00 | -5,330,433 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23,280 | 0 | -100.00 | 229.00 | -5,331,120 | ||
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 214,025 | 3,390,323 | 6.74 | 6.60 | 1,412,565 | 22,376,132 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17,066 | 313,898 | 5.75 | 6.60 | 112,636 | 2,071,727 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 52,528 | 3,176,298 | 1.68 | 6.37 | 334,399 | 20,220,631 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 4,188 | 296,832 | 1.43 | 6.37 | 26,661 | 1,889,662 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 185 | 3,123,770 | 0.01 | 6.36 | 1,176 | 19,851,558 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 15 | 292,644 | 0.01 | 6.36 | 95 | 1,859,753 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 145,749 | 3,123,585 | 4.89 | 6.50 | 947,602 | 20,308,300 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 11,621 | 292,629 | 4.14 | 6.50 | 75,555 | 1,902,557 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 71,219 | 2,977,836 | 2.45 | 5.99 | 426,751 | 17,843,491 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 5,679 | 281,008 | 2.06 | 5.99 | 34,029 | 1,683,828 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 9,649 | 2,906,617 | 0.33 | 5.76 | 55,567 | 16,738,626 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 769 | 275,329 | 0.28 | 5.76 | 4,429 | 1,585,565 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,857 | 1,699,129 | 0.23 | 221.24 | 853,330 | 375,918,358 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 308 | 178,461 | 0.17 | 221.24 | 68,142 | 39,483,033 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,408 | 1,695,272 | 0.26 | 220.65 | 972,645 | 374,069,565 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 352 | 178,153 | 0.20 | 220.65 | 77,670 | 39,310,279 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15,005 | 1,690,864 | 0.90 | 219.24 | 3,289,711 | 370,706,714 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,195 | 177,801 | 0.68 | 219.24 | 261,993 | 38,981,269 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,873 | 1,675,859 | 0.17 | 217.91 | 626,049 | 365,182,748 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 229 | 176,606 | 0.13 | 217.91 | 49,901 | 38,483,825 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1,672,986 | 0.01 | 217.90 | 40,312 | 364,543,649 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176,377 | 0.01 | 217.90 | 3,268 | 38,432,548 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,769 | 1,672,801 | 0.11 | 216.67 | 383,286 | 362,442,949 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 141 | 176,362 | 0.08 | 216.67 | 30,550 | 38,212,055 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 668 | 1,671,032 | 0.04 | 214.72 | 143,434 | 358,807,834 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 176,221 | 0.03 | 214.72 | 11,380 | 37,838,578 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 1,670,364 | 0.03 | 213.80 | 110,107 | 357,122,821 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 41 | 176,168 | 0.02 | 213.80 | 8,766 | 37,664,613 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1,669,849 | 0.01 | 213.62 | 39,521 | 356,721,493 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176,127 | 0.01 | 213.62 | 3,204 | 37,625,130 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1,669,664 | 0.04 | 212.04 | 137,403 | 354,037,892 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176,112 | 0.03 | 212.04 | 11,026 | 37,343,035 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1,669,016 | 0.01 | 209.76 | 19,508 | 350,101,141 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 176,060 | 0.00 | 209.76 | 1,468 | 36,931,226 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 370 | 1,668,923 | 0.02 | 208.69 | 77,216 | 348,289,710 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 30 | 176,053 | 0.02 | 208.69 | 6,261 | 36,740,729 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1,668,553 | 0.04 | 206.93 | 134,092 | 345,277,176 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176,023 | 0.03 | 206.93 | 10,760 | 36,424,809 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 708 | 1,667,905 | 0.04 | 205.60 | 145,565 | 342,921,268 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 56 | 175,971 | 0.03 | 205.60 | 11,514 | 36,179,638 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1,667,197 | 0.01 | 205.32 | 19,095 | 342,308,888 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 175,915 | 0.00 | 205.32 | 1,437 | 36,118,868 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,960 | 1,793,403 | 0.22 | 229.86 | 910,264 | 412,240,043 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 316 | 185,979 | 0.17 | 229.86 | 72,637 | 42,750,007 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,204 | 1,789,443 | 0.12 | 228.79 | 504,252 | 409,405,411 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 185,663 | 0.09 | 228.79 | 40,267 | 42,477,708 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 11,602 | 1,787,239 | 0.65 | 227.86 | 2,643,597 | 407,234,917 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 925 | 185,487 | 0.50 | 227.86 | 210,768 | 42,264,511 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,343 | 1,775,637 | 0.08 | 226.97 | 304,822 | 403,018,106 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 107 | 184,562 | 0.06 | 226.97 | 24,286 | 41,890,222 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,594 | 1,774,294 | 0.32 | 224.91 | 1,258,156 | 399,059,480 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 446 | 184,455 | 0.24 | 224.91 | 100,311 | 41,486,088 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 363 | 1,768,700 | 0.02 | 223.94 | 81,289 | 396,078,079 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29 | 184,009 | 0.02 | 223.94 | 6,494 | 41,206,497 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9,262 | 1,768,337 | 0.53 | 222.68 | 2,062,425 | 393,766,210 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 738 | 183,980 | 0.40 | 222.68 | 164,335 | 40,967,930 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,532 | 1,759,075 | 0.26 | 221.78 | 1,005,101 | 390,125,367 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 361 | 183,242 | 0.20 | 221.78 | 80,062 | 40,639,173 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,518 | 1,754,543 | 0.26 | 219.87 | 993,351 | 385,762,948 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 360 | 182,881 | 0.20 | 219.87 | 79,151 | 40,209,168 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29,738 | 1,750,025 | 1.73 | 218.46 | 6,496,513 | 382,307,486 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,373 | 182,521 | 1.32 | 218.46 | 518,402 | 39,873,227 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,894 | 1,720,287 | 0.64 | 217.52 | 2,369,611 | 374,188,571 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 869 | 180,148 | 0.48 | 217.52 | 189,021 | 39,184,928 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,264 | 1,709,393 | 0.60 | 216.70 | 2,224,203 | 370,424,437 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 818 | 179,279 | 0.46 | 216.70 | 177,260 | 38,849,652 | |
| 2023-11-24 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
X - Other | 1,941,607 | 2,168,818 | 854.54 | 0.00 | 194 | 217 | |
| 2023-11-24 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
X - Other | 174,742 | 196,654 | 797.47 | 0.00 | 17 | 20 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,917 | 1,667,104 | 0.48 | 190.14 | 1,505,308 | 316,976,653 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 655 | 175,908 | 0.37 | 190.14 | 124,539 | 33,446,461 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15,620 | 1,659,187 | 0.95 | 188.70 | 2,947,539 | 313,093,399 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,291 | 175,253 | 0.74 | 188.70 | 243,615 | 33,070,749 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,505 | 1,643,567 | 0.83 | 188.46 | 2,545,218 | 309,754,690 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,117 | 173,962 | 0.65 | 188.46 | 210,515 | 32,785,731 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,011 | 1,630,062 | 0.80 | 188.32 | 2,450,273 | 306,978,492 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,076 | 172,845 | 0.63 | 188.32 | 202,636 | 32,550,724 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,712 | 1,617,051 | 0.29 | 187.27 | 882,420 | 302,826,273 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 388 | 171,769 | 0.23 | 187.27 | 72,661 | 32,167,301 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,124 | 1,612,339 | 0.13 | 187.24 | 397,706 | 301,900,642 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 171,381 | 0.10 | 187.24 | 32,955 | 32,090,047 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,385 | 1,610,215 | 0.09 | 186.59 | 258,431 | 300,454,847 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 115 | 171,205 | 0.07 | 186.59 | 21,458 | 31,945,655 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 647 | 1,608,830 | 0.04 | 186.32 | 120,547 | 299,752,540 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 171,090 | 0.03 | 186.32 | 9,875 | 31,876,993 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 369 | 1,608,183 | 0.02 | 183.16 | 67,586 | 294,554,798 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31 | 171,037 | 0.02 | 183.16 | 5,678 | 31,327,137 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 146 | 1,607,814 | 0.01 | 185.94 | 27,148 | 298,963,688 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12 | 171,006 | 0.01 | 185.94 | 2,231 | 31,797,574 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,022 | 1,607,668 | 0.19 | 189.70 | 573,267 | 304,971,083 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 250 | 170,994 | 0.15 | 189.70 | 47,424 | 32,437,186 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,147 | 1,604,646 | 0.07 | 188.84 | 216,595 | 303,014,772 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 95 | 170,744 | 0.06 | 188.84 | 17,939 | 32,242,597 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,895 | 1,603,499 | 0.31 | 187.34 | 917,054 | 300,407,520 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 405 | 170,649 | 0.24 | 187.34 | 75,875 | 31,970,237 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,206 | 1,598,604 | 0.08 | 185.86 | 224,153 | 297,124,532 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 100 | 170,244 | 0.06 | 185.86 | 18,586 | 31,642,401 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,010 | 1,597,398 | 0.44 | 183.40 | 1,285,633 | 292,962,633 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 579 | 170,144 | 0.34 | 183.40 | 106,189 | 31,204,393 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,847 | 1,590,388 | 0.12 | 181.93 | 336,025 | 289,339,289 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 153 | 169,565 | 0.09 | 181.93 | 27,835 | 30,848,960 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,715 | 1,588,541 | 0.68 | 175.82 | 1,883,889 | 279,293,943 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 903 | 169,412 | 0.54 | 175.82 | 158,764 | 29,785,662 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,923 | 1,577,826 | 0.31 | 175.72 | 865,062 | 277,253,218 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 415 | 168,509 | 0.25 | 175.72 | 72,923 | 29,610,149 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 18,125 | 1,572,903 | 1.17 | 174.87 | 3,169,606 | 275,061,098 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,528 | 168,094 | 0.92 | 174.87 | 267,209 | 29,395,405 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 978 | 1,554,778 | 0.06 | 174.67 | 170,827 | 271,572,762 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 82 | 166,566 | 0.05 | 174.67 | 14,323 | 29,094,050 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,660 | 1,553,800 | 0.11 | 173.75 | 288,422 | 269,969,798 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 140 | 166,484 | 0.08 | 173.75 | 24,325 | 28,926,279 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,151 | 1,552,140 | 0.27 | 173.20 | 718,960 | 268,833,131 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 350 | 166,344 | 0.21 | 173.20 | 60,621 | 28,811,047 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 461 | 1,547,989 | 0.03 | 171.79 | 79,195 | 265,929,030 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 39 | 165,994 | 0.02 | 171.79 | 6,700 | 28,516,109 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,107 | 1,547,528 | 0.07 | 168.78 | 186,842 | 261,195,645 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 165,955 | 0.06 | 168.78 | 15,697 | 28,010,300 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1,546,421 | 0.04 | 167.63 | 108,289 | 259,226,552 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 165,862 | 0.03 | 167.63 | 9,052 | 27,803,447 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,548 | 1,500,227 | 0.91 | 154.78 | 2,096,961 | 232,205,285 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,142 | 161,969 | 0.71 | 154.78 | 176,759 | 25,069,578 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,098 | 1,486,679 | 0.55 | 153.97 | 1,246,878 | 228,909,318 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 683 | 160,827 | 0.43 | 153.97 | 105,164 | 24,763,112 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,877 | 1,478,581 | 0.19 | 153.25 | 440,907 | 226,595,939 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 242 | 160,144 | 0.15 | 153.25 | 37,087 | 24,542,436 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1,475,704 | 0.04 | 152.21 | 98,330 | 224,621,185 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 159,902 | 0.03 | 152.21 | 8,219 | 24,339,147 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6,022 | 1,475,058 | 0.41 | 152.48 | 918,235 | 224,916,844 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 507 | 159,848 | 0.32 | 152.48 | 77,307 | 24,373,623 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,542 | 1,469,036 | 0.24 | 154.60 | 547,582 | 227,108,412 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 299 | 159,341 | 0.19 | 154.60 | 46,224 | 24,633,625 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26,426 | 1,465,494 | 1.84 | 146.21 | 3,863,756 | 214,270,464 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,228 | 159,042 | 1.42 | 146.21 | 325,757 | 23,253,594 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,994 | 1,439,068 | 0.21 | 145.98 | 437,057 | 210,071,549 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 252 | 156,814 | 0.16 | 145.98 | 36,786 | 22,891,316 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6,369 | 1,436,074 | 0.45 | 145.46 | 926,430 | 208,890,175 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 537 | 156,562 | 0.34 | 145.46 | 78,112 | 22,773,383 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,291 | 1,429,705 | 0.09 | 142.86 | 184,429 | 204,244,082 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 109 | 156,025 | 0.07 | 142.86 | 15,571 | 22,289,341 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,790 | 1,428,414 | 0.76 | 141.44 | 1,526,192 | 202,042,018 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 910 | 155,916 | 0.59 | 141.44 | 128,715 | 22,053,539 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,072 | 1,417,624 | 0.36 | 140.90 | 714,657 | 199,746,624 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 427 | 155,006 | 0.28 | 140.90 | 60,165 | 21,840,717 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,631 | 1,412,552 | 0.33 | 137.69 | 637,622 | 194,487,928 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 390 | 154,579 | 0.25 | 137.69 | 53,697 | 21,283,287 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,693 | 1,407,921 | 0.26 | 136.91 | 505,605 | 192,756,915 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 311 | 154,189 | 0.20 | 136.91 | 42,579 | 21,109,846 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,144 | 1,404,228 | 0.22 | 136.18 | 428,151 | 191,228,471 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 265 | 153,878 | 0.17 | 136.18 | 36,088 | 20,955,183 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14,018 | 1,545,775 | 0.92 | 161.97 | 2,270,439 | 250,362,994 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,181 | 165,808 | 0.72 | 161.97 | 191,282 | 26,855,259 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31,530 | 1,531,757 | 2.10 | 156.42 | 4,932,061 | 239,604,170 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,658 | 164,627 | 1.64 | 156.42 | 415,776 | 25,751,680 | |
| 2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1,008,660 | 9,691,294 | -9.43 | 180.50 | -182,063,130 | 1,749,278,567 | |
| 2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -91,340 | 877,603 | -9.43 | 180.50 | -16,486,870 | 158,407,342 | |
| 2023-10-23 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
S - Sale | -251,902 | 2,971,128 | -7.82 | 0.40 | -101,391 | 1,195,879 | |
| 2023-10-23 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
S - Sale | -22,837 | 286,893 | -7.37 | 0.40 | -9,192 | 115,474 | |
| 2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 535,601 | 1,658,190 | 47.71 | ||||
| 2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 57,049 | 155,874 | 57.73 | ||||
| 2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 33,446,882 | 0.00 | ||||
| 2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 2,968,974 | 0.02 | ||||
| 2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,896,968 | 0.02 | ||||
| 2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 274,560 | 0.20 | ||||
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 61,134 | 5,612,949 | 1.10 | 0.69 | 42,354 | 3,888,651 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 5,041 | 494,133 | 1.03 | 0.69 | 3,492 | 342,335 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 93,091 | 5,551,815 | 1.71 | 0.69 | 64,456 | 3,844,077 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 7,676 | 489,092 | 1.59 | 0.69 | 5,315 | 338,647 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4,434 | 5,458,724 | 0.08 | 0.68 | 3,028 | 3,727,217 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 366 | 481,416 | 0.08 | 0.68 | 250 | 328,711 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 207,676 | 5,454,290 | 3.96 | 0.68 | 141,324 | 3,711,644 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 17,124 | 481,050 | 3.69 | 0.68 | 11,653 | 327,355 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4,342 | 5,246,614 | 0.08 | 0.66 | 2,887 | 3,488,998 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 358 | 463,926 | 0.08 | 0.66 | 238 | 308,511 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 1,740,581 | 5,242,272 | 49.71 | 0.63 | 1,097,958 | 3,306,825 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 143,519 | 463,568 | 44.84 | 0.63 | 90,532 | 292,419 | |
| 2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33,446,372 | 0.00 | ||||
| 2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33,446,372 | 0.00 | ||||
| 2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,896,414 | 0.02 | ||||
| 2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,896,414 | 0.02 | ||||
| 2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
148,821 | ||||||||
| 2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
1,396,292 | ||||||||
| 2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,792 | 1,401,084 | 0.34 | ||||
| 2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,792 | 1,401,084 | 0.34 | ||||
| 2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25,844 | 93,417 | 38.25 | ||||
| 2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25,844 | 93,417 | 38.25 | ||||
| 2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,505 | 33,445,860 | 0.01 | ||||
| 2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,505 | 33,445,860 | 0.01 | ||||
| 2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8,746 | 2,719,343 | 0.32 | ||||
| 2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8,746 | 2,719,343 | 0.32 | ||||
| 2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13,304 | 39,330,977 | 0.03 | ||||
| 2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13,304 | 39,330,977 | 0.03 | ||||
| 2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2,044 | 42,977,301 | 0.00 | ||||
| 2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2,044 | 42,977,301 | 0.00 | ||||
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 259,109 | 39,317,673 | 0.66 | 25.65 | 6,646,146 | 1,008,498,312 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,113 | 3,610,443 | 0.67 | 25.65 | 618,498 | 92,607,863 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28,878 | 39,058,564 | 0.07 | 25.51 | 736,788 | 996,532,390 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,688 | 3,586,330 | 0.08 | 25.51 | 68,581 | 91,500,906 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218,171 | 39,029,686 | 0.56 | 25.27 | 5,513,683 | 986,369,933 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 20,304 | 3,583,642 | 0.57 | 25.27 | 513,129 | 90,566,876 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 74,582 | 38,811,515 | 0.19 | 25.54 | 1,904,824 | 991,246,093 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6,941 | 3,563,338 | 0.20 | 25.54 | 177,273 | 91,007,653 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 116,672 | 38,736,933 | 0.30 | 25.33 | 2,955,325 | 981,214,260 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10,858 | 3,556,397 | 0.31 | 25.33 | 275,035 | 90,084,247 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12,500 | 38,620,261 | 0.03 | 17.01 | 212,625 | 656,930,640 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12,500 | 38,620,261 | 0.03 | 17.01 | 212,625 | 656,930,640 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 40,632 | 38,607,761 | 0.11 | 24.80 | 1,007,674 | 957,472,473 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,781 | 3,533,039 | 0.11 | 24.80 | 93,769 | 87,619,367 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 82,148 | 38,567,129 | 0.21 | 24.46 | 2,009,373 | 943,367,402 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,645 | 3,529,258 | 0.22 | 24.46 | 187,000 | 86,327,062 | |
| 2023-05-05 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
21,912 | ||||||||
| 2023-05-05 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
227,211 | ||||||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209,175 | 23,277 | -89.99 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209,175 | 23,277 | -89.99 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209,175 | 232,452 | 898.63 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209,175 | 232,452 | 898.63 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | -2,368,357 | 1,729,158 | -57.80 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8,750 | 42,975,257 | 0.02 | 36.70 | 321,125 | 1,577,191,932 | |
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8,750 | 42,975,257 | 0.02 | 36.70 | 321,125 | 1,577,191,932 | |
| 2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33,443,355 | 0.00 | ||||
| 2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33,443,355 | 0.00 | ||||
| 2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,895,860 | 0.02 | ||||
| 2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,895,860 | 0.02 | ||||
| 2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,442,926 | 0.06 | 22.74 | 454,800 | 760,492,137 | |
| 2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,442,926 | 0.06 | 22.74 | 454,800 | 760,492,137 | |
| 2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15,000 | 38,484,981 | 0.04 | 5.22 | 78,300 | 200,891,601 | |
| 2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15,000 | 38,484,981 | 0.04 | 5.22 | 78,300 | 200,891,601 | |
| 2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33,422,926 | 0.00 | ||||
| 2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33,422,926 | 0.00 | ||||
| 2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33,422,529 | 0.00 | ||||
| 2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33,422,529 | 0.00 | ||||
| 2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33,422,072 | 0.00 | ||||
| 2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33,422,072 | 0.00 | ||||
| 2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10,000 | 2,710,597 | 0.37 | ||||
| 2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10,000 | 2,710,597 | 0.37 | ||||
| 2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33,384 | 67,573 | 97.65 | ||||
| 2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33,384 | 67,569 | 97.66 | ||||
| 2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,144 | 33,421,639 | 0.01 | ||||
| 2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,144 | 33,421,639 | 0.01 | ||||
| 2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 10,622,568 | 14,575,984 | 268.69 | ||||
| 2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 1,252,432 | 1,585,054 | 376.53 | ||||
| 2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17,104 | 38,469,981 | 0.04 | ||||
| 2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17,104 | 38,469,981 | 0.04 | ||||
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 26,450 | 4,501,658 | 0.59 | 6.42 | 169,849 | 28,907,397 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 3,118 | 364,161 | 0.86 | 6.42 | 20,022 | 2,338,460 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,815 | 4,475,208 | 0.17 | 6.35 | 49,654 | 28,434,129 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 921 | 361,043 | 0.26 | 6.35 | 5,852 | 2,293,959 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,364 | 4,467,393 | 0.05 | 5.82 | 13,759 | 26,001,121 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 279 | 360,122 | 0.08 | 5.82 | 1,624 | 2,095,982 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 170,549 | 15,967,504 | 1.08 | 7.78 | 1,327,008 | 124,239,955 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 20,108 | 1,342,986 | 1.52 | 7.78 | 156,456 | 10,449,505 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 101,315 | 15,796,955 | 0.65 | 7.75 | 785,070 | 122,407,445 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,945 | 1,322,878 | 0.91 | 7.75 | 92,559 | 10,250,717 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 78,271 | 15,695,640 | 0.50 | 7.95 | 622,466 | 124,822,716 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,224 | 1,310,933 | 0.71 | 7.95 | 73,356 | 10,425,457 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13,155 | 15,617,369 | 0.08 | 7.93 | 104,363 | 123,897,273 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,550 | 1,301,709 | 0.12 | 7.93 | 12,297 | 10,326,848 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 138,122 | 15,604,214 | 0.89 | 7.68 | 1,060,680 | 119,829,441 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16,278 | 1,300,159 | 1.27 | 7.68 | 125,004 | 9,984,311 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,585 | 15,466,092 | 0.07 | 7.51 | 79,540 | 116,218,402 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,247 | 1,283,881 | 0.10 | 7.51 | 9,370 | 9,647,595 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 88,046 | 15,455,507 | 0.57 | 6.92 | 609,278 | 106,952,108 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,386 | 1,282,634 | 0.82 | 6.92 | 71,871 | 8,875,827 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 51,082 | 15,367,461 | 0.33 | 6.78 | 346,367 | 104,200,606 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,026 | 1,272,248 | 0.48 | 6.78 | 40,860 | 8,626,605 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 358 | 15,316,379 | 0.00 | 6.64 | 2,375 | 101,624,175 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42 | 1,266,222 | 0.00 | 6.64 | 279 | 8,401,383 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 984 | 15,316,021 | 0.01 | 6.76 | 6,647 | 103,459,722 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116 | 1,266,180 | 0.01 | 6.76 | 784 | 8,553,046 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 53,401 | 15,315,037 | 0.35 | 6.75 | 360,521 | 103,394,878 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,299 | 1,266,064 | 0.50 | 6.75 | 42,526 | 8,547,451 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29,090 | 15,261,636 | 0.19 | 6.71 | 195,089 | 102,350,636 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,432 | 1,259,765 | 0.27 | 6.71 | 23,016 | 8,448,488 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42,250 | 15,232,546 | 0.28 | 6.60 | 279,002 | 100,589,641 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,984 | 1,256,333 | 0.40 | 6.60 | 32,912 | 8,296,321 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 48,222 | 15,190,296 | 0.32 | 6.53 | 315,058 | 99,245,799 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,688 | 1,251,349 | 0.46 | 6.53 | 37,163 | 8,175,689 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 19,789 | 4,465,029 | 0.45 | 5.74 | 113,619 | 25,635,964 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,334 | 359,843 | 0.65 | 5.74 | 13,401 | 2,066,039 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1,521 | 4,445,240 | 0.03 | 5.93 | 9,020 | 26,360,273 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 179 | 357,509 | 0.05 | 5.93 | 1,061 | 2,120,028 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,010 | 4,443,719 | 0.16 | 5.99 | 41,972 | 26,606,323 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 827 | 357,330 | 0.23 | 5.99 | 4,952 | 2,139,478 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,772 | 4,436,709 | 0.18 | 5.84 | 45,405 | 25,919,698 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 946 | 356,503 | 0.27 | 5.84 | 5,527 | 2,082,726 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,248 | 4,428,937 | 0.16 | 5.84 | 42,335 | 25,868,978 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 883 | 355,557 | 0.25 | 5.84 | 5,158 | 2,076,773 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,489 | 15,142,074 | 0.05 | 5.97 | 44,701 | 90,381,525 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 1,245,661 | 0.07 | 5.97 | 5,444 | 7,435,226 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 182,827 | 15,134,585 | 1.22 | 5.97 | 1,091,221 | 90,332,284 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,266 | 1,244,749 | 1.82 | 5.97 | 132,897 | 7,429,409 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,157 | 14,951,758 | 0.06 | 5.95 | 54,518 | 89,018,282 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,115 | 1,222,483 | 0.09 | 5.95 | 6,638 | 7,278,297 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 90,674 | 14,942,601 | 0.61 | 5.99 | 542,929 | 89,471,812 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,043 | 1,221,368 | 0.91 | 5.99 | 66,122 | 7,313,185 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,118 | 14,851,927 | 0.05 | 5.99 | 48,599 | 88,912,546 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 989 | 1,210,325 | 0.08 | 5.99 | 5,921 | 7,245,732 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15,154 | 14,843,809 | 0.10 | 5.75 | 87,098 | 85,314,792 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,846 | 1,209,336 | 0.15 | 5.75 | 10,610 | 6,950,659 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 93,690 | 14,828,655 | 0.64 | 5.71 | 534,979 | 84,673,103 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,410 | 1,207,490 | 0.95 | 5.71 | 65,152 | 6,894,889 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 30,003 | 4,421,689 | 0.68 | 6.00 | 180,018 | 26,530,134 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 3,654 | 354,674 | 1.04 | 6.00 | 21,924 | 2,128,044 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 692 | 4,391,686 | 0.02 | 5.92 | 4,095 | 25,989,998 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 84 | 351,020 | 0.02 | 5.92 | 497 | 2,077,336 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 16,501 | 4,390,994 | 0.38 | 6.13 | 101,153 | 26,917,232 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,010 | 350,936 | 0.58 | 6.13 | 12,322 | 2,151,273 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 16,937 | 4,374,493 | 0.39 | 5.83 | 98,673 | 25,485,359 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,063 | 348,926 | 0.59 | 5.83 | 12,019 | 2,032,808 | |
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3,676 | 3,676 | |||||
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,503 | 42,966,507 | 0.00 | ||||
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,503 | 42,966,507 | 0.00 | ||||
| 2022-05-16 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25,000 | 25,000 | |||||
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 22,983 | 2,528,583 | 0.92 | 1.99 | 45,628 | 5,019,996 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 2,882 | 256,209 | 1.14 | 1.99 | 5,722 | 508,652 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 758,094 | 2,505,600 | 43.38 | 1.95 | 1,478,283 | 4,885,920 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 95,060 | 253,327 | 60.06 | 1.95 | 185,367 | 493,988 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 101,831 | 1,747,506 | 6.19 | 1.93 | 196,962 | 3,380,026 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 12,769 | 158,267 | 8.78 | 1.93 | 24,698 | 306,120 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 325,373 | 1,645,675 | 24.64 | 1.70 | 553,134 | 2,797,648 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 40,800 | 145,498 | 38.97 | 1.70 | 69,360 | 247,347 | |
| 2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 2,592,497 | 4,674,392 | 124.53 | 23.00 | 59,627,431 | 107,511,016 | |
| 2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 233,590 | 421,532 | 124.29 | 23.00 | 5,372,570 | 9,695,236 | |
| 2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33,419,495 | 0.00 | ||||
| 2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33,419,495 | 0.00 | ||||
| 2022-03-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 29,497 | 29,497 | |||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 42,965,004 | 0.04 | 20.06 | 351,050 | 861,877,980 | |
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 42,965,004 | 0.04 | 20.06 | 351,050 | 861,877,980 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 175,795 | 33,419,055 | 0.53 | 73.31 | 12,887,303 | 2,449,907,477 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 14,490 | 2,941,147 | 0.50 | 73.31 | 1,062,243 | 215,611,663 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,017 | 33,243,260 | 0.00 | 71.95 | 73,177 | 2,391,975,557 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 84 | 2,926,657 | 0.00 | 71.95 | 6,044 | 210,583,800 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25,107 | 33,242,243 | 0.08 | 71.90 | 1,805,126 | 2,390,027,518 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,070 | 2,926,573 | 0.07 | 71.90 | 148,827 | 210,412,697 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65,147 | 33,217,136 | 0.20 | 71.72 | 4,672,408 | 2,382,366,211 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5,370 | 2,924,503 | 0.18 | 71.72 | 385,142 | 209,748,280 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92,385 | 33,151,989 | 0.28 | 70.68 | 6,529,310 | 2,343,016,823 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,615 | 2,919,133 | 0.26 | 70.68 | 538,190 | 206,309,725 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,059,604 | 0.06 | 22.05 | 441,000 | 728,964,268 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,059,604 | 0.06 | 22.05 | 441,000 | 728,964,268 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92,234 | 33,039,604 | 0.28 | 68.07 | 6,278,507 | 2,249,055,404 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,566 | 2,891,518 | 0.26 | 68.07 | 515,029 | 196,829,968 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 22,178 | 32,947,370 | 0.07 | 68.43 | 1,517,656 | 2,254,611,592 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,827 | 2,883,952 | 0.06 | 68.43 | 125,023 | 197,350,854 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 100,731 | 32,925,192 | 0.31 | 68.37 | 6,886,696 | 2,251,003,187 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8,296 | 2,882,125 | 0.29 | 68.37 | 567,174 | 197,042,816 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 285,672 | 32,824,461 | 0.88 | 67.74 | 19,352,821 | 2,223,689,828 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,300 | 32,538,789 | 0.02 | 67.40 | 491,984 | 2,192,951,685 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 271,997 | 14,734,965 | 1.88 | 54.57 | 14,843,883 | 804,141,559 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,403 | 1,196,080 | 1.91 | 54.57 | 1,222,615 | 65,274,511 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,174 | 14,462,968 | 0.04 | 53.82 | 278,457 | 778,376,690 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 426 | 1,173,677 | 0.04 | 53.82 | 22,927 | 63,165,653 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 64,119 | 14,457,794 | 0.45 | 54.26 | 3,479,200 | 784,503,035 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,281 | 1,173,251 | 0.45 | 54.26 | 286,556 | 63,662,476 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 23,804 | 14,393,675 | 0.17 | 53.73 | 1,279,048 | 773,408,142 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,961 | 1,167,970 | 0.17 | 53.73 | 105,369 | 62,757,948 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,359 | 14,369,871 | 0.04 | 54.16 | 290,217 | 778,200,364 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 441 | 1,166,009 | 0.04 | 54.16 | 23,882 | 63,145,217 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 182,326 | 32,531,489 | 0.56 | 66.04 | 12,040,390 | 2,148,304,711 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 320,526 | 32,349,163 | 1.00 | 66.02 | 21,159,973 | 2,135,575,284 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10,985 | 32,028,637 | 0.03 | 66.95 | 735,433 | 2,144,278,813 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 265,522 | 32,017,652 | 0.84 | 66.81 | 17,740,295 | 2,139,192,181 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 772,751 | 31,752,130 | 2.49 | 67.54 | 52,192,839 | 2,144,589,664 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,100 | 30,979,379 | 0.02 | 67.20 | 409,899 | 2,081,705,841 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 40,164 | 30,973,279 | 0.13 | 66.57 | 2,673,577 | 2,061,782,777 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 27,841 | 14,364,512 | 0.19 | 57.22 | 1,593,076 | 821,944,559 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,307 | 1,165,568 | 0.20 | 57.22 | 132,008 | 66,694,384 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,526 | 14,336,671 | 0.08 | 51.61 | 594,898 | 739,967,202 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 953 | 1,163,261 | 0.08 | 51.61 | 49,188 | 60,040,088 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17,119 | 14,325,145 | 0.12 | 50.56 | 865,460 | 724,214,868 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,414 | 1,162,308 | 0.12 | 50.56 | 71,485 | 58,761,062 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,395 | 14,308,026 | 0.16 | 49.70 | 1,113,056 | 711,124,631 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,851 | 1,160,894 | 0.16 | 49.70 | 91,997 | 57,697,709 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 54,024 | 14,285,631 | 0.38 | 51.67 | 2,791,490 | 738,157,125 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,465 | 1,159,043 | 0.39 | 51.67 | 230,712 | 59,889,259 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 117,291 | 14,231,607 | 0.83 | 51.59 | 6,050,820 | 734,181,565 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86,479 | 14,114,316 | 0.62 | 52.04 | 4,500,497 | 734,530,176 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,500 | 14,027,837 | 0.04 | 58.90 | 323,934 | 826,198,919 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 57,547 | 14,022,337 | 0.41 | 58.87 | 3,387,844 | 825,507,599 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,350 | 13,964,790 | 0.07 | 58.76 | 549,368 | 820,513,805 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 132,367 | 13,955,440 | 0.96 | 58.13 | 7,693,938 | 811,171,114 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 25,900 | 13,823,073 | 0.19 | 57.59 | 1,491,519 | 796,037,599 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116,083 | 13,797,173 | 0.85 | 56.86 | 6,601,060 | 784,576,243 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,200 | 13,681,090 | 0.01 | 56.60 | 67,914 | 774,281,289 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19,750 | 13,679,890 | 0.14 | 56.39 | 1,113,649 | 771,372,061 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 31,207 | 13,660,140 | 0.23 | 57.53 | 1,795,292 | 785,847,364 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 102,207 | 13,628,933 | 0.76 | 56.57 | 5,782,279 | 771,045,981 | |
| 2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30,933,115 | 0.00 | ||||
| 2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30,933,115 | 0.00 | ||||
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 193,997 | 30,932,696 | 0.63 | 72.91 | 14,144,224 | 2,255,287,399 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 881,875 | 30,738,699 | 2.95 | 72.77 | 64,177,924 | 2,236,990,377 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 29,703 | 29,856,824 | 0.10 | 72.00 | 2,138,616 | 2,149,691,328 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 139,612 | 29,827,121 | 0.47 | 71.96 | 10,045,795 | 2,146,213,474 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 288,368 | 29,687,509 | 0.98 | 71.91 | 20,736,197 | 2,134,793,147 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5,382 | 29,399,141 | 0.02 | 71.03 | 382,302 | 2,088,323,882 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9,893 | 29,393,759 | 0.03 | 70.24 | 694,840 | 2,064,485,360 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 36,476 | 29,383,866 | 0.12 | 69.63 | 2,539,700 | 2,045,898,684 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9,352 | 29,347,390 | 0.03 | 68.52 | 640,841 | 2,011,015,226 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 861 | 29,338,038 | 0.00 | 67.90 | 58,460 | 1,991,999,972 | |
| 2021-12-16 | 3 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
346,863 | ||||||||
| 2021-12-16 | 3 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
4,357,556 | ||||||||
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -51,399 | 42,947,504 | -0.12 | 161.39 | -8,295,146 | 6,931,181,712 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -4,738 | 4,069,762 | -0.12 | 161.39 | -764,653 | 656,807,901 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -8,332 | 42,998,903 | -0.02 | 161.34 | -1,344,327 | 6,937,658,005 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -768 | 4,074,500 | -0.02 | 161.34 | -123,913 | 657,400,202 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -25,833 | 43,007,235 | -0.06 | 160.80 | -4,154,029 | 6,915,701,011 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2,381 | 4,075,268 | -0.06 | 160.80 | -382,872 | 655,316,135 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1,007 | 43,033,068 | 0.00 | 165.68 | -166,844 | 7,129,895,142 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -93 | 4,077,649 | 0.00 | 165.68 | -15,409 | 675,601,605 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -9,618 | 43,034,075 | -0.02 | 164.82 | -1,585,266 | 7,092,996,737 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -886 | 4,077,742 | -0.02 | 164.82 | -146,033 | 672,104,854 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1,337 | 43,043,693 | 0.00 | 163.39 | -218,449 | 7,032,809,999 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -123 | 4,078,628 | 0.00 | 163.39 | -20,097 | 666,397,648 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -20,154 | 43,045,030 | -0.05 | 160.96 | -3,243,986 | 6,928,523,724 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1,858 | 4,078,751 | -0.05 | 160.96 | -299,063 | 656,515,353 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -29,432 | 43,065,184 | -0.07 | 160.53 | -4,724,631 | 6,913,124,792 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2,713 | 4,080,609 | -0.07 | 160.53 | -435,510 | 655,047,921 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -5,860 | 43,094,616 | -0.01 | 160.08 | -938,044 | 6,898,400,822 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -540 | 4,083,322 | -0.01 | 160.08 | -86,441 | 653,640,627 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -208,597 | 43,100,476 | -0.48 | 160.00 | -33,375,520 | 6,896,076,160 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -19,226 | 4,083,862 | -0.47 | 160.00 | -3,076,160 | 653,417,920 | |
| 2021-11-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 50,000 | 7,053,176 | 0.71 | 4.36 | 218,250 | 30,787,113 | |
| 2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29,337,177 | 0.00 | ||||
| 2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29,337,177 | 0.00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86,932 | 13,526,726 | 0.65 | 95.83 | 8,330,572 | 1,296,247,215 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -138,815 | 0 | -100.00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -11,184 | 0 | -100.00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -14 | 13,439,794 | 0.00 | 102.00 | -1,428 | 1,370,858,988 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 138,815 | 13,439,808 | 1.04 | 0.01 | 1,388 | 134,398 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -2 | 1,154,578 | 0.00 | 102.00 | -204 | 117,766,956 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 11,184 | 1,154,580 | 0.98 | 0.01 | 112 | 11,546 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,153 | 13,300,993 | 0.01 | 94.59 | 109,064 | 1,258,164,870 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,299,840 | 0.00 | 94.48 | 37,791 | 1,256,535,634 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30,285 | 13,299,440 | 0.23 | 94.38 | 2,858,425 | 1,255,257,005 | |
| 2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 52,201 | 13,269,155 | 0.39 | 93.35 | 4,872,948 | 1,238,671,639 | |
| 2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,300 | 13,216,954 | 0.04 | 92.88 | 492,279 | 1,227,629,017 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 73,635 | 13,211,654 | 0.56 | 87.61 | 6,451,464 | 1,157,527,175 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,396 | 13,138,019 | 0.02 | 87.48 | 209,607 | 1,149,341,492 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,649 | 13,135,623 | 0.04 | 87.07 | 404,793 | 1,143,731,830 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,968 | 13,130,974 | 0.02 | 86.94 | 258,033 | 1,141,587,183 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,128,006 | 0.00 | 89.66 | 35,863 | 1,177,008,444 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,100 | 13,127,606 | 0.01 | 88.16 | 96,982 | 1,157,395,383 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,186 | 13,126,506 | 0.06 | 87.91 | 719,659 | 1,153,995,773 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12,898 | 13,118,320 | 0.10 | 87.79 | 1,132,303 | 1,151,644,194 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,764 | 13,105,422 | 0.06 | 85.95 | 667,333 | 1,126,439,853 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,097,658 | 0.00 | 84.80 | 33,921 | 1,110,714,143 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,097,258 | 0.00 | 88.82 | 35,526 | 1,163,232,969 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16,269 | 13,096,858 | 0.12 | 88.76 | 1,444,017 | 1,162,461,400 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21,595 | 13,080,589 | 0.17 | 88.59 | 1,913,036 | 1,158,770,138 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,086 | 13,058,994 | 0.05 | 88.01 | 535,634 | 1,149,333,815 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,600 | 13,052,908 | 0.04 | 86.44 | 397,646 | 1,128,354,716 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 300 | 13,048,308 | 0.00 | 85.58 | 25,674 | 1,116,674,199 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,500 | 13,048,008 | 0.03 | 88.00 | 395,990 | 1,148,195,998 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 44,700 | 13,043,508 | 0.34 | 86.07 | 3,847,481 | 1,122,699,081 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 600 | 12,998,808 | 0.00 | 85.72 | 51,434 | 1,114,295,518 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,723 | 12,998,208 | 0.03 | 84.39 | 314,185 | 1,096,922,673 | |
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 3,960,811 | 3,960,811 | |||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -3,960,811 | 0 | -100.00 | ||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 315,777 | 315,777 | |||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -315,777 | 0 | -100.00 | ||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 1,320,302 | 1,320,302 | 15.00 | 19,804,530 | 19,804,530 | ||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 104,698 | 104,698 | 15.00 | 1,570,470 | 1,570,470 | ||
| 2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29,336,784 | 0.00 | ||||
| 2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29,336,784 | 0.00 | ||||
| 2021-07-01 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 66,474 | 66,474 | |||||
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7,368 | 7,368 | |||||
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 121,612 | 12,994,485 | 0.94 | 92.75 | 11,279,014 | 1,205,185,206 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,009 | 12,872,873 | 0.05 | 91.64 | 642,276 | 1,179,617,303 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,353 | 12,865,864 | 0.17 | 90.20 | 2,016,332 | 1,160,553,683 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,603 | 12,843,511 | 0.04 | 89.74 | 413,070 | 1,152,566,402 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30,221 | 12,838,908 | 0.24 | 90.70 | 2,741,157 | 1,164,536,460 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,200 | 12,808,687 | 0.01 | 90.40 | 108,474 | 1,157,841,261 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,731 | 12,807,487 | 0.09 | 90.39 | 1,060,378 | 1,157,682,838 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,847 | 12,795,756 | 0.03 | 89.90 | 345,828 | 1,150,282,163 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,079 | 12,791,909 | 0.06 | 89.87 | 636,196 | 1,149,620,375 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,459 | 12,784,830 | 0.08 | 91.87 | 960,845 | 1,174,514,205 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,445 | 12,774,371 | 0.18 | 91.80 | 2,060,393 | 1,172,654,044 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,170 | 12,751,926 | 0.08 | 90.76 | 923,046 | 1,157,386,482 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,200 | 12,741,756 | 0.04 | 90.27 | 469,420 | 1,150,237,814 | |
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 23,274 | 23,274 | |||||
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12,782 | 38,452,877 | 0.03 | ||||
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12,782 | 38,452,877 | 0.03 | ||||
| 2021-06-22 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
A - Award | 23,344 | 23,344 | |||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34,996 | 34,996 | |||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15,600 | 34,189 | 83.92 | ||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15,600 | 34,189 | 83.92 | ||||
| 2021-06-10 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 40,000 | 40,000 | |||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 8,010 | 8,010 | |||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,923 | 29,336,439 | 0.01 | ||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,923 | 29,336,439 | 0.01 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3,462 | 3,462 | |||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,402 | 43,309,073 | 0.00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,402 | 43,309,073 | 0.00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 43,307,671 | 0.04 | 19.02 | 332,850 | 823,711,902 | |
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 43,307,671 | 0.04 | 19.02 | 332,850 | 823,711,902 | |
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,334,516 | 0.07 | 18.97 | 379,400 | 556,475,769 | |
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 2,870,749 | 0.70 | 18.97 | 379,400 | 54,458,109 | |
| 2021-05-13 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25,000 | 25,000 | |||||
| 2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,314,516 | 0.00 | ||||
| 2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,314,516 | 0.00 | ||||
| 2021-02-25 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 47,200 | 47,200 | |||||
| 2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
315,516 | ||||||||
| 2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
3,094,590 | ||||||||
| 2021-02-23 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 6,423 | 6,423 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6,427,576 | 27,511,741 | 30.49 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536,438 | 2,345,481 | 29.65 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7,286,794 | 21,084,165 | 52.81 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536,414 | 1,809,043 | 42.15 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 1,941 | 5,420 | 55.79 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6,654,603 | 13,797,371 | 93.17 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 598,860 | 1,272,629 | 88.88 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7,142,768 | 7,142,768 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 673,769 | 673,769 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 3,479 | 3,479 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -9,191,433 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -767,106 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -10,420,117 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -767,072 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-1 Convertible Preferred Stock |
M - Exercise | -2,776 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -9,516,082 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -856,370 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -10,214,159 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -963,490 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -4,975 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 5,792,538 | 7,003,176 | 478.47 | 16.00 | 92,680,608 | 112,050,816 | |
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 457,462 | 571,659 | 400.59 | 16.00 | 7,319,392 | 9,146,544 | |
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 9,191,433 | 9,191,433 | 8.55 | 78,586,752 | 78,586,752 | ||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 767,106 | 767,106 | 8.55 | 6,558,756 | 6,558,756 | ||
| 2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158,456 | 23,277 | -87.19 | ||||
| 2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158,460 | 23,280 | -87.19 | ||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
590 | ||||||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
114,197 | ||||||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
1,210,638 | ||||||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,188 | 41,500 | -11.11 | ||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,188 | 41,500 | -11.11 | ||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5,188 | 9,252,951 | 0.06 | 12.85 | 66,666 | 118,900,420 | |
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5,188 | 9,252,951 | 0.06 | 12.85 | 66,666 | 118,900,420 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,833 | 2,527 | -69.77 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,833 | 2,527 | -69.77 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,377 | 6,723 | -44.44 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,377 | 6,723 | -44.44 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,833 | 2,895,306 | 0.20 | 40.27 | 234,895 | 116,593,973 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,833 | 2,895,306 | 0.20 | 40.27 | 234,895 | 116,593,973 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,377 | 2,889,473 | 0.19 | 16.00 | 86,032 | 46,231,568 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,377 | 2,889,473 | 0.19 | 16.00 | 86,032 | 46,231,568 | |
| 2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 154,222 | 5,212,371 | 3.05 | 60.00 | 9,253,320 | 312,742,260 | |
| 2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 12,444 | 509,480 | 2.50 | 60.00 | 746,640 | 30,568,800 | |
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
332,622 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
3,953,416 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
1,200,369 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
13,413,895 | ||||||||
| 2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -111,094 | 10,699,954 | -1.03 | 220.50 | -24,496,227 | 2,359,339,857 | |
| 2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -10,060 | 968,943 | -1.03 | 220.50 | -2,218,230 | 213,651,932 | |
| 2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,884,096 | 0.01 | ||||
| 2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,884,096 | 0.01 | ||||
| 2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29,314,152 | 0.00 | ||||
| 2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29,314,152 | 0.00 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 518,555 | 10,283,888 | 5.31 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 38,974 | 1,199,122 | 3.36 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 394,360 | 3,501,691 | 12.69 | 15.25 | 6,013,990 | 53,400,788 | |
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 29,640 | 320,049 | 10.21 | 15.25 | 452,010 | 4,880,747 | |
| 2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 616,846 | 616,846 | 89.99 | 55,509,972 | 55,509,972 | ||
| 2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 49,820 | 49,820 | 89.99 | 4,483,302 | 4,483,302 | ||
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1,386,033 | 10,811,048 | -11.36 | 220.50 | -305,620,276 | 2,383,836,084 | |
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -125,513 | 979,003 | -11.36 | 220.50 | -27,675,616 | 215,870,162 | |
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13,516 | 10,418 | -56.47 | ||||
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13,516 | 10,418 | -56.47 | ||||
| 2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,411,619 | 12,736,556 | 12.46 | 108.00 | 152,454,852 | 1,375,548,048 | |
| 2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116,158 | 1,143,396 | 11.31 | 108.00 | 12,545,064 | 123,486,768 | |
| 2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,873 | 0.01 | ||||
| 2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,873 | 0.01 | ||||
| 2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29,313,809 | 0.00 | ||||
| 2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29,313,809 | 0.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 382,884 | 5,058,149 | 8.19 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -382,884 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 30,349 | 497,036 | 6.50 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -30,349 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -574,327 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -45,524 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 2,698,424 | 4,675,265 | 136.50 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -2,698,424 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 247,034 | 466,687 | 112.47 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -247,034 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -4,047,634 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -370,552 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 1,976,841 | 1,976,841 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -1,976,841 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 219,653 | 219,653 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -219,653 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -2,965,263 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -329,478 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 1,474,319 | 9,247,763 | 18.97 | 19.00 | 28,012,061 | 175,707,497 | |
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 104,628 | 870,873 | 13.65 | 19.00 | 1,987,932 | 16,546,587 | |
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 574,327 | 7,773,444 | 7.98 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 45,524 | 766,245 | 6.32 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 4,047,634 | 7,199,117 | 128.44 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 370,552 | 720,721 | 105.82 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 2,965,263 | 3,151,483 | 1,592.34 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 329,478 | 350,169 | 1,592.37 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Option (right to buy) |
A - Award | 46,688 | 46,688 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 957,211 | 957,211 | 14.52 | 13,898,321 | 13,898,321 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 75,873 | 75,873 | 14.52 | 1,101,646 | 1,101,646 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 3,373,029 | 3,373,029 | 3.93 | 13,264,099 | 13,264,099 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 308,793 | 308,793 | 3.93 | 1,214,298 | 1,214,298 | ||
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,843 | 11,324,937 | 0.07 | 58.09 | 455,565 | 657,814,628 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 557 | 1,027,238 | 0.05 | 58.09 | 32,354 | 59,667,633 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19,235 | 11,317,094 | 0.17 | 56.92 | 1,094,854 | 644,167,859 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,365 | 1,026,681 | 0.13 | 56.92 | 77,696 | 58,438,580 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,705 | 11,297,859 | 0.04 | 56.76 | 267,055 | 641,265,347 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 334 | 1,025,316 | 0.03 | 56.76 | 18,958 | 58,196,834 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13,153 | 11,293,154 | 0.12 | 55.35 | 728,057 | 625,108,824 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 933 | 1,024,982 | 0.09 | 55.35 | 51,644 | 56,735,726 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29,327 | 11,280,001 | 0.26 | 52.11 | 1,528,374 | 587,856,124 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,081 | 1,024,049 | 0.20 | 52.11 | 108,451 | 53,368,211 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,306 | 11,250,674 | 0.04 | 51.41 | 221,368 | 578,388,150 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 306 | 1,021,968 | 0.03 | 51.41 | 15,731 | 52,538,557 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 74,381 | 11,246,368 | 0.67 | 52.44 | 3,900,235 | 589,713,428 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,278 | 1,021,662 | 0.52 | 52.44 | 276,757 | 53,571,766 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,467 | 11,171,987 | 0.09 | 52.40 | 548,468 | 585,408,767 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 743 | 1,016,384 | 0.07 | 52.40 | 38,933 | 53,258,217 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,120 | 11,161,520 | 0.01 | 51.97 | 58,206 | 580,064,194 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 80 | 1,015,641 | 0.01 | 51.97 | 4,158 | 52,782,863 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,361 | 11,160,400 | 0.20 | 51.98 | 1,162,235 | 580,072,950 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,587 | 1,015,561 | 0.16 | 51.98 | 82,486 | 52,784,799 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 36,647 | 11,138,039 | 0.33 | 50.15 | 1,837,909 | 558,591,591 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,601 | 1,013,974 | 0.26 | 50.15 | 130,445 | 50,852,520 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,983 | 11,101,392 | 0.10 | 49.72 | 546,102 | 551,988,964 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 779 | 1,011,373 | 0.08 | 49.72 | 38,734 | 50,287,994 | |
| 2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
20,691 | ||||||||
| 2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
186,220 | ||||||||
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15,172 | 11,090,409 | 0.14 | 47.47 | 720,200 | 526,450,625 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,220 | 1,010,594 | 0.12 | 47.47 | 57,912 | 47,971,887 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 76,473 | 11,075,237 | 0.70 | 47.39 | 3,623,857 | 524,826,686 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,151 | 1,009,374 | 0.61 | 47.39 | 291,480 | 47,831,609 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15,807 | 10,998,764 | 0.14 | 47.04 | 743,482 | 517,326,865 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,272 | 1,003,223 | 0.13 | 47.04 | 59,829 | 47,186,594 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 10,982,957 | 0.00 | 45.88 | 8,487 | 503,843,152 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15 | 1,001,951 | 0.00 | 45.88 | 688 | 45,964,502 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,101 | 10,982,772 | 0.08 | 47.50 | 432,281 | 521,661,901 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 712 | 1,001,936 | 0.07 | 47.50 | 33,819 | 47,590,157 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 26,238 | 10,973,671 | 0.24 | 47.26 | 1,239,984 | 518,605,815 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,054 | 1,001,224 | 0.21 | 47.26 | 97,070 | 47,316,945 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29,319 | 10,947,433 | 0.27 | 46.62 | 1,366,767 | 510,337,579 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,295 | 999,170 | 0.23 | 46.62 | 106,986 | 46,578,408 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12,132 | 10,918,114 | 0.11 | 45.30 | 549,535 | 494,550,167 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 950 | 996,875 | 0.10 | 45.30 | 43,031 | 45,154,749 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 32,088 | 10,905,982 | 0.30 | 49.00 | 1,572,312 | 534,393,118 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,512 | 995,925 | 0.25 | 49.00 | 123,088 | 48,800,325 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 77,456 | 10,873,894 | 0.72 | 47.60 | 3,686,658 | 517,562,558 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,062 | 993,413 | 0.61 | 47.60 | 288,532 | 47,283,280 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,987 | 10,796,438 | 0.03 | 47.45 | 141,725 | 512,260,753 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 234 | 987,351 | 0.02 | 47.45 | 11,103 | 46,847,040 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,359 | 10,793,451 | 0.02 | 46.97 | 110,798 | 506,947,886 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 987,117 | 0.02 | 46.97 | 8,689 | 46,363,010 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 83,832 | 10,791,092 | 0.78 | 49.08 | 4,114,734 | 529,660,248 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,645 | 986,932 | 0.68 | 49.08 | 326,157 | 48,441,682 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,286 | 10,707,260 | 0.02 | 48.74 | 111,430 | 521,922,177 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 181 | 980,287 | 0.02 | 48.74 | 8,823 | 47,783,796 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42,714 | 10,704,974 | 0.40 | 47.74 | 2,039,256 | 511,077,939 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,386 | 980,106 | 0.35 | 47.74 | 161,655 | 46,792,319 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 754 | 10,662,260 | 0.01 | 47.82 | 36,058 | 509,896,995 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 60 | 976,720 | 0.01 | 47.82 | 2,869 | 46,709,290 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 41,155 | 10,661,506 | 0.39 | 47.72 | 1,963,970 | 508,780,926 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,262 | 976,660 | 0.34 | 47.72 | 155,667 | 46,607,485 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,640 | 10,620,351 | 0.10 | 46.50 | 494,716 | 493,802,778 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 843 | 973,398 | 0.09 | 46.50 | 39,196 | 45,259,016 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,576 | 10,609,711 | 0.03 | 46.30 | 165,575 | 491,248,717 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 283 | 972,555 | 0.03 | 46.30 | 13,103 | 45,031,047 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,585 | 10,606,135 | 0.03 | 46.99 | 168,447 | 498,345,162 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 284 | 972,272 | 0.03 | 46.99 | 13,344 | 45,683,658 | |
| 2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1,335,362 | 11,638,314 | 12.96 | 21.00 | 28,042,602 | 244,404,594 | |
| 2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 93,210 | 1,143,650 | 8.87 | 21.00 | 1,957,410 | 24,016,650 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 728,370 | 6,173,327 | 13.38 | 16.00 | 11,653,920 | 98,773,232 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 52,880 | 542,114 | 10.81 | 16.00 | 846,080 | 8,673,824 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 728,370 | 6,173,327 | 13.38 | 16.00 | 11,653,920 | 98,773,232 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 52,880 | 542,114 | 10.81 | 16.00 | 846,080 | 8,673,824 | |
| 2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 13,589,904 | 18,840,379 | 258.83 | 14.23 | 193,395,206 | 268,113,665 | |
| 2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 994,276 | 1,021,851 | 3,605.72 | 14.23 | 14,149,343 | 14,541,757 | |
| 2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,650 | 0.01 | ||||
| 2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,650 | 0.01 | ||||
| 2020-07-02 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7,106 | 7,106 | |||||
| 2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29,313,492 | 0.00 | ||||
| 2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29,313,492 | 0.00 | ||||
| 2020-07-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37,520 | 37,520 | |||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 11,158 | 11,158 | |||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6,118 | 38,440,095 | 0.02 | ||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6,118 | 38,440,095 | 0.02 | ||||
| 2020-06-19 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 90,766 | 90,766 | |||||
| 2020-06-10 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 4,135 | 4,135 | |||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29,313,198 | 0.00 | 102.55 | 103 | 3,006,068,455 | |
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29,313,198 | 0.00 | 102.55 | 103 | 3,006,068,455 | |
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 10,514 | 10,514 | |||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,282 | 29,313,197 | 0.00 | ||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,282 | 29,313,197 | 0.00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 3,171 | 3,171 | |||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1,335 | 43,290,171 | 0.00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1,335 | 43,290,171 | 0.00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1,602,312 | 43,288,836 | -3.57 | 160.00 | -256,369,920 | 6,926,213,760 | |
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -147,688 | 4,082,851 | -3.49 | 160.00 | -23,630,080 | 653,256,160 | |
| 2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1,465,603 | 10,302,952 | 16.58 | 18.25 | 26,747,255 | 188,028,874 | |
| 2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 134,397 | 1,050,440 | 14.67 | 18.25 | 2,452,745 | 19,170,530 | |
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,189 | 7,846,213 | 0.02 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,189 | 7,846,213 | 0.02 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,468 | 7,845,024 | 0.04 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,468 | 7,845,024 | 0.04 | ||||
| 2020-05-12 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 9,000 | 9,000 | |||||
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -457,803 | 44,891,148 | -1.01 | 158.50 | -72,561,776 | 7,115,246,958 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -42,197 | 4,230,539 | -0.99 | 158.50 | -6,688,224 | 670,540,432 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4,343 | 45,348,951 | -0.01 | 166.15 | -721,610 | 7,534,941,349 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -400 | 4,272,736 | -0.01 | 166.15 | -66,462 | 709,935,168 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -48,880 | 45,353,294 | -0.11 | 164.96 | -8,063,118 | 7,481,361,460 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4,505 | 4,273,136 | -0.11 | 164.96 | -743,133 | 704,885,404 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -84,663 | 45,402,174 | -0.19 | 164.19 | -13,901,157 | 7,454,764,558 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -7,805 | 4,277,641 | -0.18 | 164.19 | -1,281,534 | 702,362,986 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16,159 | 45,486,837 | -0.04 | 163.41 | -2,640,610 | 7,433,195,079 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1,489 | 4,285,446 | -0.03 | 163.41 | -243,324 | 700,302,730 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -41,072 | 45,502,996 | -0.09 | 166.62 | -6,843,564 | 7,581,873,004 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -3,786 | 4,286,935 | -0.09 | 166.62 | -630,837 | 714,304,543 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -91,613 | 45,544,068 | -0.20 | 165.70 | -15,180,641 | 7,546,834,244 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -8,444 | 4,290,721 | -0.20 | 165.70 | -1,399,205 | 710,989,633 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -178,862 | 45,635,681 | -0.39 | 164.60 | -29,440,041 | 7,511,468,804 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16,485 | 4,299,165 | -0.38 | 164.60 | -2,713,372 | 707,627,082 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -45,606 | 45,814,543 | -0.10 | 164.06 | -7,482,107 | 7,516,320,180 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4,204 | 4,315,650 | -0.10 | 164.06 | -689,707 | 708,024,244 | |
| 2020-05-07 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25,000 | 25,000 | |||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,311,915 | 0.07 | 13.34 | 266,800 | 391,020,946 | |
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,311,915 | 0.07 | 13.34 | 266,800 | 391,020,946 | |
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17,500 | 45,860,149 | 0.04 | 12.76 | 223,300 | 585,175,501 | |
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17,500 | 45,860,149 | 0.04 | 12.76 | 223,300 | 585,175,501 | |
| 2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,427 | 0.01 | ||||
| 2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,427 | 0.01 | ||||
| 2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29,291,915 | 0.00 | 73.23 | 28,706 | 2,145,046,935 | |
| 2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29,291,915 | 0.00 | 73.23 | 28,706 | 2,145,046,935 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 42,473 | 38,433,977 | 0.11 | 34.47 | 1,463,896 | 1,324,684,668 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,837 | 3,470,609 | 0.11 | 34.47 | 132,248 | 119,619,745 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 33,464 | 38,391,504 | 0.09 | 33.63 | 1,125,465 | 1,291,186,902 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,023 | 3,466,772 | 0.09 | 33.63 | 101,670 | 116,594,823 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,201 | 38,358,040 | 0.01 | 32.85 | 72,302 | 1,260,053,942 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 199 | 3,463,749 | 0.01 | 32.85 | 6,537 | 113,783,462 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 46,225 | 38,355,839 | 0.12 | 32.61 | 1,507,268 | 1,250,676,513 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,175 | 3,463,550 | 0.12 | 32.61 | 136,135 | 112,936,668 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 275 | 38,309,614 | 0.00 | 31.94 | 8,782 | 1,223,417,523 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25 | 3,459,375 | 0.00 | 31.94 | 798 | 110,475,141 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 93,006 | 38,309,339 | 0.24 | 33.86 | 3,149,406 | 1,297,246,161 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8,402 | 3,459,350 | 0.24 | 33.86 | 284,512 | 117,141,893 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,223 | 38,216,333 | 0.06 | 32.32 | 782,873 | 1,235,128,953 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,188 | 3,450,948 | 0.06 | 32.32 | 70,715 | 111,532,569 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 29,624 | 38,192,110 | 0.08 | 32.19 | 953,620 | 1,229,434,575 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,676 | 3,448,760 | 0.08 | 32.19 | 86,143 | 111,018,343 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,612 | 38,162,486 | 0.02 | 31.83 | 242,290 | 1,214,711,929 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 688 | 3,446,084 | 0.02 | 31.83 | 21,899 | 109,688,854 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43,212 | 38,154,874 | 0.11 | 31.74 | 1,371,359 | 1,210,867,819 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,903 | 3,445,396 | 0.11 | 31.74 | 123,864 | 109,341,709 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,913 | 38,111,662 | 0.01 | 31.00 | 121,285 | 1,181,290,020 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 353 | 3,441,493 | 0.01 | 31.00 | 10,941 | 106,670,796 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 631,281 | 38,107,749 | 1.68 | 31.51 | 19,893,937 | 1,200,912,359 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 57,022 | 3,441,140 | 1.68 | 31.51 | 1,796,968 | 108,442,710 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,503 | 37,476,468 | 0.01 | 31.19 | 171,613 | 1,168,714,898 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 497 | 3,384,118 | 0.01 | 31.19 | 15,499 | 105,534,735 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,172 | 10,602,550 | 0.09 | 38.38 | 352,019 | 406,922,688 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 971,988 | 0.09 | 38.38 | 31,778 | 37,304,608 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,237 | 10,593,378 | 0.06 | 37.75 | 235,433 | 399,876,714 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 563 | 971,160 | 0.06 | 37.75 | 21,252 | 36,659,153 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17,058 | 10,587,141 | 0.16 | 36.69 | 625,914 | 388,477,141 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,542 | 970,597 | 0.16 | 36.69 | 56,581 | 35,614,407 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,172 | 10,570,083 | 0.09 | 38.98 | 357,570 | 412,074,686 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 969,055 | 0.09 | 38.98 | 32,280 | 37,778,609 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 95,934 | 10,560,911 | 0.92 | 39.97 | 3,834,588 | 422,131,230 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,666 | 968,227 | 0.90 | 39.97 | 346,390 | 38,701,098 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14,731 | 7,841,556 | 0.19 | 83.14 | 1,224,797 | 651,979,900 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,331 | 994,296 | 0.13 | 83.14 | 110,665 | 82,669,945 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,321 | 7,826,825 | 0.02 | 82.92 | 109,537 | 648,995,633 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 119 | 992,965 | 0.01 | 82.92 | 9,867 | 82,336,062 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15,928 | 7,825,504 | 0.20 | 82.13 | 1,308,149 | 642,700,035 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,439 | 992,846 | 0.15 | 82.13 | 118,183 | 81,541,350 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 25,640 | 7,809,576 | 0.33 | 81.79 | 2,097,003 | 638,717,107 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,314 | 991,407 | 0.23 | 81.79 | 189,254 | 81,083,609 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,203 | 7,783,936 | 0.05 | 81.47 | 342,438 | 634,193,850 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 380 | 989,093 | 0.04 | 81.47 | 30,960 | 80,586,055 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12,815 | 7,779,733 | 0.16 | 81.09 | 1,039,177 | 630,863,995 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,158 | 988,713 | 0.12 | 81.09 | 93,903 | 80,175,429 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,298 | 7,766,918 | 0.04 | 80.91 | 266,845 | 628,431,432 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 298 | 987,555 | 0.03 | 80.91 | 24,112 | 79,904,359 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,285 | 7,763,620 | 0.13 | 79.87 | 821,429 | 620,054,709 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 929 | 987,257 | 0.09 | 79.87 | 74,196 | 78,848,959 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26,022 | 7,753,335 | 0.34 | 79.72 | 2,074,362 | 618,062,527 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,351 | 986,328 | 0.24 | 79.72 | 187,412 | 78,625,827 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,888 | 7,727,313 | 0.04 | 79.29 | 228,980 | 612,673,148 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 261 | 983,977 | 0.03 | 79.29 | 20,694 | 78,016,289 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,191 | 7,724,425 | 0.05 | 79.16 | 331,760 | 611,467,028 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 379 | 983,716 | 0.04 | 79.16 | 30,002 | 77,871,155 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 565 | 7,720,234 | 0.01 | 78.66 | 44,443 | 607,273,606 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 51 | 983,337 | 0.01 | 78.66 | 4,012 | 77,349,288 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 65,505 | 7,719,669 | 0.86 | 76.67 | 5,022,445 | 591,887,865 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,917 | 983,286 | 0.61 | 76.67 | 453,672 | 75,391,192 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 27,866 | 7,654,164 | 0.37 | 76.10 | 2,120,480 | 582,448,202 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,517 | 977,369 | 0.26 | 76.10 | 191,533 | 74,373,480 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 62,129 | 7,626,298 | 0.82 | 79.76 | 4,955,720 | 608,311,660 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,612 | 974,852 | 0.58 | 79.76 | 447,641 | 77,759,070 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 133,042 | 7,564,169 | 1.79 | 79.14 | 10,529,170 | 598,641,194 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12,017 | 969,240 | 1.26 | 79.14 | 951,046 | 76,707,301 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,612 | 7,431,127 | 0.10 | 77.94 | 593,260 | 579,163,461 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 688 | 957,223 | 0.07 | 77.94 | 53,621 | 74,603,568 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,309 | 7,423,515 | 0.11 | 77.89 | 647,203 | 578,230,946 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 750 | 956,535 | 0.08 | 77.89 | 58,419 | 74,506,233 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 32,228 | 7,415,206 | 0.44 | 75.66 | 2,438,422 | 561,046,350 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,911 | 955,785 | 0.31 | 75.66 | 220,251 | 72,316,222 | |
| 2020-03-16 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 18,000 | 18,000 | |||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 82,740 | 10,464,977 | 0.80 | 57.82 | 4,783,944 | 605,074,505 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,460 | 959,561 | 0.78 | 57.82 | 431,330 | 55,480,857 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,989 | 10,382,237 | 0.09 | 59.61 | 535,824 | 618,873,727 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 811 | 952,101 | 0.09 | 59.61 | 48,343 | 56,753,693 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14,631 | 10,373,248 | 0.14 | 59.99 | 877,642 | 622,240,319 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,319 | 951,290 | 0.14 | 59.99 | 79,120 | 57,063,226 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 145,994 | 10,358,617 | 1.43 | 57.68 | 8,421,518 | 597,526,463 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13,164 | 949,971 | 1.41 | 57.68 | 759,352 | 54,798,127 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14,051 | 10,212,623 | 0.14 | 57.22 | 803,980 | 584,353,012 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,267 | 936,807 | 0.14 | 57.22 | 72,496 | 53,602,879 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14,402 | 10,198,572 | 0.14 | 58.80 | 846,819 | 599,662,775 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,298 | 935,540 | 0.14 | 58.80 | 76,321 | 55,008,536 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,623 | 10,184,170 | 0.08 | 60.77 | 524,043 | 618,919,508 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 777 | 934,242 | 0.08 | 60.77 | 47,220 | 56,776,409 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,788 | 10,175,547 | 0.07 | 58.54 | 397,393 | 595,711,118 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 612 | 933,465 | 0.07 | 58.54 | 35,829 | 54,648,215 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,122 | 10,168,759 | 0.07 | 58.39 | 415,826 | 593,714,180 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 642 | 932,853 | 0.07 | 58.39 | 37,484 | 54,465,649 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,577 | 10,161,637 | 0.04 | 57.62 | 206,108 | 585,517,589 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 323 | 932,211 | 0.03 | 57.62 | 18,611 | 53,714,371 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21,301 | 10,158,060 | 0.21 | 56.69 | 1,207,513 | 575,841,121 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,921 | 931,888 | 0.21 | 56.69 | 108,898 | 52,826,960 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,804 | 10,136,759 | 0.06 | 56.62 | 328,631 | 573,958,500 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 523 | 929,967 | 0.06 | 56.62 | 29,613 | 52,656,126 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,121 | 10,130,955 | 0.10 | 56.25 | 569,277 | 569,836,839 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 929,444 | 0.10 | 56.25 | 51,297 | 52,278,530 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 92 | 10,120,834 | 0.00 | 55.45 | 5,102 | 561,225,547 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8 | 928,532 | 0.00 | 55.45 | 444 | 51,489,421 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,813 | 10,120,742 | 0.02 | 55.77 | 101,117 | 564,468,192 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 164 | 928,524 | 0.02 | 55.77 | 9,147 | 51,786,940 | |
| 2020-02-07 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 10,000 | 10,000 | |||||
| 2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29,291,523 | 0.00 | 87.32 | 27,593 | 2,557,735,788 | |
| 2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29,291,523 | 0.00 | 87.32 | 27,593 | 2,557,735,788 | |
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 9,765,333 | 9,765,333 | |||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 1,160,148 | 1,161,048 | 128,905.33 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -9,765,333 | 3,107,331 | -75.86 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -1,160,148 | 290,409 | -79.98 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 2,767,505 | 12,872,664 | 27.39 | 8.40 | 23,247,042 | 108,130,378 | |
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 250,037 | 1,450,557 | 20.83 | 8.40 | 2,100,311 | 12,184,679 | |
| 2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,743,993 | 10,118,929 | 20.82 | 46.00 | 80,223,678 | 465,470,734 | |
| 2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 158,180 | 928,360 | 20.54 | 46.00 | 7,276,280 | 42,704,560 | |
| 2019-10-15 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 22,000 | 22,000 | |||||
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7,642,042 | 0.00 | 67.28 | 24,894 | 514,156,586 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7,642,042 | 0.00 | 67.28 | 24,894 | 514,156,586 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 1,217,279 | 0.03 | 67.28 | 24,894 | 81,898,531 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 244,595 | 0.15 | 67.28 | 24,894 | 16,456,352 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 160,223 | 0.23 | 67.28 | 24,894 | 10,779,803 | |
| 2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,291,207 | 0.00 | 74.23 | 27,020 | 2,174,286,296 | |
| 2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,291,207 | 0.00 | 74.23 | 27,020 | 2,174,286,296 | |
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 2,081,895 | 2,081,895 | |||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -2,081,895 | 0 | -100.00 | ||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 187,942 | 187,942 | |||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -187,942 | 0 | -100.00 | ||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 2,883,204 | 2,883,204 | 16.00 | 46,131,264 | 46,131,264 | ||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 260,796 | 260,796 | 16.00 | 4,172,736 | 4,172,736 | ||
| 2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,494,025 | 37,470,965 | 4.15 | 40.00 | 59,761,000 | 1,498,838,600 | |
| 2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 68,475 | 3,383,621 | 2.07 | 40.00 | 2,739,000 | 135,344,840 | |
| 2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
X - Other | -1 | 138,815 | 0.00 | ||||
| 2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
X - Other | 1 | 8,374,936 | 0.00 | 0.01 | 0 | 83,749 | |
| 2019-09-19 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 12,100 | 12,100 | |||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95,289 | 0 | -100.00 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95,289 | 0 | -100.00 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8,341 | 95,289 | 9.59 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8,340 | 95,289 | 9.59 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -8,866 | 43,361 | -16.98 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -7,815 | 165,610 | -4.51 | ||||
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 50,436 | 10,105,159 | 0.50 | 3.15 | 159,020 | 31,860,556 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,564 | 1,200,520 | 0.38 | 3.15 | 14,390 | 3,785,120 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 209,382 | 10,054,723 | 2.13 | 3.02 | 633,255 | 30,409,504 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 18,943 | 1,195,956 | 1.61 | 3.02 | 57,291 | 3,617,049 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,869 | 9,845,341 | 0.06 | 2.96 | 17,358 | 29,118,581 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 531 | 1,177,013 | 0.05 | 2.96 | 1,570 | 3,481,134 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 65,568 | 9,839,472 | 0.67 | 2.85 | 186,666 | 28,011,993 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,932 | 1,176,482 | 0.51 | 2.85 | 16,888 | 3,349,327 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,445 | 9,773,904 | 0.10 | 2.83 | 26,756 | 27,687,515 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 855 | 1,170,550 | 0.07 | 2.83 | 2,422 | 3,315,934 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7,641,672 | 0.01 | 58.86 | 24,957 | 449,788,814 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7,641,672 | 0.01 | 58.86 | 24,957 | 449,788,814 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 1,390,806 | 0.03 | 58.86 | 24,957 | 81,862,841 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 418,122 | 0.10 | 58.86 | 24,957 | 24,610,661 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 333,750 | 0.13 | 58.86 | 24,957 | 19,644,525 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 226,124 | 0.19 | 58.86 | 24,957 | 13,309,659 | |
| 2019-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,964 | 4,290,995 | 0.07 | 2.61 | 7,736 | 11,199,497 | |
| 2019-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,964 | 4,290,995 | 0.07 | 2.61 | 7,736 | 11,199,497 | |
| 2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29,290,843 | 0.00 | 84.96 | 26,338 | 2,488,550,021 | |
| 2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29,290,843 | 0.00 | 84.96 | 26,338 | 2,488,550,021 | |
| 2019-06-28 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
P - Purchase | 1,904,850 | 5,444,957 | 53.81 | 17.00 | 32,382,450 | 92,564,269 | |
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
P - Purchase | 95,150 | 489,234 | 24.14 | 17.00 | 1,617,550 | 8,316,978 | |
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
C - Conversion | 3,540,107 | 3,540,107 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series C2 Preferred Stock |
C - Conversion | -3,540,107 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
C - Conversion | 394,084 | 394,084 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series C2 Preferred Stock |
C - Conversion | -394,084 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series B Preferred Stock |
C - Conversion | -920,361 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series B Preferred Stock |
C - Conversion | -89,878 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series A Preferred Stock |
C - Conversion | -2,302,669 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series A Preferred Stock |
C - Conversion | -219,852 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
C - Conversion | 3,223,030 | 3,223,030 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
C - Conversion | 309,730 | 309,730 | |||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 13,166 | 13,166 | |||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 7,641,248 | 0.03 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 7,641,248 | 0.03 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 1,390,382 | 0.14 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 417,698 | 0.46 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 333,326 | 0.58 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 225,700 | 0.85 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74,229 | 181,733 | 69.05 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74,229 | 181,733 | 69.05 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -1,002,483 | 4,302,354 | -18.90 | ||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14,840 | 14,840 | |||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14,840 | 14,840 | |||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | -200,423 | 98,980 | -66.94 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31,229 | 102,876 | 43.59 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31,229 | 102,876 | 43.59 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -421,756 | 3,315,146 | -11.29 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 880 | 880 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 880 | 880 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 1,660 | 1,660 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 1,660 | 1,660 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 6,256 | 6,256 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 6,256 | 6,256 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -6,009 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -11,337 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -42,724 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | 21,929 | 21,929 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | 21,929 | 21,929 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -59,267 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -178,967 | 347,757 | -33.98 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43,109 | 43,109 | |||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43,109 | 43,109 | |||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | -582,200 | 18,591 | -96.91 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13,516 | 20,618 | 190.31 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13,516 | 20,618 | 190.31 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -182,539 | 1,028,034 | -15.08 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Shares Option (Right to Buy) |
A - Award | 129,220 | 129,220 | |||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220,141 | 281,190 | 360.60 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220,141 | 281,190 | 360.60 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -692,706 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -1,603,238 | 2,826,766 | -36.19 | ||||
| 2019-06-05 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 24,747 | 24,747 | |||||
| 2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37,520 | 37,520 | |||||
| 2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37,520 | 37,520 | |||||
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22,720 | 7,382,978 | -0.31 | 120.77 | -2,743,928 | 891,653,328 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2,729 | 952,874 | -0.29 | 120.77 | -329,585 | 115,080,022 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -13,213 | 7,405,698 | -0.18 | 122.31 | -1,616,054 | 905,775,370 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1,587 | 955,603 | -0.17 | 122.31 | -194,103 | 116,877,796 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15,355 | 7,418,911 | -0.21 | 120.12 | -1,844,459 | 891,167,750 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1,845 | 957,190 | -0.19 | 120.12 | -221,623 | 114,978,716 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -35,796 | 7,434,266 | -0.48 | 122.37 | -4,380,432 | 909,746,742 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4,300 | 959,035 | -0.45 | 122.37 | -526,200 | 117,359,127 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -30,766 | 7,470,062 | -0.41 | 123.06 | -3,786,036 | 919,259,107 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3,696 | 963,335 | -0.38 | 123.06 | -454,826 | 118,547,138 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -39,732 | 7,500,828 | -0.53 | 121.37 | -4,822,189 | 910,359,743 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4,772 | 967,031 | -0.49 | 121.37 | -579,168 | 117,366,522 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -71,819 | 7,540,560 | -0.94 | 127.06 | -9,125,258 | 958,096,767 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -8,627 | 971,803 | -0.88 | 127.06 | -1,096,139 | 123,476,415 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22,886 | 7,612,379 | -0.30 | 125.05 | -2,861,901 | 951,930,278 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2,749 | 980,430 | -0.28 | 125.05 | -343,763 | 122,603,066 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15,541 | 7,635,265 | -0.20 | 126.25 | -1,962,085 | 963,969,004 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1,867 | 983,179 | -0.19 | 126.25 | -235,713 | 124,128,512 | |
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7,038 | 7,038 | |||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7,038 | 7,038 | |||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2,963 | 45,842,649 | 0.01 | ||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2,963 | 45,842,649 | 0.01 | ||||
| 2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,726 | 7,650,806 | 0.04 | ||||
| 2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,726 | 7,650,806 | 0.04 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 45,839,686 | 0.02 | 8.38 | 83,800 | 384,136,569 | |
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 45,839,686 | 0.02 | 8.38 | 83,800 | 384,136,569 | |
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12,472 | 12,472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12,472 | 12,472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12,472 | 12,472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,520 | 812,602 | 0.19 | ||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,520 | 812,602 | 0.19 | ||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,520 | 812,602 | 0.19 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 529,758 | 529,758 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series D Preferred Stock |
C - Conversion | -529,758 | 0 | -100.00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 60,194 | 60,194 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series D Preferred Stock |
C - Conversion | -60,194 | 0 | -100.00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 2,905,359 | 2,905,359 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series C Preferred Stock |
C - Conversion | -2,905,359 | 0 | -100.00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 324,421 | 324,421 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series C Preferred Stock |
C - Conversion | -324,421 | 0 | -100.00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Common Stock |
P - Purchase | 820,729 | 820,729 | 14.00 | 11,490,206 | 11,490,206 | ||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Common Stock |
P - Purchase | 72,128 | 72,128 | 14.00 | 1,009,792 | 1,009,792 | ||
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,232 | 7,639,338 | -0.12 | 65.32 | -603,070 | 499,031,352 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,417 | 1,214,575 | -0.12 | 65.32 | -92,564 | 79,340,776 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -244 | 241,891 | -0.10 | 65.32 | -15,939 | 15,801,263 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -142 | 157,519 | -0.09 | 65.32 | -9,276 | 10,289,755 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 49,893 | -0.02 | 65.32 | -719 | 3,259,205 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -158 | 171,091 | -0.09 | 65.32 | -10,321 | 11,176,331 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63,775 | 7,648,570 | -0.83 | 67.13 | -4,281,177 | 513,443,915 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,791 | 1,215,992 | -0.80 | 67.13 | -657,264 | 81,628,813 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,688 | 242,135 | -0.69 | 67.13 | -113,314 | 16,254,377 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -979 | 157,661 | -0.62 | 67.13 | -65,720 | 10,583,688 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 49,904 | -0.15 | 67.13 | -4,968 | 3,350,026 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,093 | 171,249 | -0.63 | 67.13 | -73,372 | 11,495,843 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -173,085 | 7,712,345 | -2.19 | 64.62 | -11,184,701 | 498,369,420 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -26,575 | 1,225,783 | -2.12 | 64.62 | -1,717,269 | 79,209,730 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,581 | 243,823 | -1.84 | 64.62 | -296,023 | 15,755,769 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,656 | 158,640 | -1.65 | 64.62 | -171,630 | 10,251,269 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -202 | 49,978 | -0.40 | 64.62 | -13,053 | 3,229,563 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,966 | 172,342 | -1.69 | 64.62 | -191,662 | 11,136,688 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106,054 | 7,885,430 | -1.33 | 66.61 | -7,063,981 | 525,227,990 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16,282 | 1,252,358 | -1.28 | 66.61 | -1,084,502 | 83,416,310 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,807 | 248,404 | -1.12 | 66.61 | -186,967 | 16,545,545 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,628 | 161,296 | -1.00 | 66.61 | -108,437 | 10,743,507 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -124 | 50,180 | -0.25 | 66.61 | -8,259 | 3,342,359 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,817 | 175,308 | -1.03 | 66.61 | -121,026 | 11,676,810 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -60,618 | 7,991,484 | -0.75 | 67.42 | -4,086,914 | 538,792,244 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,307 | 1,268,640 | -0.73 | 67.42 | -627,485 | 85,532,724 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,604 | 251,211 | -0.63 | 67.42 | -108,143 | 16,936,847 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -930 | 162,924 | -0.57 | 67.42 | -62,701 | 10,984,466 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 50,304 | -0.14 | 67.42 | -4,787 | 3,391,536 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,039 | 177,125 | -0.58 | 67.42 | -70,050 | 11,941,909 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,832 | 8,052,102 | -0.13 | 69.12 | -748,735 | 556,581,420 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,663 | 1,277,947 | -0.13 | 69.12 | -114,951 | 88,334,892 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 252,815 | -0.11 | 69.12 | -19,838 | 17,475,205 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -166 | 163,854 | -0.10 | 69.12 | -11,474 | 11,325,998 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 50,375 | -0.03 | 69.12 | -899 | 3,482,046 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -185 | 178,164 | -0.10 | 69.12 | -12,788 | 12,315,141 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -102,618 | 8,062,934 | -1.26 | 68.70 | -7,049,918 | 553,928,404 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,755 | 1,279,610 | -1.22 | 68.70 | -1,082,378 | 87,909,975 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,716 | 253,102 | -1.06 | 68.70 | -186,591 | 17,388,259 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,575 | 164,020 | -0.95 | 68.70 | -108,203 | 11,268,272 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -120 | 50,388 | -0.24 | 68.70 | -8,244 | 3,461,686 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,758 | 178,349 | -0.98 | 68.70 | -120,776 | 12,252,683 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,543 | 8,165,552 | -0.19 | 67.68 | -1,051,888 | 552,611,897 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,386 | 1,295,365 | -0.18 | 67.68 | -161,475 | 87,665,122 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -411 | 255,818 | -0.16 | 67.68 | -27,815 | 17,312,739 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -239 | 165,595 | -0.14 | 67.68 | -16,175 | 11,206,807 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 50,508 | -0.04 | 67.68 | -1,218 | 3,418,179 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -266 | 180,107 | -0.15 | 67.68 | -18,002 | 12,188,921 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,813 | 8,181,095 | -0.02 | 67.87 | -123,047 | 555,244,373 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -278 | 1,297,751 | -0.02 | 67.87 | -18,868 | 88,077,322 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 256,229 | -0.02 | 67.87 | -3,258 | 17,390,057 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 165,834 | -0.02 | 67.87 | -1,900 | 11,255,021 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50,526 | 0.00 | 67.87 | -136 | 3,429,159 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31 | 180,373 | -0.02 | 67.87 | -2,104 | 12,241,771 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18,661 | 8,182,908 | -0.23 | 67.90 | -1,267,017 | 555,590,813 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,865 | 1,298,029 | -0.22 | 67.90 | -194,523 | 88,131,626 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -494 | 256,277 | -0.19 | 67.90 | -33,541 | 17,400,311 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 165,862 | -0.17 | 67.90 | -19,418 | 11,261,449 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 50,528 | -0.04 | 67.90 | -1,494 | 3,430,674 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -320 | 180,404 | -0.18 | 67.90 | -21,727 | 12,248,800 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42,863 | 8,201,569 | -0.52 | 68.72 | -2,945,370 | 563,578,195 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,581 | 1,300,894 | -0.50 | 68.72 | -452,219 | 89,392,102 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,134 | 256,771 | -0.44 | 68.72 | -77,924 | 17,644,250 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -658 | 166,148 | -0.39 | 68.72 | -45,215 | 11,417,009 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 50,550 | -0.10 | 68.72 | -3,436 | 3,473,589 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -734 | 180,724 | -0.40 | 68.72 | -50,437 | 12,418,612 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21,116 | 8,244,432 | -0.26 | 68.63 | -1,449,147 | 565,798,055 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,242 | 1,307,475 | -0.25 | 68.63 | -222,492 | 89,729,264 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 257,905 | -0.22 | 68.63 | -38,363 | 17,699,479 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -324 | 166,806 | -0.19 | 68.63 | -22,235 | 11,447,545 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 50,600 | -0.05 | 68.63 | -1,716 | 3,472,572 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -362 | 181,458 | -0.20 | 68.63 | -24,843 | 12,453,081 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66,784 | 8,265,548 | -0.80 | 66.64 | -4,450,459 | 550,812,813 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,253 | 1,310,717 | -0.78 | 66.64 | -683,256 | 87,345,657 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,768 | 258,464 | -0.68 | 66.64 | -117,819 | 17,223,938 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,025 | 167,130 | -0.61 | 66.64 | -68,306 | 11,137,476 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -78 | 50,625 | -0.15 | 66.64 | -5,198 | 3,373,630 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,145 | 181,820 | -0.63 | 66.64 | -76,302 | 12,116,412 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -80,146 | 8,332,332 | -0.95 | 68.90 | -5,521,963 | 574,087,676 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12,305 | 1,320,970 | -0.92 | 68.90 | -847,800 | 91,013,248 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,121 | 260,232 | -0.81 | 68.90 | -146,134 | 17,929,673 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,230 | 168,155 | -0.73 | 68.90 | -84,746 | 11,585,678 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -93 | 50,703 | -0.18 | 68.90 | -6,408 | 3,493,376 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,374 | 182,965 | -0.75 | 68.90 | -94,667 | 12,606,069 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,161 | 89,233 | 4.89 | 2.59 | 10,777 | 231,113 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,161 | 89,233 | 4.89 | 2.59 | 10,777 | 231,113 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,161 | 4,288,031 | 0.10 | 2.59 | 10,777 | 11,106,000 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8,412,478 | 0.00 | 66.84 | 19,918 | 562,290,030 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8,412,478 | 0.00 | 66.84 | 19,918 | 562,290,030 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 1,507,172 | 0.02 | 66.84 | 19,918 | 100,739,376 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 436,250 | 0.07 | 66.84 | 19,918 | 29,158,950 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 343,282 | 0.09 | 66.84 | 19,918 | 22,944,969 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 224,693 | 0.13 | 66.84 | 19,918 | 15,018,480 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811,082 | 0.03 | 86.01 | 18,922 | 69,761,163 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811,082 | 0.03 | 86.01 | 18,922 | 69,761,163 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811,082 | 0.03 | 86.01 | 18,922 | 69,761,163 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46,678 | 8,412,180 | -0.55 | 74.71 | -3,487,122 | 628,439,478 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,167 | 1,332,977 | -0.53 | 74.71 | -535,417 | 99,581,246 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,235 | 262,055 | -0.47 | 74.71 | -92,262 | 19,577,055 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -716 | 169,087 | -0.42 | 74.71 | -53,489 | 12,631,797 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55 | 50,498 | -0.11 | 74.71 | -4,109 | 3,772,499 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -800 | 184,041 | -0.43 | 74.71 | -59,765 | 13,748,949 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41,281 | 8,458,858 | -0.49 | 74.34 | -3,068,962 | 628,858,572 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,338 | 1,340,144 | -0.47 | 74.34 | -471,187 | 99,630,593 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,092 | 263,290 | -0.41 | 74.34 | -81,183 | 19,573,821 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169,803 | -0.37 | 74.34 | -47,134 | 12,623,698 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50,553 | -0.09 | 74.34 | -3,568 | 3,758,272 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184,841 | -0.38 | 74.34 | -52,561 | 13,741,671 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -86,620 | 8,500,139 | -1.01 | 74.63 | -6,464,529 | 634,373,024 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,298 | 1,346,482 | -0.98 | 74.63 | -992,442 | 100,489,163 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,293 | 264,382 | -0.86 | 74.63 | -171,129 | 19,731,067 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,329 | 170,437 | -0.77 | 74.63 | -99,184 | 12,719,867 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -101 | 50,601 | -0.20 | 74.63 | -7,538 | 3,776,398 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,485 | 185,548 | -0.79 | 74.63 | -110,827 | 13,847,614 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -90,251 | 8,586,759 | -1.04 | 74.19 | -6,695,487 | 637,029,325 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,856 | 1,359,780 | -1.01 | 74.19 | -1,027,941 | 100,878,543 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,388 | 266,675 | -0.89 | 74.19 | -177,160 | 19,783,925 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,385 | 171,766 | -0.80 | 74.19 | -102,750 | 12,742,873 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106 | 50,702 | -0.21 | 74.19 | -7,864 | 3,761,450 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,547 | 187,033 | -0.82 | 74.19 | -114,768 | 13,875,492 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -413 | 8,677,010 | 0.00 | 74.56 | -30,795 | 647,001,251 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 1,373,636 | 0.00 | 74.56 | -4,698 | 102,425,168 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 269,063 | 0.00 | 74.56 | -820 | 20,062,683 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 173,151 | 0.00 | 74.56 | -447 | 12,911,004 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 188,580 | 0.00 | 74.56 | -522 | 14,061,468 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42,124 | 8,677,423 | -0.48 | 74.50 | -3,138,238 | 646,468,014 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,467 | 1,373,699 | -0.47 | 74.50 | -481,792 | 102,340,576 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,115 | 269,074 | -0.41 | 74.50 | -83,068 | 20,046,013 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -647 | 173,157 | -0.37 | 74.50 | -48,202 | 12,900,196 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 50,808 | -0.10 | 74.50 | -3,650 | 3,785,196 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -722 | 188,587 | -0.38 | 74.50 | -53,789 | 14,049,732 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,068 | 8,719,547 | -0.04 | 76.57 | -234,915 | 667,649,610 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -471 | 1,380,166 | -0.03 | 76.57 | -36,064 | 105,678,345 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -81 | 270,189 | -0.03 | 76.57 | -6,202 | 20,688,183 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -47 | 173,804 | -0.03 | 76.57 | -3,599 | 13,308,051 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 50,857 | -0.01 | 76.57 | -306 | 3,894,085 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 189,309 | -0.03 | 76.57 | -3,982 | 14,495,258 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41,281 | 8,458,858 | -0.49 | 74.34 | -3,068,962 | 628,858,572 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,338 | 1,340,144 | -0.47 | 74.34 | -471,187 | 99,630,593 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,092 | 263,290 | -0.41 | 74.34 | -81,183 | 19,573,821 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169,803 | -0.37 | 74.34 | -47,134 | 12,623,698 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50,553 | -0.09 | 74.34 | -3,568 | 3,758,272 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184,841 | -0.38 | 74.34 | -52,561 | 13,741,671 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,648 | 8,722,615 | -0.02 | 76.03 | -125,301 | 663,197,864 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1,380,637 | -0.02 | 76.03 | -19,236 | 104,972,592 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 270,270 | -0.02 | 76.03 | -3,345 | 20,549,169 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 173,851 | -0.01 | 76.03 | -1,901 | 13,218,239 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50,861 | 0.00 | 76.03 | -152 | 3,867,064 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 189,361 | -0.01 | 76.03 | -2,129 | 14,397,496 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51,987 | 8,724,263 | -0.59 | 76.50 | -3,977,031 | 667,410,482 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,982 | 1,380,890 | -0.57 | 76.50 | -610,627 | 105,638,775 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,375 | 270,314 | -0.51 | 76.50 | -105,188 | 20,679,156 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -798 | 173,876 | -0.46 | 76.50 | -61,047 | 13,301,601 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61 | 50,863 | -0.12 | 76.50 | -4,667 | 3,891,045 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -891 | 189,389 | -0.47 | 76.50 | -68,162 | 14,488,353 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 8,776,250 | 0.00 | 75.40 | -18,624 | 661,729,250 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 1,388,872 | 0.00 | 75.40 | -2,941 | 104,720,949 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 271,689 | 0.00 | 75.40 | -528 | 20,485,351 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174,674 | 0.00 | 75.40 | -302 | 13,170,420 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174,674 | 0.00 | 75.40 | -302 | 13,170,420 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 50,924 | 0.00 | 75.40 | -75 | 3,839,670 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63,047 | 8,776,497 | -0.71 | 75.92 | -4,786,390 | 666,292,344 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,679 | 1,388,911 | -0.69 | 75.92 | -734,808 | 105,443,068 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,668 | 271,696 | -0.61 | 75.92 | -126,631 | 20,626,563 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -967 | 174,678 | -0.55 | 75.92 | -73,413 | 13,261,169 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -73 | 50,925 | -0.14 | 75.92 | -5,542 | 3,866,114 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,080 | 190,284 | -0.56 | 75.92 | -81,991 | 14,445,943 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,832 | 8,839,544 | -0.03 | 76.05 | -215,369 | 672,232,294 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -435 | 1,398,590 | -0.03 | 76.05 | -33,081 | 106,360,392 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75 | 273,364 | -0.03 | 76.05 | -5,704 | 20,788,867 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 175,645 | -0.02 | 76.05 | -3,270 | 13,357,504 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 50,998 | -0.01 | 76.05 | -228 | 3,878,311 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 191,364 | -0.03 | 76.05 | -3,726 | 14,552,907 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61,122 | 8,842,376 | -0.69 | 75.63 | -4,622,669 | 668,750,665 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,384 | 1,399,025 | -0.67 | 75.63 | -709,714 | 105,808,541 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,618 | 273,439 | -0.59 | 75.63 | -122,370 | 20,680,246 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -938 | 175,688 | -0.53 | 75.63 | -70,941 | 13,287,319 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 51,001 | -0.14 | 75.63 | -5,370 | 3,857,216 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,047 | 191,413 | -0.54 | 75.63 | -79,185 | 14,476,603 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,296 | 8,903,498 | -0.04 | 74.03 | -244,007 | 659,137,531 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1,408,409 | -0.04 | 74.03 | -37,460 | 104,266,349 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 275,057 | -0.03 | 74.03 | -6,441 | 20,362,827 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 176,626 | -0.03 | 74.03 | -3,776 | 13,075,852 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 51,072 | -0.01 | 74.03 | -296 | 3,780,927 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 192,460 | -0.03 | 74.03 | -4,146 | 14,248,064 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37,107 | 8,906,794 | -0.41 | 75.08 | -2,786,101 | 668,747,923 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,697 | 1,408,915 | -0.40 | 75.08 | -427,747 | 105,785,424 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -982 | 275,144 | -0.36 | 75.08 | -73,731 | 20,658,609 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -569 | 176,677 | -0.32 | 75.08 | -42,722 | 13,265,422 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 51,076 | -0.08 | 75.08 | -3,229 | 3,834,934 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -637 | 192,516 | -0.33 | 75.08 | -47,828 | 14,454,660 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18,703 | 8,943,901 | -0.21 | 73.55 | -1,375,551 | 657,797,981 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,872 | 1,414,612 | -0.20 | 73.55 | -211,227 | 104,040,610 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -495 | 276,126 | -0.18 | 73.55 | -36,406 | 20,308,267 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 177,246 | -0.16 | 73.55 | -21,108 | 13,035,929 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 51,119 | -0.04 | 73.55 | -1,618 | 3,759,654 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -321 | 193,153 | -0.17 | 73.55 | -23,609 | 14,205,843 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,647 | 8,962,604 | -0.02 | 73.72 | -121,421 | 660,745,573 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1,417,484 | -0.02 | 73.72 | -18,652 | 104,500,464 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 276,621 | -0.02 | 73.72 | -3,244 | 20,393,192 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 177,533 | -0.01 | 73.72 | -1,843 | 13,088,177 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51,141 | 0.00 | 73.72 | -147 | 3,770,242 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 193,474 | -0.01 | 73.72 | -2,138 | 14,263,387 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,486 | 8,964,251 | -0.09 | 77.04 | -653,755 | 690,598,726 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,303 | 1,417,737 | -0.09 | 77.04 | -100,382 | 109,221,324 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -225 | 276,665 | -0.08 | 77.04 | -17,334 | 21,314,050 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -130 | 177,558 | -0.07 | 77.04 | -10,015 | 13,678,926 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51,143 | -0.02 | 77.04 | -770 | 3,940,016 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 193,503 | -0.08 | 77.04 | -11,248 | 14,907,316 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22,914 | 8,972,737 | -0.25 | 76.49 | -1,752,680 | 686,320,167 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,518 | 1,419,040 | -0.25 | 76.49 | -269,090 | 108,541,660 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -607 | 276,890 | -0.22 | 76.49 | -46,429 | 21,179,178 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -352 | 177,688 | -0.20 | 76.49 | -26,924 | 13,591,266 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51,153 | -0.05 | 76.49 | -2,065 | 3,912,667 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -393 | 193,649 | -0.20 | 76.49 | -30,060 | 14,812,115 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -58,412 | 8,995,651 | -0.65 | 77.15 | -4,506,626 | 694,036,064 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,968 | 1,422,558 | -0.63 | 77.15 | -691,903 | 109,753,764 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,546 | 277,497 | -0.55 | 77.15 | -119,278 | 21,409,560 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -896 | 178,040 | -0.50 | 77.15 | -69,129 | 13,736,213 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 51,180 | -0.13 | 77.15 | -5,246 | 3,948,660 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,001 | 194,042 | -0.51 | 77.15 | -77,230 | 14,970,806 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,909 | 9,054,063 | -0.08 | 77.64 | -536,386 | 702,919,424 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,060 | 1,431,526 | -0.07 | 77.64 | -82,294 | 111,137,666 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -183 | 279,043 | -0.07 | 77.64 | -14,207 | 21,663,727 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -107 | 178,936 | -0.06 | 77.64 | -8,307 | 13,891,840 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51,248 | -0.02 | 77.64 | -621 | 3,978,679 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 195,043 | -0.06 | 77.64 | -9,161 | 15,142,319 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9,060,972 | -0.01 | 76.20 | -37,565 | 690,423,414 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1,432,586 | -0.01 | 76.20 | -5,791 | 109,159,472 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 279,226 | 0.00 | 76.20 | -991 | 21,276,323 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 179,043 | 0.00 | 76.20 | -610 | 13,642,629 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,256 | 0.00 | 76.20 | -76 | 3,905,579 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 195,161 | 0.00 | 76.20 | -686 | 14,870,780 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -742 | 9,061,465 | -0.01 | 76.20 | -56,540 | 690,483,633 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 1,432,662 | -0.01 | 76.20 | -8,687 | 109,168,844 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20 | 279,239 | -0.01 | 76.20 | -1,524 | 21,278,012 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 179,051 | -0.01 | 76.20 | -838 | 13,643,686 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,257 | 0.00 | 76.20 | -76 | 3,905,783 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 195,170 | -0.01 | 76.20 | -991 | 14,871,954 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31,482 | 9,062,207 | -0.35 | 76.66 | -2,413,501 | 694,735,069 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,833 | 1,432,776 | -0.34 | 76.66 | -370,512 | 109,840,763 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -833 | 279,259 | -0.30 | 76.66 | -63,860 | 21,408,805 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -484 | 179,062 | -0.27 | 76.66 | -37,105 | 13,727,412 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 51,258 | -0.07 | 76.66 | -2,837 | 3,929,587 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -539 | 195,183 | -0.28 | 76.66 | -41,321 | 14,963,295 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 9,093,689 | -0.01 | 77.81 | -48,239 | 707,539,019 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 1,437,609 | -0.01 | 77.81 | -7,392 | 111,853,887 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 280,092 | -0.01 | 77.81 | -1,245 | 21,792,698 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 179,546 | -0.01 | 77.81 | -778 | 13,969,666 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,295 | 0.00 | 77.81 | -78 | 3,991,033 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 195,722 | -0.01 | 77.81 | -856 | 15,228,248 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,506 | 9,094,309 | -0.07 | 78.13 | -508,342 | 710,577,468 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -999 | 1,437,704 | -0.07 | 78.13 | -78,056 | 112,333,996 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -172 | 280,108 | -0.06 | 78.13 | -13,439 | 21,886,043 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -100 | 179,556 | -0.06 | 78.13 | -7,813 | 14,029,482 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51,296 | -0.02 | 78.13 | -625 | 4,007,977 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112 | 195,733 | -0.06 | 78.13 | -8,751 | 15,293,461 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 9,100,815 | 0.09 | 17.59 | 145,118 | 160,083,336 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 9,100,815 | 0.09 | 17.59 | 145,118 | 160,083,336 | |
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,288,793 | 0.07 | 2.80 | 56,000 | 82,008,620 | |
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,288,793 | 0.07 | 2.80 | 56,000 | 82,008,620 | |
| 2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1,818,475 | 8,837,349 | 25.91 | ||||
| 2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 181,525 | 916,043 | 24.71 | ||||
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,634 | 9,092,565 | -0.15 | 70.55 | -961,887 | 641,485,916 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,093 | 1,430,453 | -0.15 | 70.55 | -147,662 | 100,919,317 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -361 | 280,280 | -0.13 | 70.55 | -25,469 | 19,773,922 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -210 | 179,656 | -0.12 | 70.55 | -14,816 | 12,674,839 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51,304 | -0.03 | 70.55 | -1,129 | 3,619,528 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 195,845 | -0.12 | 70.55 | -16,509 | 13,816,982 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24,660 | 9,106,199 | -0.27 | 71.35 | -1,759,553 | 649,750,064 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,786 | 1,432,546 | -0.26 | 71.35 | -270,141 | 102,215,738 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -653 | 280,641 | -0.23 | 71.35 | -46,593 | 20,024,437 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -378 | 179,866 | -0.21 | 71.35 | -26,971 | 12,833,889 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 51,320 | -0.06 | 71.35 | -2,069 | 3,661,810 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -423 | 196,079 | -0.22 | 71.35 | -30,182 | 13,990,727 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75,736 | 9,130,859 | -0.82 | 72.20 | -5,468,397 | 659,279,065 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,627 | 1,436,332 | -0.80 | 72.20 | -839,509 | 103,708,054 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,004 | 281,294 | -0.71 | 72.20 | -144,696 | 20,310,383 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,162 | 180,244 | -0.64 | 72.20 | -83,900 | 13,014,230 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51,349 | -0.17 | 72.20 | -6,426 | 3,707,572 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,298 | 196,502 | -0.66 | 72.20 | -93,720 | 14,188,113 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65,426 | 9,206,595 | -0.71 | 72.02 | -4,711,967 | 663,057,131 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,044 | 1,447,959 | -0.69 | 72.02 | -723,367 | 104,281,718 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,732 | 283,298 | -0.61 | 72.02 | -124,738 | 20,403,065 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,004 | 181,406 | -0.55 | 72.02 | -72,308 | 13,064,824 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 51,438 | -0.15 | 72.02 | -5,474 | 3,704,554 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,121 | 197,800 | -0.56 | 72.02 | -80,734 | 14,245,516 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,648 | 9,272,021 | -0.02 | 73.46 | -121,054 | 681,076,303 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1,458,003 | -0.02 | 73.46 | -18,584 | 107,097,610 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 285,030 | -0.02 | 73.46 | -3,232 | 20,936,879 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 182,410 | -0.01 | 73.46 | -1,836 | 13,398,927 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51,514 | 0.00 | 73.46 | -147 | 3,783,961 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 198,921 | -0.01 | 73.46 | -2,057 | 14,611,742 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29,260 | 9,273,669 | -0.31 | 70.52 | -2,063,313 | 653,946,680 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,492 | 1,458,256 | -0.31 | 70.52 | -316,760 | 102,831,109 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -774 | 285,074 | -0.27 | 70.52 | -54,580 | 20,102,421 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -450 | 182,435 | -0.25 | 70.52 | -31,732 | 12,864,678 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34 | 51,516 | -0.07 | 70.52 | -2,398 | 3,632,728 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -502 | 198,949 | -0.25 | 70.52 | -35,399 | 14,029,187 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42,521 | 9,302,929 | -0.45 | 71.00 | -3,018,995 | 660,508,889 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,529 | 1,462,748 | -0.44 | 71.00 | -463,560 | 103,855,254 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,125 | 285,848 | -0.39 | 71.00 | -79,875 | 20,295,237 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -652 | 182,885 | -0.36 | 71.00 | -46,292 | 12,984,853 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 51,550 | -0.10 | 71.00 | -3,550 | 3,660,055 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -729 | 199,451 | -0.36 | 71.00 | -51,759 | 14,161,041 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,547 | 9,345,450 | -0.11 | 71.61 | -755,298 | 669,251,973 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,619 | 1,469,277 | -0.11 | 71.61 | -115,941 | 105,218,746 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -279 | 286,973 | -0.10 | 71.61 | -19,980 | 20,550,883 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -162 | 183,537 | -0.09 | 71.61 | -11,601 | 13,143,562 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12 | 51,600 | -0.02 | 71.61 | -859 | 3,695,210 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -181 | 200,180 | -0.09 | 71.61 | -12,962 | 14,335,410 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,595 | 9,355,997 | -0.15 | 72.23 | -981,964 | 675,781,792 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,087 | 1,470,896 | -0.14 | 72.23 | -150,744 | 106,242,524 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 287,252 | -0.13 | 72.23 | -26,003 | 20,748,155 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 183,699 | -0.11 | 72.23 | -15,096 | 13,268,542 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51,612 | -0.03 | 72.23 | -1,156 | 3,727,924 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 200,361 | -0.12 | 72.23 | -16,830 | 14,472,035 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132,363 | 9,369,592 | -1.39 | 72.79 | -9,634,226 | 681,978,871 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20,322 | 1,472,983 | -1.36 | 72.79 | -1,479,165 | 107,213,130 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,503 | 287,612 | -1.20 | 72.79 | -254,971 | 20,934,242 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,031 | 183,908 | -1.09 | 72.79 | -147,829 | 13,386,001 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -155 | 51,628 | -0.30 | 72.79 | -11,282 | 3,757,816 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,268 | 200,594 | -1.12 | 72.79 | -165,080 | 14,600,515 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -149,754 | 9,501,955 | -1.55 | 70.79 | -10,601,295 | 672,656,697 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22,991 | 1,493,305 | -1.52 | 70.79 | -1,627,565 | 105,713,152 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,963 | 291,115 | -1.34 | 70.79 | -280,546 | 20,608,438 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,298 | 185,939 | -1.22 | 70.79 | -162,679 | 13,162,882 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -175 | 51,783 | -0.34 | 70.79 | -12,388 | 3,665,791 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,566 | 202,862 | -1.25 | 70.79 | -181,651 | 14,360,885 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9,651,709 | -0.01 | 70.07 | -34,545 | 676,311,658 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1,516,296 | -0.01 | 70.07 | -5,325 | 106,249,438 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 295,078 | 0.00 | 70.07 | -911 | 20,676,617 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 188,237 | 0.00 | 70.07 | -561 | 13,190,087 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,958 | 0.00 | 70.07 | -70 | 3,640,785 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 205,428 | 0.00 | 70.07 | -631 | 14,394,689 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23,462 | 9,652,202 | -0.24 | 70.22 | -1,647,574 | 677,807,546 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,602 | 1,516,372 | -0.24 | 70.22 | -252,944 | 106,484,343 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -621 | 295,091 | -0.21 | 70.22 | -43,609 | 20,722,205 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 188,245 | -0.19 | 70.22 | -25,280 | 13,219,147 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51,959 | -0.05 | 70.22 | -1,896 | 3,648,722 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -402 | 205,437 | -0.20 | 70.22 | -28,230 | 14,426,423 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,392 | 9,675,664 | -0.09 | 70.28 | -589,772 | 679,985,347 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,288 | 1,519,974 | -0.08 | 70.28 | -90,518 | 106,820,581 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -222 | 295,712 | -0.08 | 70.28 | -15,602 | 20,782,018 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 188,605 | -0.07 | 70.28 | -9,066 | 13,254,763 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51,986 | -0.02 | 70.28 | -703 | 3,653,467 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -144 | 205,839 | -0.07 | 70.28 | -10,120 | 14,465,933 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,658 | 85,072 | 4.49 | 3.52 | 12,876 | 299,453 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,658 | 85,072 | 4.49 | 3.52 | 12,876 | 299,453 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,658 | 85,072 | 4.49 | 3.52 | 12,876 | 299,453 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295,934 | 0.10 | 64.41 | 19,967 | 19,061,109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295,934 | 0.10 | 64.41 | 19,967 | 19,061,109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295,934 | 0.10 | 64.41 | 19,967 | 19,061,109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 1,695,159 | 0.02 | 64.41 | 19,967 | 109,185,191 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 225,893 | 0.14 | 64.41 | 19,967 | 14,549,768 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 362,631 | 0.09 | 64.41 | 19,967 | 23,357,063 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810,862 | 0.04 | 63.59 | 18,950 | 51,562,715 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810,862 | 0.04 | 63.59 | 18,950 | 51,562,715 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 29,421,884 | 0.00 | 63.59 | 18,950 | 1,870,937,604 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,243 | 9,683,746 | -0.16 | 73.09 | -1,114,047 | 707,744,323 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,340 | 1,520,952 | -0.15 | 73.09 | -171,021 | 111,159,994 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -403 | 295,624 | -0.14 | 73.09 | -29,454 | 21,605,917 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 188,424 | -0.12 | 73.09 | -17,102 | 13,771,119 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 51,686 | -0.03 | 73.09 | -1,316 | 3,777,513 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -262 | 205,673 | -0.13 | 73.09 | -19,148 | 15,031,776 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12,627 | 9,698,989 | -0.13 | 71.81 | -906,797 | 696,524,166 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,939 | 1,523,292 | -0.13 | 71.81 | -139,248 | 109,393,844 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -334 | 296,027 | -0.11 | 71.81 | -23,986 | 21,258,913 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -194 | 188,658 | -0.10 | 71.81 | -13,932 | 13,548,304 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15 | 51,704 | -0.03 | 71.81 | -1,077 | 3,713,076 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 205,935 | -0.10 | 71.81 | -15,512 | 14,789,037 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34,794 | 9,711,616 | -0.36 | 74.88 | -2,605,510 | 727,243,681 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,342 | 1,525,231 | -0.35 | 74.88 | -400,030 | 114,215,246 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -921 | 296,361 | -0.31 | 74.88 | -68,968 | 22,192,667 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -534 | 188,852 | -0.28 | 74.88 | -39,988 | 14,141,974 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41 | 51,719 | -0.08 | 74.88 | -3,070 | 3,872,920 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -597 | 206,151 | -0.29 | 74.88 | -44,706 | 15,437,391 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,718 | 9,746,410 | -0.08 | 73.83 | -569,813 | 719,568,679 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,185 | 1,530,573 | -0.08 | 73.83 | -87,487 | 113,000,827 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 297,282 | -0.07 | 73.83 | -15,061 | 21,948,063 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 189,386 | -0.06 | 73.83 | -8,712 | 13,982,198 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 51,760 | -0.02 | 73.83 | -664 | 3,821,394 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132 | 206,748 | -0.06 | 73.83 | -9,745 | 15,264,019 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84,418 | 9,754,128 | -0.86 | 76.15 | -6,428,768 | 742,815,864 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12,961 | 1,531,758 | -0.84 | 76.15 | -987,032 | 116,649,499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,234 | 297,486 | -0.75 | 76.15 | -170,128 | 22,654,749 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,296 | 189,504 | -0.68 | 76.15 | -98,696 | 14,431,488 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99 | 51,769 | -0.19 | 76.15 | -7,539 | 3,942,416 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,447 | 206,880 | -0.69 | 76.15 | -110,195 | 15,754,740 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76,364 | 9,838,546 | -0.77 | 75.46 | -5,762,481 | 742,423,568 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,724 | 1,544,719 | -0.75 | 75.46 | -884,701 | 116,565,577 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,021 | 299,720 | -0.67 | 75.46 | -152,506 | 22,617,081 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,172 | 190,800 | -0.61 | 75.46 | -88,440 | 14,397,902 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51,868 | -0.17 | 75.46 | -6,716 | 3,913,996 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,309 | 208,327 | -0.62 | 75.46 | -98,778 | 15,720,501 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,538 | 9,914,910 | -0.03 | 77.75 | -197,318 | 770,839,635 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -390 | 1,556,443 | -0.03 | 77.75 | -30,321 | 121,006,439 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -67 | 301,741 | -0.02 | 77.75 | -5,209 | 23,459,005 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 191,972 | -0.02 | 77.75 | -3,032 | 14,924,959 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 51,957 | -0.01 | 77.75 | -233 | 4,039,423 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 209,636 | -0.02 | 77.75 | -3,343 | 16,298,256 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,493 | 9,917,448 | -0.06 | 73.81 | -405,449 | 732,025,680 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -843 | 1,556,833 | -0.05 | 73.81 | -62,223 | 114,912,802 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 301,808 | -0.05 | 73.81 | -10,777 | 22,277,022 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84 | 192,011 | -0.04 | 73.81 | -6,200 | 14,172,697 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 51,960 | -0.01 | 73.81 | -443 | 3,835,266 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 209,679 | -0.05 | 73.81 | -7,012 | 15,476,805 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18,604 | 9,922,941 | -0.19 | 75.83 | -1,410,758 | 752,465,547 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,856 | 1,557,676 | -0.18 | 75.83 | -216,573 | 118,119,973 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -492 | 301,954 | -0.16 | 75.83 | -37,309 | 22,897,444 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 192,095 | -0.15 | 75.83 | -21,688 | 14,566,737 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 51,966 | -0.04 | 75.83 | -1,592 | 3,940,629 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -319 | 209,774 | -0.15 | 75.83 | -24,190 | 15,907,351 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -371 | 9,941,545 | 0.00 | 77.11 | -28,608 | 766,592,535 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57 | 1,560,532 | 0.00 | 77.11 | -4,395 | 120,332,623 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 302,446 | 0.00 | 77.11 | -771 | 23,321,611 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192,381 | 0.00 | 77.11 | -463 | 14,834,499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192,381 | 0.00 | 77.11 | -463 | 14,834,499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,987 | 0.00 | 77.11 | -77 | 4,008,718 | |
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1,569 | 1,569 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1,569 | 1,569 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | -10,731 | 0 | -100.00 | ||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71,647 | 71,647 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71,647 | 71,647 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -489,977 | 0 | -100.00 | ||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11,178,823 | 35,976,940 | 45.08 | 17.00 | 190,039,991 | 611,607,980 | |
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 585,882 | 3,736,902 | 18.59 | 17.00 | 9,959,994 | 63,527,334 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 9,941,916 | 0.00 | 76.62 | -18,925 | 761,724,749 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 1,560,589 | 0.00 | 76.62 | -2,911 | 119,568,428 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 302,456 | 0.00 | 76.62 | -460 | 23,173,423 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192,387 | 0.00 | 76.62 | -306 | 14,740,211 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192,387 | 0.00 | 76.62 | -306 | 14,740,211 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,988 | 0.00 | 76.62 | -77 | 3,983,191 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -32,598 | 9,942,163 | -0.33 | 77.52 | -2,527,147 | 770,762,210 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,005 | 1,560,627 | -0.32 | 77.52 | -388,011 | 120,986,984 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -863 | 302,462 | -0.28 | 77.52 | -66,904 | 23,448,246 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -500 | 192,391 | -0.26 | 77.52 | -38,762 | 14,915,035 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 51,989 | -0.07 | 77.52 | -2,946 | 4,030,426 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 210,103 | -0.27 | 77.52 | -43,336 | 16,288,151 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89,047 | 9,974,761 | -0.88 | 78.05 | -6,950,074 | 778,525,109 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,671 | 1,565,632 | -0.87 | 78.05 | -1,067,015 | 122,196,795 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,357 | 303,325 | -0.77 | 78.05 | -183,963 | 23,674,365 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,367 | 192,891 | -0.70 | 78.05 | -106,694 | 15,055,046 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -104 | 52,027 | -0.20 | 78.05 | -8,117 | 4,060,681 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,526 | 210,662 | -0.72 | 78.05 | -119,104 | 16,442,064 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44,659 | 10,063,808 | -0.44 | 80.09 | -3,576,721 | 806,006,357 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,856 | 1,579,303 | -0.43 | 80.09 | -549,094 | 126,485,746 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,182 | 305,682 | -0.39 | 80.09 | -94,666 | 24,481,949 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -685 | 194,258 | -0.35 | 80.09 | -54,861 | 15,558,046 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 52,131 | -0.10 | 80.09 | -4,165 | 4,175,151 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -765 | 212,188 | -0.36 | 80.09 | -61,269 | 16,994,052 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129,121 | 10,108,467 | -1.26 | 79.07 | -10,209,675 | 799,282,551 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19,824 | 1,586,159 | -1.23 | 79.07 | -1,567,496 | 125,418,544 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,417 | 306,864 | -1.10 | 79.07 | -270,184 | 24,263,921 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,981 | 194,943 | -1.01 | 79.07 | -156,639 | 15,414,260 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -151 | 52,183 | -0.29 | 79.07 | -11,940 | 4,126,141 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,214 | 212,953 | -1.03 | 79.07 | -175,062 | 16,838,321 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39,591 | 10,237,588 | -0.39 | 79.63 | -3,152,536 | 815,194,562 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,078 | 1,605,983 | -0.38 | 79.63 | -483,977 | 127,880,572 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,048 | 310,281 | -0.34 | 79.63 | -83,450 | 24,706,931 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -608 | 196,924 | -0.31 | 79.63 | -48,414 | 15,680,586 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46 | 52,334 | -0.09 | 79.63 | -3,663 | 4,167,231 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -678 | 215,167 | -0.31 | 79.63 | -53,988 | 17,133,232 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30,257 | 10,277,179 | -0.29 | 77.61 | -2,348,376 | 797,656,054 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,646 | 1,612,061 | -0.29 | 77.61 | -360,596 | 125,118,986 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -801 | 311,329 | -0.26 | 77.61 | -62,169 | 24,163,582 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -465 | 197,532 | -0.23 | 77.61 | -36,091 | 15,331,308 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -35 | 52,380 | -0.07 | 77.61 | -2,717 | 4,065,437 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -518 | 215,845 | -0.24 | 77.61 | -40,204 | 16,752,659 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,994 | 10,307,436 | -0.12 | 78.80 | -945,149 | 812,244,510 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,841 | 1,616,707 | -0.11 | 78.80 | -145,074 | 127,399,422 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -317 | 312,130 | -0.10 | 78.80 | -24,980 | 24,596,406 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -184 | 197,997 | -0.09 | 78.80 | -14,500 | 15,602,520 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 52,415 | -0.03 | 78.80 | -1,103 | 4,130,396 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -206 | 216,363 | -0.10 | 78.80 | -16,233 | 17,049,794 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77,976 | 10,319,430 | -0.75 | 76.81 | -5,989,017 | 792,593,109 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,972 | 1,618,548 | -0.73 | 76.81 | -919,520 | 124,314,036 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,064 | 312,447 | -0.66 | 76.81 | -158,527 | 23,997,773 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,197 | 198,181 | -0.60 | 76.81 | -91,937 | 15,221,470 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52,429 | -0.17 | 76.81 | -6,989 | 4,026,857 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,335 | 216,569 | -0.61 | 76.81 | -102,536 | 16,633,777 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,595 | 10,397,406 | -0.13 | 74.01 | -1,006,150 | 769,499,541 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,087 | 1,630,520 | -0.13 | 74.01 | -154,456 | 120,672,829 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 314,511 | -0.11 | 74.01 | -26,643 | 23,276,582 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 199,378 | -0.10 | 74.01 | -15,468 | 14,755,727 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 52,520 | -0.03 | 74.01 | -1,184 | 3,886,942 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 217,904 | -0.11 | 74.01 | -17,244 | 16,126,814 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57,979 | 10,411,001 | -0.55 | 74.71 | -4,331,524 | 777,790,268 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,901 | 1,632,607 | -0.54 | 74.71 | -664,980 | 121,969,620 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,534 | 314,871 | -0.48 | 74.71 | -114,603 | 23,523,540 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -890 | 199,587 | -0.44 | 74.71 | -66,491 | 14,910,845 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 52,536 | -0.13 | 74.71 | -5,080 | 3,924,886 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -994 | 218,137 | -0.45 | 74.71 | -74,260 | 16,296,688 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56,764 | 10,468,980 | -0.54 | 75.27 | -4,272,831 | 788,037,813 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,715 | 1,641,508 | -0.53 | 75.27 | -656,009 | 123,562,217 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,502 | 316,405 | -0.47 | 75.27 | -113,061 | 23,816,943 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -871 | 200,477 | -0.43 | 75.27 | -65,563 | 15,090,626 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 52,604 | -0.13 | 75.27 | -4,968 | 3,959,692 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -973 | 219,131 | -0.44 | 75.27 | -73,241 | 16,494,779 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36,652 | 10,525,744 | -0.35 | 73.76 | -2,703,294 | 776,333,617 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,627 | 1,650,223 | -0.34 | 73.76 | -415,023 | 121,713,353 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -970 | 317,907 | -0.30 | 73.76 | -71,543 | 23,447,453 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -563 | 201,348 | -0.28 | 73.76 | -41,524 | 14,850,563 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 52,670 | -0.08 | 73.76 | -3,171 | 3,884,713 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -628 | 220,104 | -0.28 | 73.76 | -46,319 | 16,233,925 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77,558 | 10,562,396 | -0.73 | 74.24 | -5,758,092 | 784,177,629 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,907 | 1,655,850 | -0.71 | 74.24 | -884,004 | 122,934,278 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,052 | 318,877 | -0.64 | 74.24 | -152,345 | 23,674,194 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,190 | 201,911 | -0.59 | 74.24 | -88,348 | 14,990,357 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52,713 | -0.17 | 74.24 | -6,756 | 3,913,540 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,329 | 220,732 | -0.60 | 74.24 | -98,668 | 16,387,673 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,204 | 10,639,954 | -0.08 | 74.05 | -607,484 | 787,859,866 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,260 | 1,667,757 | -0.08 | 74.05 | -93,300 | 123,492,903 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -217 | 320,929 | -0.07 | 74.05 | -16,068 | 23,763,926 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -126 | 203,101 | -0.06 | 74.05 | -9,330 | 15,039,081 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 52,804 | -0.02 | 74.05 | -740 | 3,909,994 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -141 | 222,061 | -0.06 | 74.05 | -10,441 | 16,443,017 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24,487 | 10,648,158 | -0.23 | 74.36 | -1,820,848 | 791,794,899 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,759 | 1,669,017 | -0.22 | 74.36 | -279,518 | 124,107,770 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -648 | 321,146 | -0.20 | 74.36 | -48,185 | 23,880,352 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -376 | 203,227 | -0.18 | 74.36 | -27,959 | 15,111,919 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 52,814 | -0.05 | 74.36 | -2,082 | 3,927,238 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -419 | 222,202 | -0.19 | 74.36 | -31,157 | 16,522,896 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55,365 | 10,672,645 | -0.52 | 76.35 | -4,227,024 | 814,838,302 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,499 | 1,672,776 | -0.51 | 76.35 | -648,884 | 127,713,604 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,466 | 321,794 | -0.45 | 76.35 | -111,927 | 24,568,425 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -850 | 203,603 | -0.42 | 76.35 | -64,896 | 15,544,743 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65 | 52,842 | -0.12 | 76.35 | -4,963 | 4,034,397 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -949 | 222,621 | -0.42 | 76.35 | -72,455 | 16,996,735 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16,646 | 10,728,010 | -0.15 | 77.66 | -1,292,763 | 833,159,785 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,556 | 1,681,275 | -0.15 | 77.66 | -198,504 | 130,571,347 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -440 | 323,260 | -0.14 | 77.66 | -34,171 | 25,105,050 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -255 | 204,453 | -0.12 | 77.66 | -19,804 | 15,878,249 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19 | 52,907 | -0.04 | 77.66 | -1,476 | 4,108,869 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -285 | 223,570 | -0.13 | 77.66 | -22,134 | 17,362,916 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38,330 | 10,744,656 | -0.36 | 79.13 | -3,033,110 | 850,240,746 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,885 | 1,683,831 | -0.35 | 79.13 | -465,689 | 133,244,073 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,014 | 323,700 | -0.31 | 79.13 | -80,239 | 25,614,867 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -588 | 204,708 | -0.29 | 79.13 | -46,529 | 16,198,851 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -45 | 52,926 | -0.08 | 79.13 | -3,561 | 4,188,114 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -657 | 223,855 | -0.29 | 79.13 | -51,989 | 17,713,982 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,296 | 10,782,986 | -0.03 | 80.09 | -263,978 | 863,613,662 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1,689,716 | -0.03 | 80.09 | -40,526 | 135,330,030 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 324,714 | -0.03 | 80.09 | -6,968 | 26,006,474 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 205,296 | -0.02 | 80.09 | -4,085 | 16,442,239 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 52,971 | -0.01 | 80.09 | -320 | 4,242,469 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 224,512 | -0.02 | 80.09 | -4,485 | 17,981,256 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -53,013 | 10,786,282 | -0.49 | 80.07 | -4,244,714 | 863,650,049 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,139 | 1,690,222 | -0.48 | 80.07 | -651,684 | 135,334,892 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,403 | 324,801 | -0.43 | 80.07 | -112,337 | 26,006,589 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -814 | 205,347 | -0.39 | 80.07 | -65,176 | 16,441,991 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62 | 52,975 | -0.12 | 80.07 | -4,964 | 4,241,671 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -908 | 224,568 | -0.40 | 80.07 | -72,703 | 17,981,003 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99,280 | 10,839,295 | -0.91 | 78.09 | -7,752,428 | 846,402,609 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,242 | 1,698,361 | -0.89 | 78.09 | -1,190,194 | 132,619,066 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,628 | 326,204 | -0.80 | 78.09 | -205,211 | 25,472,129 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,524 | 206,161 | -0.73 | 78.09 | -119,004 | 16,098,391 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -115 | 53,037 | -0.22 | 78.09 | -8,980 | 4,141,474 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,702 | 225,476 | -0.75 | 78.09 | -132,903 | 17,606,632 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,014 | 10,938,575 | -0.14 | 81.26 | -1,220,038 | 888,868,604 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,305 | 1,713,603 | -0.13 | 81.26 | -187,304 | 139,247,380 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -397 | 328,832 | -0.12 | 81.26 | -32,260 | 26,720,888 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -230 | 207,685 | -0.11 | 81.26 | -18,690 | 16,876,483 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53,152 | -0.03 | 81.26 | -1,463 | 4,319,132 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -257 | 227,178 | -0.11 | 81.26 | -20,884 | 18,460,484 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46,511 | 10,953,589 | -0.42 | 81.16 | -3,774,912 | 889,011,904 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,140 | 1,715,908 | -0.41 | 81.16 | -579,495 | 139,266,010 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,231 | 329,229 | -0.37 | 81.16 | -99,910 | 26,720,785 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -714 | 207,915 | -0.34 | 81.16 | -57,949 | 16,874,735 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -54 | 53,170 | -0.10 | 81.16 | -4,383 | 4,315,368 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -796 | 227,435 | -0.35 | 81.16 | -64,605 | 18,459,011 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,533 | 11,000,100 | -0.07 | 80.51 | -606,473 | 885,604,851 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,156 | 1,723,048 | -0.07 | 80.51 | -93,068 | 138,720,527 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -199 | 330,460 | -0.06 | 80.51 | -16,021 | 26,604,938 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -116 | 208,629 | -0.06 | 80.51 | -9,339 | 16,796,470 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53,224 | -0.02 | 80.51 | -725 | 4,285,000 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 228,231 | -0.06 | 80.51 | -10,386 | 18,374,604 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,877 | 11,007,633 | -0.11 | 80.38 | -954,711 | 884,828,765 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,824 | 1,724,204 | -0.11 | 80.38 | -146,619 | 138,597,035 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -314 | 330,659 | -0.09 | 80.38 | -25,240 | 26,579,429 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -182 | 208,745 | -0.09 | 80.38 | -14,630 | 16,779,591 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 53,233 | -0.03 | 80.38 | -1,125 | 4,279,039 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 228,360 | -0.09 | 80.38 | -16,398 | 18,356,308 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19,367 | 11,019,510 | -0.18 | 85.11 | -1,648,296 | 937,853,967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,973 | 1,726,028 | -0.17 | 85.11 | -253,028 | 146,899,654 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -513 | 330,973 | -0.15 | 85.11 | -43,661 | 28,168,616 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -297 | 208,927 | -0.14 | 85.11 | -25,277 | 17,781,464 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23 | 53,247 | -0.04 | 85.11 | -1,957 | 4,531,772 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -332 | 228,564 | -0.15 | 85.11 | -28,256 | 19,452,739 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112,010 | 11,038,877 | -1.00 | 82.06 | -9,191,025 | 905,799,468 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17,198 | 1,729,001 | -0.98 | 82.06 | -1,411,189 | 141,873,869 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,964 | 331,486 | -0.89 | 82.06 | -243,212 | 27,200,216 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,720 | 209,224 | -0.82 | 82.06 | -141,135 | 17,167,959 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 53,270 | -0.24 | 82.06 | -10,585 | 4,371,091 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,919 | 228,896 | -0.83 | 82.06 | -157,464 | 18,782,153 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,157 | 11,150,887 | -0.07 | 82.55 | -673,321 | 920,452,198 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,252 | 1,746,199 | -0.07 | 82.55 | -103,347 | 144,140,346 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 334,450 | -0.06 | 82.55 | -17,830 | 27,607,242 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -125 | 210,944 | -0.06 | 82.55 | -10,318 | 17,412,415 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53,399 | -0.02 | 82.55 | -743 | 4,407,831 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -140 | 230,815 | -0.06 | 82.55 | -11,556 | 19,052,670 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,120 | 11,159,044 | -0.04 | 83.90 | -345,678 | 936,271,689 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1,747,451 | -0.04 | 83.90 | -53,110 | 146,615,508 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 334,666 | -0.03 | 83.90 | -9,145 | 28,079,314 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 211,069 | -0.03 | 83.90 | -5,286 | 17,709,217 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53,408 | -0.01 | 83.90 | -420 | 4,481,065 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 230,955 | -0.03 | 83.90 | -5,957 | 19,377,702 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62,929 | 11,163,164 | -0.56 | 83.20 | -5,235,598 | 928,758,500 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,661 | 1,748,084 | -0.55 | 83.20 | -803,781 | 145,437,967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,665 | 334,775 | -0.49 | 83.20 | -138,526 | 27,852,778 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -966 | 211,132 | -0.46 | 83.20 | -80,370 | 17,565,866 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 53,413 | -0.14 | 83.20 | -6,157 | 4,443,881 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,078 | 231,026 | -0.46 | 83.20 | -89,688 | 19,221,017 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17,602 | 11,226,093 | -0.16 | 85.87 | -1,511,565 | 964,036,246 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,702 | 1,757,745 | -0.15 | 85.87 | -232,033 | 150,945,649 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -466 | 336,440 | -0.14 | 85.87 | -40,018 | 28,891,650 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -270 | 212,098 | -0.13 | 85.87 | -23,186 | 18,213,831 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 53,487 | -0.04 | 85.87 | -1,803 | 4,593,175 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -302 | 232,104 | -0.13 | 85.87 | -25,934 | 19,931,838 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,120 | 11,243,695 | -0.04 | 82.00 | -337,840 | 921,982,990 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1,760,447 | -0.04 | 82.00 | -51,906 | 144,356,654 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 336,906 | -0.03 | 82.00 | -8,938 | 27,626,292 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 212,368 | -0.03 | 82.00 | -5,166 | 17,414,176 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53,508 | -0.01 | 82.00 | -410 | 4,387,656 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 232,406 | -0.03 | 82.00 | -5,822 | 19,057,292 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,565 | 11,247,815 | -0.01 | 83.85 | -131,227 | 943,138,286 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -240 | 1,761,080 | -0.01 | 83.85 | -20,124 | 147,667,967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 337,015 | -0.01 | 83.85 | -3,522 | 28,258,977 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24 | 212,431 | -0.01 | 83.85 | -2,012 | 17,812,509 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 53,513 | 0.00 | 83.85 | -168 | 4,487,108 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 232,477 | -0.01 | 83.85 | -2,264 | 19,493,382 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,301 | 11,249,380 | -0.08 | 84.84 | -789,121 | 954,426,648 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,428 | 1,761,320 | -0.08 | 84.84 | -121,155 | 149,434,968 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -246 | 337,057 | -0.07 | 84.84 | -20,871 | 28,596,792 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -143 | 212,455 | -0.07 | 84.84 | -12,132 | 18,025,235 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 53,515 | -0.02 | 84.84 | -933 | 4,540,352 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -159 | 232,504 | -0.07 | 84.84 | -13,490 | 19,726,244 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21,423 | 11,258,681 | -0.19 | 89.34 | -1,913,901 | 1,005,834,798 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,289 | 1,762,748 | -0.19 | 89.34 | -293,835 | 157,481,438 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -567 | 337,303 | -0.17 | 89.34 | -50,655 | 30,134,178 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -329 | 212,598 | -0.15 | 89.34 | -29,392 | 18,993,208 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 53,526 | -0.05 | 89.34 | -2,233 | 4,781,938 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -367 | 232,663 | -0.16 | 89.34 | -32,787 | 20,785,787 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30,555 | 11,280,104 | -0.27 | 85.15 | -2,601,670 | 960,468,143 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,692 | 1,766,037 | -0.26 | 85.15 | -399,510 | 150,372,929 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -809 | 337,870 | -0.24 | 85.15 | -68,884 | 28,768,651 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -470 | 212,927 | -0.22 | 85.15 | -40,019 | 18,130,117 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 53,551 | -0.07 | 85.15 | -3,150 | 4,559,712 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -522 | 233,030 | -0.22 | 85.15 | -44,447 | 19,841,829 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36,174 | 11,310,659 | -0.32 | 85.78 | -3,102,970 | 970,217,018 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,554 | 1,770,729 | -0.31 | 85.78 | -476,417 | 151,891,363 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -957 | 338,679 | -0.28 | 85.78 | -82,091 | 29,051,546 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -555 | 213,397 | -0.26 | 85.78 | -47,607 | 18,304,981 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 53,588 | -0.08 | 85.78 | -3,603 | 4,596,725 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 233,552 | -0.26 | 85.78 | -53,183 | 20,033,857 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,663 | 11,346,833 | -0.03 | 87.30 | -319,780 | 990,579,656 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -562 | 1,776,283 | -0.03 | 87.30 | -49,063 | 155,069,684 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -97 | 339,636 | -0.03 | 87.30 | -8,468 | 29,650,257 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 213,952 | -0.03 | 87.30 | -4,889 | 18,678,031 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 53,630 | -0.01 | 87.30 | -349 | 4,681,904 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 234,172 | -0.03 | 87.30 | -5,500 | 20,443,239 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,306 | 11,350,496 | -0.04 | 88.38 | -380,544 | 1,003,104,624 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -661 | 1,776,845 | -0.04 | 88.38 | -58,416 | 157,029,388 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 339,733 | -0.03 | 88.38 | -10,075 | 30,024,040 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 214,008 | -0.03 | 88.38 | -5,833 | 18,913,043 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53,634 | -0.01 | 88.38 | -442 | 4,739,926 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 234,235 | -0.03 | 88.38 | -6,540 | 20,700,612 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,798 | 11,354,802 | -0.14 | 83.94 | -1,326,160 | 953,176,583 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,425 | 1,777,506 | -0.14 | 83.94 | -203,566 | 149,212,386 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -418 | 339,847 | -0.12 | 83.94 | -35,089 | 28,528,388 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -242 | 214,074 | -0.11 | 83.94 | -20,315 | 17,970,399 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53,639 | -0.03 | 83.94 | -1,511 | 4,502,715 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -271 | 234,309 | -0.12 | 83.94 | -22,749 | 19,669,022 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -3,660,993 | 0 | -100.00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -294,948 | 0 | -100.00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -4,627,208 | 0 | -100.00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -372,792 | 0 | -100.00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,248,102 | 8,374,935 | 36.69 | 10.00 | 22,481,020 | 83,749,350 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 251,898 | 770,180 | 48.60 | 10.00 | 2,518,980 | 7,701,800 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 767,427 | 6,126,833 | 14.32 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 86,501 | 518,282 | 20.03 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 732,198 | 5,359,406 | 15.82 | 5.00 | 3,660,990 | 26,797,030 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 58,989 | 431,781 | 15.82 | 5.00 | 294,945 | 2,158,905 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 4,627,208 | 4,627,208 | |||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 372,792 | 372,792 | |||||
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340,265 | 0.08 | 70.18 | 19,931 | 23,879,798 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340,265 | 0.08 | 70.18 | 19,931 | 23,879,798 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 11,544,497 | 0.00 | 70.18 | 19,931 | 810,192,799 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 1,953,828 | 0.01 | 70.18 | 19,931 | 137,119,649 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 227,554 | 0.12 | 70.18 | 19,931 | 15,969,740 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 388,213 | 0.07 | 70.18 | 19,931 | 27,244,788 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,340 | 81,414 | 2.96 | 8.71 | 20,381 | 709,116 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,340 | 81,414 | 2.96 | 8.71 | 20,381 | 709,116 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,340 | 4,280,212 | 0.05 | 8.71 | 20,381 | 37,280,647 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810,564 | 0.03 | 69.08 | 18,997 | 55,993,761 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810,564 | 0.03 | 69.08 | 18,997 | 55,993,761 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 1,269,837 | 0.02 | 69.08 | 18,997 | 87,720,340 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 131,007 | 24,798,117 | 0.53 | 19.09 | 2,501,238 | 473,455,569 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14,555 | 3,151,020 | 0.46 | 19.09 | 277,890 | 60,160,534 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38,207 | 24,667,110 | 0.16 | 19.01 | 726,353 | 468,946,428 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,245 | 3,136,465 | 0.14 | 19.01 | 80,702 | 59,627,336 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 920,495 | 24,628,903 | 3.88 | 18.64 | 17,154,897 | 458,999,014 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102,267 | 3,132,220 | 3.38 | 18.64 | 1,905,909 | 58,373,931 | |
| 2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 5,231,900 | 5,250,491 | 28,142.11 | 108.00 | 565,045,200 | 567,053,028 | |
| 2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 582,200 | 600,791 | 3,131.62 | 108.00 | 62,877,600 | 64,885,428 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16,383 | 632,599 | 2.66 | 1.32 | 21,626 | 835,031 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16,383 | 632,599 | 2.66 | 1.32 | 21,626 | 835,031 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16,383 | 34,222,983 | 0.05 | 1.32 | 21,626 | 45,174,338 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810,289 | 0.03 | 67.00 | 18,961 | 54,289,363 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810,289 | 0.03 | 67.00 | 18,961 | 54,289,363 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810,289 | 0.03 | 67.00 | 18,961 | 54,289,363 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339,981 | 0.12 | 50.40 | 19,958 | 17,135,042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339,981 | 0.12 | 50.40 | 19,958 | 17,135,042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339,981 | 0.12 | 50.40 | 19,958 | 17,135,042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 1,953,544 | 0.02 | 50.40 | 19,958 | 98,458,618 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 227,270 | 0.17 | 50.40 | 19,958 | 11,454,408 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 387,929 | 0.10 | 50.40 | 19,958 | 19,551,622 | |
| 2018-06-21 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100,000 | 100,000 | |||||
| 2018-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2018-06-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34,884 | 34,884 | |||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18,580 | 73,180,602 | 0.03 | ||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18,580 | 73,180,602 | 0.03 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 14,658,102 | 14,658,102 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -14,658,102 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 1,399,516 | 1,399,516 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -1,399,516 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3,284,771 | 7,018,874 | 87.97 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -3,284,771 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 313,621 | 734,518 | 74.51 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -313,621 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3,734,103 | 3,734,103 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -3,734,103 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 420,897 | 420,897 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -420,897 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 2,700,597 | 2,700,597 | 18.00 | 48,610,746 | 48,610,746 | ||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 299,403 | 299,403 | 18.00 | 5,389,254 | 5,389,254 | ||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 3,734,103 | 3,734,103 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 420,897 | 420,897 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 45,829,686 | 0.01 | 56.77 | 210,049 | 2,601,751,274 | |
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 45,829,686 | 0.01 | 56.77 | 210,049 | 2,601,751,274 | |
| 2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,174 | 7,648,080 | 0.03 | ||||
| 2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,174 | 7,648,080 | 0.03 | ||||
| 2018-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 126,399 | 45,825,986 | 0.28 | 54.02 | 6,828,339 | 2,475,615,998 | |
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129,715 | 45,699,587 | 0.28 | 53.70 | 6,966,305 | 2,454,282,610 | |
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 204,537 | 45,569,872 | 0.45 | 52.68 | 10,775,582 | 2,400,748,453 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 810,006 | 2.53 | 9.92 | 198,400 | 8,035,260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 810,006 | 2.53 | 9.92 | 198,400 | 8,035,260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 810,006 | 2.53 | 9.92 | 198,400 | 8,035,260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,105 | 45,365,335 | 0.02 | 54.42 | 495,488 | 2,468,749,775 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,442 | 45,356,230 | 0.05 | 52.26 | 1,120,576 | 2,370,352,865 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37,400 | 45,334,788 | 0.08 | 52.33 | 1,957,022 | 2,372,224,385 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,000 | 45,297,388 | 0.00 | 51.88 | 103,750 | 2,349,802,002 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,951 | 45,295,388 | 0.01 | 52.33 | 311,418 | 2,370,321,243 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37,963 | 45,289,437 | 0.08 | 52.06 | 1,976,213 | 2,357,600,519 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57,270 | 45,251,474 | 0.13 | 51.37 | 2,941,708 | 2,324,369,113 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,500 | 45,194,204 | 0.02 | 51.36 | 539,280 | 2,321,174,317 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22,700 | 45,183,704 | 0.05 | 51.30 | 1,164,424 | 2,317,752,317 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,533 | 45,161,004 | 0.16 | 51.26 | 3,717,693 | 2,314,736,292 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100,000 | 45,088,471 | 0.22 | 51.14 | 5,114,000 | 2,305,824,407 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 44,988,471 | 0.02 | 10.08 | 100,800 | 453,483,788 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 44,988,471 | 0.02 | 10.08 | 100,800 | 453,483,788 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 168,097 | 44,978,471 | 0.38 | 51.25 | 8,614,786 | 2,305,097,162 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 52,700 | 44,810,374 | 0.12 | 51.07 | 2,691,173 | 2,288,282,078 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 248,121 | 44,757,674 | 0.56 | 51.03 | 12,661,069 | 2,283,885,637 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 154,218 | 44,509,553 | 0.35 | 50.90 | 7,849,897 | 2,265,594,110 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,349 | 616,216 | 2.21 | 1.62 | 21,625 | 998,270 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,349 | 616,216 | 2.21 | 1.62 | 21,625 | 998,270 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,349 | 616,216 | 2.21 | 1.62 | 21,625 | 998,270 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339,585 | 0.19 | 31.29 | 19,963 | 10,625,615 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339,585 | 0.19 | 31.29 | 19,963 | 10,625,615 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790,006 | 0.03 | 83.33 | 18,999 | 65,831,200 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 1,249,279 | 0.02 | 83.33 | 18,999 | 104,102,419 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790,006 | 0.03 | 83.33 | 18,999 | 65,831,200 | |
| 2018-03-29 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 999,514 | 7,480,182 | 15.42 | 4.50 | 4,497,813 | 33,660,819 | |
| 2018-03-29 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 111,597 | 845,858 | 15.20 | 4.50 | 502,186 | 3,806,361 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -439,036 | 0 | -100.00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -17,626,445 | 0 | -100.00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -2,250,846 | 0 | -100.00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 439,036 | 602,867 | 267.98 | 0.47 | 206,347 | 283,347 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 17,626,445 | 34,193,251 | 106.40 | 0.47 | 8,284,429 | 16,070,828 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 2,250,846 | 4,102,796 | 121.54 | 0.47 | 1,057,898 | 1,928,314 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 338,947 | 2.49 | 18.50 | 152,625 | 6,270,520 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 338,947 | 2.49 | 18.50 | 152,625 | 6,270,520 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,382,329 | 0.60 | 18.50 | 152,625 | 25,573,086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,382,329 | 0.60 | 18.50 | 152,625 | 25,573,086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,382,329 | 0.60 | 18.50 | 152,625 | 25,573,086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 338,947 | 2.49 | 18.50 | 152,625 | 6,270,520 | |
| 2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,456,543 | 44,355,335 | 8.45 | 52.00 | 179,740,236 | 2,306,477,420 | |
| 2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 389,610 | 5,278,174 | 7.97 | 52.00 | 20,259,720 | 274,465,048 | |
| 2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1,645,148 | 5,121,404 | 47.33 | 101.00 | 166,159,948 | 517,261,804 | |
| 2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 335,050 | 708,025 | 89.83 | 101.00 | 33,840,050 | 71,510,525 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -4,136 | 58,131 | -6.64 | 7.91 | -32,715 | 459,799 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -265,708 | 3,734,776 | -6.64 | 7.91 | -2,101,671 | 29,540,958 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -25,517 | 358,671 | -6.64 | 7.91 | -201,832 | 2,836,980 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -4,548 | 62,267 | -6.81 | 8.12 | -36,910 | 505,340 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -292,168 | 4,000,484 | -6.81 | 8.12 | -2,371,148 | 32,466,728 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -28,058 | 384,188 | -6.81 | 8.12 | -227,710 | 3,117,955 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -3,649 | 66,815 | -5.18 | 8.63 | -31,476 | 576,340 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -234,437 | 4,292,652 | -5.18 | 8.63 | -2,022,230 | 37,027,987 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -22,514 | 412,246 | -5.18 | 8.63 | -194,204 | 3,555,993 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,333 | 163,831 | 6.04 | 2.21 | 20,626 | 362,067 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,333 | 163,831 | 6.04 | 2.21 | 20,626 | 362,067 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,333 | 163,831 | 6.04 | 2.21 | 20,626 | 362,067 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330,697 | 0.18 | 34.20 | 19,973 | 11,309,837 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330,697 | 0.18 | 34.20 | 19,973 | 11,309,837 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1,374,079 | 0.04 | 34.20 | 19,973 | 46,993,502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1,374,079 | 0.04 | 34.20 | 19,973 | 46,993,502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1,374,079 | 0.04 | 34.20 | 19,973 | 46,993,502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330,697 | 0.18 | 34.20 | 19,973 | 11,309,837 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789,778 | 0.03 | 94.71 | 18,942 | 74,799,874 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789,778 | 0.03 | 94.71 | 18,942 | 74,799,874 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789,778 | 0.03 | 94.71 | 18,942 | 74,799,874 | |
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -39,378 | 0 | -100.00 | ||||
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -1,941 | 489,977 | -0.39 | 28.00 | -54,348 | 13,719,356 | |
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 39,378 | 491,918 | 8.70 | 1.38 | 54,342 | 678,847 | |
| 2017-11-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
P - Purchase | 1,618,684 | 1,618,684 | 13.00 | 21,041,273 | 21,041,273 | ||
| 2017-11-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
P - Purchase | 304,392 | 304,392 | 13.00 | 3,956,792 | 3,956,792 | ||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -5,996 | 0 | -100.00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -249,801 | 0 | -100.00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -24,466 | 0 | -100.00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 5,996 | 35,999 | 19.98 | 7.86 | 47,129 | 282,952 | |
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 249,801 | 2,372,218 | 11.77 | 7.86 | 1,963,436 | 18,645,633 | |
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 24,466 | 141,244 | 20.95 | 7.86 | 192,303 | 1,110,178 | |
| 2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,204,652 | 16,557,473 | 77.03 | 1.50 | 10,806,978 | 24,836,210 | |
| 2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 795,348 | 1,842,617 | 75.94 | 1.50 | 1,193,022 | 2,763,926 | |
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -1,426,590 | 0 | -100.00 | ||||
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -55,457 | 23,708,408 | -0.23 | 35.40 | -1,963,178 | 839,277,643 | |
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1,426,590 | 23,763,865 | 6.39 | 1.38 | 1,968,694 | 32,794,134 | |
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7,102 | 7,102 | |||||
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7,102 | 7,102 | |||||
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -49,200 | 0 | -100.00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Series A Convertible Prefered |
C - Conversion | -9,913,242 | 0 | -100.00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Series A Convertible Prefered |
C - Conversion | -760,829 | 0 | -100.00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 797,191 | 1,878,242 | 73.74 | 17.00 | 13,552,247 | 31,930,114 | |
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 87,809 | 170,778 | 105.83 | 17.00 | 1,492,753 | 2,903,226 | |
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 1,081,051 | 1,081,051 | |||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 82,969 | 82,969 | |||||
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,045 | 154,498 | 6.22 | 2.28 | 20,623 | 352,255 | |
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,045 | 154,498 | 6.22 | 2.28 | 20,623 | 352,255 | |
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,045 | 154,498 | 6.22 | 2.28 | 20,623 | 352,255 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330,113 | 0.19 | 32.09 | 19,960 | 10,593,326 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330,113 | 0.19 | 32.09 | 19,960 | 10,593,326 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1,373,495 | 0.05 | 32.09 | 19,960 | 44,075,455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1,373,495 | 0.05 | 32.09 | 19,960 | 44,075,455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1,373,495 | 0.05 | 32.09 | 19,960 | 44,075,455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330,113 | 0.19 | 32.09 | 19,960 | 10,593,326 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789,578 | 0.02 | 116.74 | 18,912 | 92,175,336 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789,578 | 0.02 | 116.74 | 18,912 | 92,175,336 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789,578 | 0.02 | 116.74 | 18,912 | 92,175,336 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,029 | 789,416 | 0.26 | 132.00 | 267,828 | 104,202,912 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 85,402 | 29,247,347 | 0.29 | 132.00 | 11,273,064 | 3,860,649,804 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12,569 | 4,386,818 | 0.29 | 132.00 | 1,659,108 | 579,059,976 | |
| 2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 158,279 | 3,476,256 | 4.77 | 71.00 | 11,237,809 | 246,814,176 | |
| 2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 17,777 | 372,975 | 5.00 | 71.00 | 1,262,167 | 26,481,225 | |
| 2017-08-02 |
|
4 | NVTA |
Invitae Corp
Series A Convertible Preferred |
P - Purchase | 3,109,063 | 3,109,063 | 8.50 | 26,427,036 | 26,427,036 | ||
| 2017-08-02 |
|
4 | NVTA |
Invitae Corp
Series A Convertible Preferred |
P - Purchase | 349,760 | 349,760 | 8.50 | 2,972,960 | 2,972,960 | ||
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11,787 | 145,453 | 8.82 | 1.75 | 20,627 | 254,543 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11,787 | 145,453 | 8.82 | 1.75 | 20,627 | 254,543 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11,787 | 145,453 | 8.82 | 1.75 | 20,627 | 254,543 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 329,491 | 0.19 | 32.55 | 19,986 | 10,724,932 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1,246,660 | 0.01 | 125.91 | 18,886 | 156,966,961 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1,246,660 | 0.01 | 125.91 | 18,886 | 156,966,961 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 787,387 | 0.02 | 125.91 | 18,886 | 99,139,897 | |
| 2017-06-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22,560 | 7,317,906 | 0.31 | 117.95 | 2,660,914 | 863,134,572 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,564 | 647,367 | 0.40 | 117.95 | 302,419 | 76,355,837 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 197,126 | 7,295,346 | 2.78 | 117.51 | 23,163,488 | 857,246,927 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22,399 | 644,803 | 3.60 | 117.51 | 2,632,017 | 75,768,221 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32,172 | 7,098,220 | 0.46 | 117.22 | 3,771,228 | 832,059,027 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,656 | 622,404 | 0.59 | 117.22 | 428,559 | 72,958,695 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 65,264 | 7,066,048 | 0.93 | 117.01 | 7,636,802 | 826,826,541 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,416 | 618,748 | 1.21 | 117.01 | 867,776 | 72,402,178 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 898 | 7,000,784 | 0.01 | 116.96 | 105,030 | 818,811,697 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102 | 611,332 | 0.02 | 116.96 | 11,930 | 71,501,391 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 31,974 | 6,999,886 | 0.46 | 116.71 | 3,731,542 | 816,925,196 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,634 | 611,230 | 0.60 | 116.71 | 424,108 | 71,333,903 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 12,726 | 6,967,912 | 0.18 | 116.37 | 1,480,897 | 810,840,590 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,446 | 607,596 | 0.24 | 116.37 | 168,268 | 70,704,610 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 385,774 | 6,955,186 | 5.87 | 116.37 | 44,891,517 | 809,356,911 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43,835 | 606,150 | 7.80 | 116.37 | 5,100,965 | 70,536,100 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,976 | 6,569,412 | 0.03 | 116.18 | 229,562 | 763,202,753 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 224 | 562,315 | 0.04 | 116.18 | 26,023 | 65,327,058 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 169,897 | 6,567,436 | 2.66 | 115.77 | 19,668,568 | 760,296,304 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19,305 | 562,091 | 3.56 | 115.77 | 2,234,894 | 65,071,926 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 207,814 | 6,397,539 | 3.36 | 115.71 | 24,046,636 | 740,273,952 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 23,614 | 542,786 | 4.55 | 115.71 | 2,732,430 | 62,807,016 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 18,678 | 6,189,725 | 0.30 | 115.06 | 2,149,048 | 712,175,522 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,122 | 519,172 | 0.41 | 115.06 | 244,152 | 59,734,736 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 64,455 | 6,171,047 | 1.06 | 114.33 | 7,369,301 | 705,551,231 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,324 | 517,050 | 1.44 | 114.33 | 837,371 | 59,115,619 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 160,000 | 980,146 | 19.51 | 117.71 | 18,832,960 | 115,369,065 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103,200 | 820,146 | 14.39 | 117.63 | 12,139,416 | 96,473,774 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32,008 | 716,946 | 4.67 | 117.60 | 3,764,067 | 84,311,201 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 300 | 684,938 | 0.04 | 116.75 | 35,025 | 79,966,512 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,747 | 7,645,906 | 0.05 | 116.75 | 437,462 | 892,659,526 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 426 | 684,638 | 0.06 | 116.75 | 49,736 | 79,931,486 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 44,898 | 7,642,159 | 0.59 | 117.50 | 5,275,484 | 897,948,333 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,102 | 684,212 | 0.75 | 117.50 | 599,481 | 80,394,431 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,373 | 7,597,261 | 0.07 | 117.21 | 629,790 | 890,504,591 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 611 | 679,110 | 0.09 | 117.21 | 71,618 | 79,601,132 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 217,305 | 7,591,888 | 2.95 | 117.05 | 25,434,638 | 888,598,604 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,692 | 678,499 | 3.78 | 117.05 | 2,890,095 | 79,415,458 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8,950 | 7,374,583 | 0.12 | 116.95 | 1,046,720 | 862,471,494 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,017 | 653,807 | 0.16 | 116.95 | 118,940 | 76,463,971 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 39,473 | 7,365,633 | 0.54 | 116.65 | 4,604,506 | 859,197,407 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,485 | 652,790 | 0.69 | 116.65 | 523,173 | 76,147,627 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,310 | 7,326,160 | 0.06 | 116.54 | 502,277 | 853,773,836 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 490 | 648,305 | 0.08 | 116.54 | 57,103 | 75,551,974 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,944 | 7,321,850 | 0.05 | 118.00 | 465,392 | 863,978,300 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 448 | 647,815 | 0.07 | 118.00 | 52,864 | 76,442,170 | |
| 2017-06-14 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
| 2017-06-09 |
|
4/A | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100,000 | 100,000 | |||||
| 2017-06-08 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100,000 | 100,000 | |||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 328,877 | 2.57 | 18.13 | 149,572 | 5,962,540 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 328,877 | 2.57 | 18.13 | 149,572 | 5,962,540 | |
| 2017-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 40,898,792 | 0.01 | 66.60 | 246,420 | 2,723,859,547 | |
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 40,898,792 | 0.01 | 66.60 | 246,420 | 2,723,859,547 | |
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 40,895,092 | 0.02 | 10.20 | 102,000 | 417,129,938 | |
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 40,895,092 | 0.02 | 10.20 | 102,000 | 417,129,938 | |
| 2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,030 | 6,559,338 | 0.03 | ||||
| 2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,030 | 6,106,592 | 0.03 | ||||
| 2017-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 36,000 | 36,000 | |||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 787,237 | 2.61 | 7.26 | 145,200 | 5,715,341 | |
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 787,237 | 2.61 | 7.26 | 145,200 | 5,715,341 | |
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 787,237 | 2.61 | 7.26 | 145,200 | 5,715,341 | |
| 2017-04-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (right to buy) |
A - Award | 399,984 | 399,984 | |||||
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,487 | 133,666 | 6.78 | 2.43 | 20,623 | 324,808 | |
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,487 | 133,666 | 6.78 | 2.43 | 20,623 | 324,808 | |
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,487 | 133,666 | 6.78 | 2.43 | 20,623 | 324,808 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767,237 | 0.02 | 133.67 | 18,981 | 102,556,570 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 1,226,510 | 0.01 | 133.67 | 18,981 | 163,947,592 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767,237 | 0.02 | 133.67 | 18,981 | 102,556,570 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320,627 | 0.20 | 31.49 | 19,965 | 10,096,544 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320,627 | 0.20 | 31.49 | 19,965 | 10,096,544 | |
| 2017-03-28 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 151,177 | 4,527,089 | 3.45 | 12.00 | 1,814,124 | 54,325,068 | |
| 2017-03-28 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 15,489 | 434,760 | 3.69 | 12.00 | 185,868 | 5,217,120 | |
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -6,050,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -5,674,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -243,450,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -228,326,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -25,000,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -25,000,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 121,672 | 767,095 | 18.85 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 111,514 | 645,423 | 20.89 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4,896,067 | 29,141,653 | 20.19 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4,487,412 | 24,245,586 | 22.71 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 502,779 | 4,353,957 | 13.06 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 491,338 | 3,851,178 | 14.62 | ||||
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 32,051 | 9,764,459 | 0.33 | 17.76 | 569,226 | 173,416,792 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,389 | 1,169,695 | 0.29 | 17.76 | 60,189 | 20,773,783 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 235,169 | 9,732,408 | 2.48 | 17.60 | 4,138,880 | 171,286,488 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 24,871 | 1,166,306 | 2.18 | 17.60 | 437,720 | 20,526,519 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 35,360 | 9,497,239 | 0.37 | 16.31 | 576,555 | 154,855,331 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,739 | 1,141,435 | 0.33 | 16.31 | 60,966 | 18,611,440 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,006 | 9,461,879 | 0.05 | 15.62 | 78,207 | 147,819,151 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 529 | 1,137,696 | 0.05 | 15.62 | 8,264 | 17,773,770 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 15,148 | 9,456,873 | 0.16 | 15.13 | 229,189 | 143,082,488 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,602 | 1,137,167 | 0.14 | 15.13 | 24,238 | 17,205,337 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,143 | 9,441,725 | 0.10 | 16.20 | 148,089 | 152,927,620 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 967 | 1,135,565 | 0.09 | 16.20 | 15,662 | 18,392,746 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 8,671 | 9,432,582 | 0.09 | 15.35 | 133,078 | 144,766,552 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 917 | 1,134,598 | 0.08 | 15.35 | 14,074 | 17,413,243 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,442 | 9,423,911 | 0.03 | 16.85 | 41,156 | 158,823,999 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 258 | 1,133,681 | 0.02 | 16.85 | 4,348 | 19,106,266 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 11,305 | 9,421,469 | 0.12 | 15.32 | 173,204 | 144,346,327 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,195 | 1,133,423 | 0.11 | 15.32 | 18,309 | 17,365,174 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,697 | 9,410,164 | 0.06 | 16.74 | 95,365 | 157,521,440 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 603 | 1,132,228 | 0.05 | 16.74 | 10,094 | 18,952,931 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14,169 | 125,179 | 12.76 | 1.50 | 21,254 | 187,768 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14,169 | 125,179 | 12.76 | 1.50 | 21,254 | 187,768 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14,169 | 125,179 | 12.76 | 1.50 | 21,254 | 187,768 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993,182 | 0.02 | 100.27 | 18,951 | 99,586,359 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993,182 | 0.02 | 100.27 | 18,951 | 99,586,359 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 533,909 | 0.04 | 100.27 | 18,951 | 53,535,055 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 1,363,375 | 0.05 | 29.39 | 19,985 | 40,069,591 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 319,993 | 0.21 | 29.39 | 19,985 | 9,404,594 | |
| 2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1,594,671 | 3,317,977 | 92.54 | 32.00 | 51,029,472 | 106,175,264 | |
| 2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 165,824 | 355,198 | 87.56 | 32.00 | 5,306,368 | 11,366,336 | |
| 2016-11-18 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 664,259 | 6,480,668 | 11.42 | 6.00 | 3,985,554 | 38,884,008 | |
| 2016-11-18 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 69,074 | 734,261 | 10.38 | 6.00 | 414,444 | 4,405,566 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 294,178 | 40,885,092 | 0.72 | 59.46 | 17,493,177 | 2,431,215,642 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,122 | 4,874,864 | 0.66 | 59.46 | 1,910,122 | 289,881,838 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50,667 | 40,590,914 | 0.12 | 58.74 | 2,976,321 | 2,384,423,943 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,533 | 4,842,742 | 0.11 | 58.74 | 325,024 | 284,476,225 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,616 | 40,540,247 | 0.05 | 55.99 | 1,042,351 | 2,269,937,618 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,039 | 4,837,209 | 0.04 | 55.99 | 114,168 | 270,845,974 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,854 | 40,521,631 | 0.04 | 56.42 | 950,861 | 2,286,129,117 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,846 | 4,835,170 | 0.04 | 56.42 | 104,147 | 272,788,203 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 143,016 | 40,504,777 | 0.35 | 56.48 | 8,078,001 | 2,287,839,420 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15,662 | 4,833,324 | 0.33 | 56.48 | 884,640 | 273,001,606 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 361 | 40,361,761 | 0.00 | 56.49 | 20,393 | 2,280,035,879 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39 | 4,817,662 | 0.00 | 56.49 | 2,203 | 272,149,726 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456 | 40,361,400 | 0.00 | 56.55 | 25,788 | 2,282,558,254 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50 | 4,817,623 | 0.00 | 56.55 | 2,828 | 272,451,034 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 341,438 | 40,360,944 | 0.85 | 56.91 | 19,430,383 | 2,296,840,421 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37,392 | 4,817,573 | 0.78 | 56.91 | 2,127,885 | 274,156,035 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95,280 | 40,019,506 | 0.24 | 55.84 | 5,320,673 | 2,234,789,264 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,434 | 4,780,181 | 0.22 | 55.84 | 582,661 | 266,937,257 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,335 | 39,924,226 | 0.01 | 55.87 | 186,336 | 2,230,686,279 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 365 | 4,769,747 | 0.01 | 55.87 | 20,394 | 266,500,074 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,289 | 39,920,891 | 0.02 | 56.12 | 352,915 | 2,240,208,704 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 689 | 4,769,382 | 0.01 | 56.12 | 38,664 | 267,639,594 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 26,381 | 39,914,602 | 0.07 | 56.13 | 1,480,758 | 2,240,394,636 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,889 | 4,768,693 | 0.06 | 56.13 | 162,159 | 267,665,307 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 289,278 | 39,888,221 | 0.73 | 56.26 | 16,274,202 | 2,244,031,537 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,679 | 4,765,804 | 0.67 | 56.26 | 1,782,197 | 268,114,601 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,884 | 39,598,943 | 0.01 | 51.83 | 149,479 | 2,052,425,095 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 316 | 4,734,125 | 0.01 | 51.83 | 16,378 | 245,371,119 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,434 | 39,596,059 | 0.01 | 53.33 | 129,815 | 2,111,812,251 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 266 | 4,733,809 | 0.01 | 53.33 | 14,187 | 252,472,496 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,717 | 39,593,625 | 0.08 | 53.66 | 1,755,578 | 2,124,574,121 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,583 | 4,733,543 | 0.08 | 53.66 | 192,262 | 253,999,551 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,332 | 39,560,908 | 0.10 | 54.37 | 2,192,976 | 2,151,049,207 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,417 | 4,729,960 | 0.09 | 54.37 | 240,166 | 257,182,588 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 924 | 39,520,576 | 0.00 | 54.51 | 50,365 | 2,154,183,605 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4,725,543 | 0.00 | 54.51 | 5,505 | 257,579,425 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,803 | 39,519,652 | 0.00 | 54.61 | 98,455 | 2,158,021,973 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 197 | 4,725,442 | 0.00 | 54.61 | 10,757 | 258,038,903 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 85,353 | 39,517,849 | 0.22 | 54.93 | 4,688,039 | 2,170,529,712 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,347 | 4,725,245 | 0.20 | 54.93 | 513,387 | 259,535,499 | |
| 2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,928,596 | 9,309,333 | 45.90 | 2.00 | 5,857,192 | 18,618,666 | |
| 2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 321,404 | 1,003,781 | 47.10 | 2.00 | 642,808 | 2,007,562 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,299 | 111,010 | 8.08 | 2.56 | 21,245 | 284,186 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,299 | 111,010 | 8.08 | 2.56 | 21,245 | 284,186 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,299 | 111,010 | 8.08 | 2.56 | 21,245 | 284,186 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992,993 | 0.02 | 94.29 | 18,952 | 93,629,310 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992,993 | 0.02 | 94.29 | 18,952 | 93,629,310 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 533,720 | 0.04 | 94.29 | 18,952 | 50,324,459 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 319,313 | 0.22 | 28.92 | 19,955 | 9,234,532 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12,550 | 1,131,625 | 1.12 | 13.15 | 165,029 | 14,880,529 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,476,348 | 9,404,467 | 35.74 | 12.25 | 30,335,263 | 115,204,721 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 294,707 | 1,119,075 | 35.75 | 12.25 | 3,610,161 | 13,708,669 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,339 | 39,432,496 | 0.06 | 51.55 | 1,254,571 | 2,032,575,609 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,730 | 4,715,898 | 0.06 | 51.55 | 140,720 | 243,084,264 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 58,541 | 39,408,157 | 0.15 | 51.41 | 3,009,341 | 2,025,803,896 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,565 | 4,713,168 | 0.14 | 51.41 | 337,478 | 242,283,700 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39,349,616 | 0.00 | 50.64 | 45,523 | 1,992,546,505 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4,706,603 | 0.00 | 50.64 | 5,114 | 238,328,256 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,804 | 39,348,717 | 0.06 | 50.42 | 1,099,388 | 1,984,017,399 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,445 | 4,706,502 | 0.05 | 50.42 | 123,280 | 237,308,420 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,290 | 39,326,913 | 0.05 | 50.41 | 1,073,191 | 1,982,398,896 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,388 | 4,704,057 | 0.05 | 50.41 | 120,375 | 237,123,046 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90 | 39,305,623 | 0.00 | 50.00 | 4,500 | 1,965,281,150 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 | 4,701,669 | 0.00 | 50.00 | 500 | 235,083,450 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39,305,533 | 0.00 | 49.84 | 44,802 | 1,958,791,237 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4,701,659 | 0.00 | 49.84 | 5,033 | 234,307,176 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,380 | 39,304,634 | 0.02 | 50.99 | 427,266 | 2,004,001,791 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4,701,558 | 0.02 | 50.99 | 47,927 | 239,715,517 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,338 | 39,296,254 | 0.01 | 50.48 | 118,029 | 1,983,788,861 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 262 | 4,700,618 | 0.01 | 50.48 | 13,227 | 237,300,828 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,241 | 39,293,916 | 0.08 | 51.25 | 1,703,751 | 2,013,990,018 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,728 | 4,700,356 | 0.08 | 51.25 | 191,077 | 240,914,397 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,440 | 39,260,675 | 0.06 | 50.33 | 1,179,656 | 1,975,856,286 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,637 | 4,696,628 | 0.06 | 50.33 | 132,711 | 236,365,319 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170,652 | 39,237,235 | 0.44 | 50.38 | 8,597,226 | 1,976,720,891 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,201 | 4,693,991 | 0.41 | 50.38 | 967,321 | 236,477,164 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,944 | 39,066,583 | 0.02 | 51.05 | 405,541 | 1,994,349,062 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 894 | 4,674,790 | 0.02 | 51.05 | 45,639 | 238,648,030 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 28,271 | 39,058,639 | 0.07 | 50.55 | 1,428,963 | 1,974,226,720 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,181 | 4,673,896 | 0.07 | 50.55 | 160,784 | 236,243,008 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,893 | 39,030,368 | 0.09 | 50.48 | 1,710,844 | 1,970,167,110 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,813 | 4,670,715 | 0.08 | 50.48 | 192,472 | 235,767,418 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48,036 | 38,996,475 | 0.12 | 50.10 | 2,406,829 | 1,953,906,681 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,405 | 4,666,902 | 0.12 | 50.10 | 270,816 | 233,833,725 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101,290 | 38,948,439 | 0.26 | 50.05 | 5,069,433 | 1,949,318,739 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,397 | 4,661,497 | 0.25 | 50.05 | 570,405 | 233,301,865 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,581 | 38,847,149 | 0.01 | 49.46 | 276,030 | 1,921,337,258 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 628 | 4,650,100 | 0.01 | 49.46 | 31,060 | 229,988,831 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 944 | 38,841,568 | 0.00 | 49.18 | 46,427 | 1,910,267,156 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106 | 4,649,472 | 0.00 | 49.18 | 5,213 | 228,665,682 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,825 | 38,840,624 | 0.04 | 48.61 | 672,033 | 1,888,042,733 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,556 | 4,649,366 | 0.03 | 48.61 | 75,637 | 226,005,681 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 12,955 | 38,826,799 | 0.03 | 48.95 | 634,191 | 1,900,703,822 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,457 | 4,647,810 | 0.03 | 48.95 | 71,325 | 227,526,102 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 548 | 38,813,844 | 0.00 | 47.27 | 25,904 | 1,834,718,762 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62 | 4,646,353 | 0.00 | 47.27 | 2,931 | 219,631,712 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,681 | 38,813,296 | 0.03 | 48.16 | 562,550 | 1,869,225,047 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,314 | 4,646,291 | 0.03 | 48.16 | 63,281 | 223,762,587 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,598 | 38,801,615 | 0.02 | 48.44 | 416,460 | 1,879,426,065 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 967 | 4,644,977 | 0.02 | 48.44 | 46,838 | 224,987,822 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,930 | 38,793,017 | 0.02 | 48.29 | 286,332 | 1,873,132,464 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 667 | 4,644,010 | 0.01 | 48.29 | 32,206 | 224,237,416 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 84,331 | 4,643,343 | 1.85 | 46.17 | 3,893,638 | 214,387,325 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,600 | 4,559,012 | 0.08 | 45.10 | 162,369 | 205,623,295 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 35,263 | 4,555,412 | 0.78 | 45.39 | 1,600,457 | 206,753,296 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,360 | 4,520,149 | 0.19 | 46.10 | 385,414 | 208,388,813 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,735 | 4,511,789 | 0.06 | 44.98 | 123,025 | 202,948,842 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,074 | 4,509,054 | 0.20 | 45.80 | 415,623 | 206,531,357 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -850 | 9,418,390 | -0.01 | 4.29 | -3,645 | 40,392,649 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -140 | 1,551,387 | -0.01 | 4.29 | -600 | 6,653,433 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -343,583 | 9,419,240 | -3.52 | 4.83 | -1,658,681 | 45,472,323 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -56,417 | 1,551,527 | -3.51 | 4.83 | -272,359 | 7,490,152 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -296,856 | 9,762,823 | -2.95 | 5.25 | -1,559,711 | 51,294,848 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -48,744 | 1,607,944 | -2.94 | 5.25 | -256,106 | 8,448,299 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -2,834,561 | 10,059,679 | -21.98 | 5.00 | -14,172,805 | 50,298,395 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -465,439 | 1,656,688 | -21.93 | 5.00 | -2,327,195 | 8,283,440 | |
| 2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 89,896 | 11,348,958 | 0.80 | 27.02 | 2,428,621 | 306,602,314 | |
| 2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10,104 | 1,758,289 | 0.58 | 27.02 | 272,969 | 47,501,760 | |
| 2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,169,877 | 22,337,275 | 5.53 | 33.00 | 38,605,941 | 737,130,075 | |
| 2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 133,153 | 3,029,953 | 4.60 | 33.00 | 4,394,049 | 99,988,449 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,038 | 102,711 | 14.54 | 1.63 | 21,252 | 167,419 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,038 | 102,711 | 14.54 | 1.63 | 21,252 | 167,419 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,038 | 102,711 | 14.54 | 1.63 | 21,252 | 167,419 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13,937,394 | 0.01 | 26.74 | 19,948 | 372,685,916 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13,937,394 | 0.01 | 26.74 | 19,948 | 372,685,916 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1,362,005 | 0.05 | 26.74 | 19,948 | 36,420,014 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1,362,005 | 0.05 | 26.74 | 19,948 | 36,420,014 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318,623 | 0.23 | 26.74 | 19,948 | 8,519,979 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318,623 | 0.23 | 26.74 | 19,948 | 8,519,979 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 23,803,844 | 0.00 | 79.98 | 18,955 | 1,903,831,443 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533,519 | 0.04 | 79.98 | 18,955 | 42,670,850 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533,519 | 0.04 | 79.98 | 18,955 | 42,670,850 | |
| 2016-06-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70,000 | 70,000 | |||||
| 2016-06-13 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 26,500 | 26,500 | |||||
| 2016-06-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -2,318 | 30,003 | -7.17 | 9.56 | -22,157 | 286,787 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -158,684 | 2,122,417 | -6.96 | 9.56 | -1,516,797 | 20,287,335 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -9,056 | 116,778 | -7.20 | 9.56 | -86,563 | 1,116,234 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -5,111 | 32,321 | -13.65 | 9.40 | -48,043 | 303,817 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -349,919 | 2,281,101 | -13.30 | 9.40 | -3,289,239 | 21,442,349 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -19,970 | 125,834 | -13.70 | 9.40 | -187,718 | 1,182,840 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -2,154 | 37,432 | -5.44 | 9.21 | -19,844 | 344,839 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -147,529 | 2,631,020 | -5.31 | 9.21 | -1,359,096 | 24,238,009 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -8,417 | 145,804 | -5.46 | 9.21 | -77,541 | 1,343,205 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -4,201 | 39,586 | -9.59 | 9.44 | -39,648 | 373,605 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -275,506 | 2,778,549 | -9.02 | 9.44 | -2,600,171 | 26,223,390 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -16,493 | 154,221 | -9.66 | 9.44 | -155,658 | 1,455,507 | |
| 2016-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 38,787,087 | 0.01 | 38.82 | 143,634 | 1,505,714,717 | |
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 38,787,087 | 0.01 | 38.82 | 143,634 | 1,505,714,717 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 317,877 | 2.66 | 10.73 | 88,522 | 3,410,820 | |
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2,294 | 2,294 | |||||
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6,104,562 | 0.01 | ||||
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6,104,562 | 0.01 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -1,232,130 | 0 | -100.00 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -101,204 | 0 | -100.00 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
P - Purchase | 179,531 | 976,214 | 22.53 | 18.00 | 3,231,558 | 17,571,852 | |
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
P - Purchase | 20,469 | 85,906 | 31.28 | 18.00 | 368,442 | 1,546,308 | |
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
C - Conversion | 796,683 | 796,683 | |||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
C - Conversion | 65,437 | 65,437 | |||||
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10,788 | 7,110,113 | 0.15 | 1.97 | 21,252 | 14,006,923 | |
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10,788 | 89,673 | 13.68 | 1.97 | 21,252 | 176,656 | |
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10,788 | 89,673 | 13.68 | 1.97 | 21,252 | 176,656 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309,627 | 0.25 | 25.48 | 19,976 | 7,889,296 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309,627 | 0.25 | 25.48 | 19,976 | 7,889,296 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533,282 | 0.05 | 72.47 | 18,987 | 38,646,947 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533,282 | 0.05 | 72.47 | 18,987 | 38,646,947 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533,282 | 0.05 | 72.47 | 18,987 | 38,646,947 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 137 | 3,268,830 | 0.00 | 6.74 | 923 | 22,031,914 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -3,479 | 0 | -100.00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -310,003 | 0 | -100.00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -137 | 0 | -100.00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -137 | 0 | -100.00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 3,479 | 43,787 | 8.63 | 6.74 | 23,448 | 295,124 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 310,003 | 3,054,055 | 11.30 | 6.74 | 2,089,420 | 20,584,331 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 137 | 137 | 6.74 | 923 | 923 | ||
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 262,253 | 21,167,398 | 1.25 | 28.55 | 7,486,904 | 604,295,345 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28,647 | 2,896,800 | 1.00 | 28.55 | 817,826 | 82,699,005 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10,818 | 20,905,145 | 0.05 | 27.82 | 300,959 | 581,585,315 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,182 | 2,868,153 | 0.04 | 27.82 | 32,883 | 79,792,590 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 318,969 | 20,894,327 | 1.55 | 27.72 | 8,840,959 | 579,134,330 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 34,844 | 2,866,971 | 1.23 | 27.72 | 965,782 | 79,464,695 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 60,587 | 20,575,358 | 0.30 | 27.56 | 1,669,705 | 567,032,176 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6,618 | 2,832,127 | 0.23 | 27.56 | 182,384 | 78,050,022 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28,433 | 20,514,771 | 0.14 | 26.55 | 755,024 | 544,759,487 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,106 | 2,825,509 | 0.11 | 26.55 | 82,478 | 75,029,979 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 180,122 | 20,486,338 | 0.89 | 26.49 | 4,772,224 | 542,773,234 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19,676 | 2,822,403 | 0.70 | 26.49 | 521,304 | 74,777,874 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13,433 | 20,306,216 | 0.07 | 26.28 | 353,086 | 533,748,888 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,467 | 2,802,727 | 0.05 | 26.28 | 38,560 | 73,669,679 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14,775 | 20,292,783 | 0.07 | 25.61 | 378,343 | 519,637,294 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,614 | 2,801,260 | 0.06 | 25.61 | 41,330 | 71,731,865 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 16,057 | 2,799,646 | 0.58 | 26.35 | 423,057 | 73,762,833 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 37,882 | 2,783,589 | 1.38 | 25.98 | 983,985 | 72,303,724 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 408,607 | 2,745,707 | 17.48 | 25.92 | 10,593,014 | 71,181,630 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 92,140 | 38,783,387 | 0.24 | 31.73 | 2,923,547 | 1,230,573,599 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,034 | 4,496,280 | 0.22 | 31.73 | 318,373 | 142,664,267 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,741 | 38,691,247 | 0.05 | 32.41 | 639,713 | 1,253,801,466 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,150 | 4,486,246 | 0.05 | 32.41 | 69,671 | 145,378,148 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 206,421,153 | 0.01 | 3.86 | 77,200 | 796,785,651 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 90,179 | 19,757,285 | 0.46 | 62.59 | 5,644,024 | 1,236,547,221 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9,821 | 3,358,951 | 0.29 | 62.59 | 614,666 | 210,226,330 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 127,964 | 19,667,106 | 0.65 | 61.38 | 7,854,149 | 1,207,123,699 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13,936 | 3,349,130 | 0.42 | 61.38 | 855,361 | 205,562,231 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 24,431 | 19,539,142 | 0.13 | 61.03 | 1,490,975 | 1,192,434,758 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,660 | 3,335,194 | 0.08 | 61.03 | 162,334 | 203,540,219 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20,659 | 19,514,711 | 0.11 | 60.95 | 1,259,178 | 1,189,433,344 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,250 | 3,332,534 | 0.07 | 60.95 | 137,139 | 203,119,947 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 97,484 | 19,494,052 | 0.50 | 60.85 | 5,931,960 | 1,186,224,761 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10,616 | 3,330,284 | 0.32 | 60.85 | 645,990 | 202,649,780 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 533,020 | 3.90 | 3.86 | 77,200 | 2,057,457 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 533,020 | 3.90 | 3.86 | 77,200 | 2,057,457 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,182 | 19,376,568 | 0.01 | 65.29 | 77,176 | 1,265,142,628 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 129 | 3,299,668 | 0.00 | 65.29 | 8,423 | 215,443,243 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 179,176 | 19,375,386 | 0.93 | 65.80 | 11,789,387 | 1,274,857,773 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19,513 | 3,299,539 | 0.59 | 65.80 | 1,283,912 | 217,102,407 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 180,358 | 19,196,210 | 0.95 | 67.15 | 12,110,607 | 1,288,979,431 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19,642 | 3,280,026 | 0.60 | 67.15 | 1,318,913 | 220,245,874 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198,484 | 38,671,506 | 0.52 | 31.60 | 6,272,531 | 1,222,104,667 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,616 | 4,484,096 | 0.48 | 31.60 | 683,113 | 141,707,299 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,810 | 38,473,022 | 0.09 | 31.86 | 1,045,205 | 1,225,608,131 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,573 | 4,462,480 | 0.08 | 31.86 | 113,823 | 142,158,102 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,627 | 38,440,212 | 0.02 | 31.50 | 271,712 | 1,210,693,697 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4,458,907 | 0.02 | 31.50 | 29,606 | 140,435,505 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 273,381 | 38,431,585 | 0.72 | 31.89 | 8,719,077 | 1,225,717,756 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,772 | 4,457,967 | 0.67 | 31.89 | 949,533 | 142,180,171 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 145,272 | 38,158,204 | 0.38 | 31.74 | 4,611,296 | 1,211,236,790 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15,821 | 4,428,195 | 0.36 | 31.74 | 502,198 | 140,561,980 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63,560 | 38,012,932 | 0.17 | 31.50 | 2,002,401 | 1,197,563,211 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,922 | 4,412,374 | 0.16 | 31.50 | 218,071 | 139,007,872 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 387,336 | 37,949,372 | 1.03 | 32.31 | 12,514,051 | 1,226,068,311 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42,182 | 4,405,452 | 0.97 | 32.31 | 1,362,816 | 142,331,343 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 107,260 | 37,562,036 | 0.29 | 33.77 | 3,622,063 | 1,268,432,394 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,681 | 4,363,270 | 0.27 | 33.77 | 394,456 | 147,343,265 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 128,975 | 6,928,119 | 1.90 | 8.16 | 1,051,920 | 56,505,739 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 14,046 | 824,368 | 1.73 | 8.16 | 114,559 | 6,723,545 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 185,413 | 6,799,144 | 2.80 | 7.91 | 1,466,320 | 53,770,350 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20,192 | 810,322 | 2.56 | 7.91 | 159,686 | 6,408,351 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 11,840 | 6,613,731 | 0.18 | 7.70 | 91,160 | 50,921,099 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,289 | 790,130 | 0.16 | 7.70 | 9,924 | 6,083,448 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 68,132 | 6,601,891 | 1.04 | 8.03 | 546,807 | 52,984,797 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 7,420 | 788,841 | 0.95 | 8.03 | 59,551 | 6,331,001 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 30,986 | 6,533,759 | 0.48 | 7.88 | 244,126 | 51,476,874 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,374 | 781,421 | 0.43 | 7.88 | 26,582 | 6,156,503 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,874 | 37,454,776 | 0.01 | 32.34 | 157,646 | 1,211,448,511 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 547 | 4,351,589 | 0.01 | 32.34 | 17,692 | 140,749,100 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 147,831 | 37,449,902 | 0.40 | 33.15 | 4,900,997 | 1,241,565,366 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,608 | 4,351,042 | 0.38 | 33.15 | 550,600 | 144,248,790 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,289 | 37,302,071 | 0.06 | 32.96 | 767,582 | 1,229,438,958 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,616 | 4,334,434 | 0.06 | 32.96 | 86,221 | 142,858,610 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95,682 | 37,278,782 | 0.26 | 32.41 | 3,100,652 | 1,208,048,754 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,749 | 4,331,818 | 0.25 | 32.41 | 348,330 | 140,376,028 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 165,237 | 37,183,100 | 0.45 | 32.30 | 5,337,915 | 1,201,185,172 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,563 | 4,321,069 | 0.43 | 32.30 | 599,670 | 139,590,406 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 36,589 | 37,017,863 | 0.10 | 31.15 | 1,139,842 | 1,153,202,679 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,111 | 4,302,506 | 0.10 | 31.15 | 128,068 | 134,034,248 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97,272 | 36,981,274 | 0.26 | 32.12 | 3,124,484 | 1,187,879,200 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,927 | 4,298,395 | 0.25 | 32.12 | 350,987 | 138,069,176 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 53,734 | 36,884,002 | 0.15 | 32.47 | 1,744,598 | 1,197,523,958 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,037 | 4,287,468 | 0.14 | 32.47 | 196,005 | 139,202,510 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 286,671,473 | 0.00 | 4.18 | 41,800 | 1,198,286,757 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88,732 | 36,830,268 | 0.24 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,968 | 4,281,431 | 0.23 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48,996 | 36,741,536 | 0.13 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,504 | 4,271,463 | 0.13 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 36,692,540 | 0.03 | 4.18 | 41,800 | 153,374,817 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,157 | 36,682,540 | 0.04 | 33.72 | 477,445 | 1,237,118,662 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,590 | 4,255,959 | 0.04 | 33.72 | 53,623 | 143,532,217 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,921 | 36,668,383 | 0.11 | 33.68 | 1,378,043 | 1,234,833,465 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,597 | 4,254,369 | 0.11 | 33.68 | 154,807 | 143,268,854 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218,550 | 36,627,462 | 0.60 | 32.49 | 7,101,280 | 1,190,125,135 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,908 | 4,249,772 | 0.57 | 32.49 | 776,835 | 138,086,567 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 41,104 | 36,408,912 | 0.11 | 31.68 | 1,302,257 | 1,153,507,150 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,496 | 4,225,864 | 0.11 | 31.68 | 142,442 | 133,883,823 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59,492 | 36,367,808 | 0.16 | 32.24 | 1,918,022 | 1,172,498,130 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,508 | 4,221,368 | 0.15 | 32.24 | 209,818 | 136,096,904 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 301,066 | 36,308,316 | 0.84 | 32.76 | 9,862,139 | 1,189,366,031 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,934 | 4,214,860 | 0.79 | 32.76 | 1,078,832 | 138,067,855 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,814 | 36,007,250 | 0.06 | 31.24 | 681,563 | 1,125,021,321 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,386 | 4,181,926 | 0.06 | 31.24 | 74,549 | 130,661,351 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 172,462 | 35,985,436 | 0.48 | 30.34 | 5,232,928 | 1,091,888,092 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,866 | 4,179,540 | 0.45 | 30.34 | 572,442 | 126,817,692 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 54,439 | 35,812,974 | 0.15 | 30.55 | 1,663,024 | 1,094,029,055 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,955 | 4,160,674 | 0.14 | 30.55 | 181,916 | 127,101,934 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,022 | 19,015,852 | 0.03 | 74.00 | 445,628 | 1,407,173,048 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 678 | 3,260,384 | 0.02 | 74.00 | 50,172 | 241,268,416 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20,492 | 19,009,830 | 0.11 | 69.70 | 1,428,282 | 1,324,975,646 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,308 | 3,259,706 | 0.07 | 69.70 | 160,866 | 227,199,878 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 23,157 | 18,989,338 | 0.12 | 70.50 | 1,632,684 | 1,338,843,276 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,608 | 3,257,398 | 0.08 | 70.50 | 183,877 | 229,662,846 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8,111 | 18,966,181 | 0.04 | 71.96 | 583,702 | 1,364,886,043 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 914 | 3,254,790 | 0.03 | 71.96 | 65,775 | 234,228,359 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39,815 | 35,758,535 | 0.11 | 30.13 | 1,199,793 | 1,077,554,845 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,485 | 4,154,719 | 0.11 | 30.13 | 135,152 | 125,199,133 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 128,255 | 35,718,720 | 0.36 | 29.86 | 3,830,118 | 1,066,678,851 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,447 | 4,150,234 | 0.35 | 29.86 | 431,435 | 123,939,683 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 67,407 | 35,590,465 | 0.19 | 28.52 | 1,922,670 | 1,015,157,510 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,593 | 4,135,787 | 0.18 | 28.52 | 216,577 | 117,966,293 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,134 | 35,523,058 | 0.01 | 28.46 | 117,674 | 1,011,163,846 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 466 | 4,128,194 | 0.01 | 28.46 | 13,265 | 117,509,042 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,056 | 35,518,924 | 0.12 | 29.77 | 1,281,975 | 1,057,561,755 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,850 | 4,127,728 | 0.12 | 29.77 | 144,407 | 122,901,450 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218,768 | 35,475,868 | 0.62 | 30.21 | 6,610,053 | 1,071,899,804 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,643 | 4,122,878 | 0.60 | 30.21 | 744,586 | 124,572,346 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456,849 | 35,257,100 | 1.31 | 29.20 | 13,339,991 | 1,029,507,320 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,677 | 4,098,235 | 1.23 | 29.20 | 1,450,568 | 119,668,462 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 226,865 | 34,800,251 | 0.66 | 29.94 | 6,791,816 | 1,041,839,474 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,669 | 4,048,558 | 0.61 | 29.94 | 738,533 | 121,204,515 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 726,291 | 34,573,386 | 2.15 | 31.25 | 22,694,197 | 1,080,304,220 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78,976 | 4,023,889 | 2.00 | 31.25 | 2,467,739 | 125,733,252 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 902 | 33,847,095 | 0.00 | 29.50 | 26,609 | 998,489,302 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98 | 3,944,913 | 0.00 | 29.50 | 2,891 | 116,374,934 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106,444 | 33,846,193 | 0.32 | 29.19 | 3,107,590 | 988,126,066 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,575 | 3,944,815 | 0.29 | 29.19 | 337,927 | 115,167,296 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151,144 | 33,739,749 | 0.45 | 30.27 | 4,574,645 | 1,021,194,235 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,435 | 3,933,240 | 0.42 | 30.27 | 497,435 | 119,046,588 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 631 | 33,588,605 | 0.00 | 27.93 | 17,626 | 938,227,145 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69 | 3,916,805 | 0.00 | 27.93 | 1,927 | 109,407,722 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,073 | 33,587,974 | 0.22 | 27.28 | 1,966,043 | 916,229,549 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,909 | 3,916,736 | 0.20 | 27.28 | 215,746 | 106,842,683 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 87,049 | 33,515,901 | 0.26 | 28.07 | 2,443,831 | 940,932,108 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,551 | 3,908,827 | 0.24 | 28.07 | 268,137 | 109,737,191 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15,187 | 18,958,070 | 0.08 | 69.45 | 1,054,742 | 1,316,643,649 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,651 | 3,253,876 | 0.05 | 69.45 | 114,662 | 225,982,664 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8,250 | 18,942,883 | 0.04 | 70.86 | 584,597 | 1,342,296,478 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 897 | 3,252,225 | 0.03 | 70.86 | 63,562 | 230,453,314 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 67,373 | 18,934,633 | 0.36 | 69.54 | 4,684,923 | 1,316,659,468 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,326 | 3,251,328 | 0.23 | 69.54 | 509,429 | 226,087,920 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 124,057 | 18,867,260 | 0.66 | 70.21 | 8,710,228 | 1,324,698,625 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13,490 | 3,244,002 | 0.42 | 70.21 | 947,153 | 227,766,246 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 397,079 | 18,743,203 | 2.16 | 71.10 | 28,233,945 | 1,332,718,580 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 43,178 | 3,230,512 | 1.35 | 71.10 | 3,070,133 | 229,702,648 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 149,927 | 18,346,124 | 0.82 | 67.94 | 10,186,595 | 1,246,503,545 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 16,450 | 3,187,334 | 0.52 | 67.94 | 1,117,674 | 216,559,265 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 38,117 | 18,196,197 | 0.21 | 63.98 | 2,438,547 | 1,164,107,162 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 4,183 | 3,170,884 | 0.13 | 63.98 | 267,609 | 202,858,255 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 168,055 | 18,158,080 | 0.93 | 64.87 | 10,902,350 | 1,177,981,834 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 18,441 | 3,166,701 | 0.59 | 64.87 | 1,196,336 | 205,435,611 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 541,340 | 17,990,025 | 3.10 | 65.80 | 35,621,958 | 1,183,803,012 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 59,401 | 3,148,260 | 1.92 | 65.80 | 3,908,782 | 207,165,897 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 49,021 | 17,448,685 | 0.28 | 66.68 | 3,268,823 | 1,163,514,958 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5,379 | 3,088,859 | 0.17 | 66.68 | 358,683 | 205,971,605 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 72,894 | 17,399,664 | 0.42 | 67.68 | 4,933,706 | 1,177,666,678 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,999 | 3,083,480 | 0.26 | 67.68 | 541,399 | 208,700,102 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,939 | 17,326,770 | 0.04 | 60.85 | 422,220 | 1,054,288,905 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 761 | 3,075,481 | 0.02 | 60.85 | 46,305 | 187,135,023 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 57,865 | 17,319,831 | 0.34 | 61.73 | 3,572,047 | 1,069,165,292 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,349 | 3,074,720 | 0.21 | 61.73 | 391,928 | 189,804,618 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 136,793 | 17,261,966 | 0.80 | 58.13 | 7,952,133 | 1,003,482,965 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15,010 | 3,068,371 | 0.49 | 58.13 | 872,570 | 178,372,384 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 114,908 | 17,125,173 | 0.68 | 59.01 | 6,780,526 | 1,010,527,346 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12,609 | 3,053,361 | 0.41 | 59.01 | 744,036 | 180,173,642 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65,309 | 17,010,265 | 0.39 | 60.40 | 3,944,513 | 1,027,380,882 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,166 | 3,040,752 | 0.24 | 60.40 | 432,810 | 183,654,427 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 113,546 | 16,944,956 | 0.67 | 61.40 | 6,971,475 | 1,040,383,019 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12,459 | 3,033,586 | 0.41 | 61.40 | 764,955 | 186,255,507 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 289,755 | 16,831,410 | 1.75 | 62.56 | 18,126,986 | 1,052,967,960 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 31,795 | 3,021,127 | 1.06 | 62.56 | 1,989,086 | 189,000,799 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 176,647 | 16,541,655 | 1.08 | 63.37 | 11,194,368 | 1,048,267,836 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19,383 | 2,989,332 | 0.65 | 63.37 | 1,228,328 | 189,438,154 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 235,734 | 16,365,008 | 1.46 | 64.46 | 15,195,814 | 1,054,916,236 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25,869 | 2,969,949 | 0.88 | 64.46 | 1,667,560 | 191,447,961 | |
| 2016-02-09 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 45,000 | 12,894,240 | 0.35 | 6.33 | 284,656 | 81,565,094 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -56,853 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -2,296,890 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -238,850 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -26,292,961 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -1,912,167 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -582,747 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -44,572,171 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -4,382,118 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1,723,306 | 1,723,306 | 24.00 | 41,359,344 | 41,359,344 | ||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 189,374 | 189,374 | 24.00 | 4,544,976 | 4,544,976 | ||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 56,853 | 639,600 | 9.76 | 0.68 | 38,376 | 431,730 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 2,296,890 | 73,162,022 | 3.24 | 0.68 | 1,550,401 | 49,384,365 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 238,850 | 6,533,135 | 3.79 | 0.68 | 161,224 | 4,409,866 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 26,292,961 | 70,865,132 | 58.99 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 1,912,167 | 6,294,285 | 43.64 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 582,747 | 582,747 | |||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 44,572,171 | 44,572,171 | |||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 4,382,118 | 4,382,118 | |||||
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,800 | 12,849,240 | 0.19 | 6.65 | 164,915 | 85,444,876 | |
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 91,187 | 12,824,440 | 0.72 | 6.29 | 573,311 | 80,629,819 | |
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 91,728 | 12,733,253 | 0.73 | 6.52 | 598,360 | 83,061,556 | |
| 2016-01-29 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25,000 | 12,641,525 | 0.20 | 6.88 | 172,015 | 86,981,277 | |
| 2016-01-29 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 63,345 | 12,616,525 | 0.50 | 6.98 | 441,971 | 88,028,018 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,581 | 6,502,773 | 0.06 | 11.00 | 39,377 | 71,504,492 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 395 | 778,047 | 0.05 | 11.00 | 4,343 | 8,555,405 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 66,345 | 6,499,192 | 1.03 | 10.80 | 716,745 | 70,212,721 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 7,318 | 777,652 | 0.95 | 10.80 | 79,059 | 8,401,208 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,522 | 6,432,847 | 0.04 | 11.20 | 28,257 | 72,075,548 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 278 | 770,334 | 0.04 | 11.20 | 3,115 | 8,631,053 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,503 | 6,430,325 | 0.07 | 10.98 | 49,423 | 70,576,032 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 497 | 770,056 | 0.06 | 10.98 | 5,455 | 8,451,750 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,833 | 6,425,822 | 0.04 | 11.23 | 31,822 | 72,178,688 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 312 | 769,559 | 0.04 | 11.23 | 3,505 | 8,644,148 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 25,650 | 6,422,989 | 0.40 | 10.69 | 274,219 | 68,666,891 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,810 | 769,247 | 0.37 | 10.69 | 30,041 | 8,223,866 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 156 | 6,397,339 | 0.00 | 10.60 | 1,654 | 67,811,793 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 17 | 766,437 | 0.00 | 10.60 | 180 | 8,124,232 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,021 | 6,397,183 | 0.06 | 10.69 | 42,999 | 68,409,556 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 440 | 766,420 | 0.06 | 10.69 | 4,705 | 8,195,866 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 17,221 | 6,393,162 | 0.27 | 10.78 | 185,666 | 68,927,237 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,887 | 765,980 | 0.25 | 10.78 | 20,345 | 8,258,337 | |
| 2016-01-25 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,200 | 12,553,180 | 0.03 | 7.00 | 22,389 | 87,829,579 | |
| 2016-01-25 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103,600 | 12,549,980 | 0.83 | 7.29 | 755,368 | 91,504,414 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,734 | 6,375,941 | 0.03 | 8.90 | 15,433 | 56,745,875 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 190 | 764,093 | 0.02 | 8.90 | 1,691 | 6,800,428 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 27,996 | 6,374,207 | 0.44 | 8.96 | 250,766 | 57,095,047 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,067 | 763,903 | 0.40 | 8.96 | 27,472 | 6,842,432 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 13,789 | 6,346,211 | 0.22 | 8.96 | 123,493 | 56,836,031 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,511 | 760,836 | 0.20 | 8.96 | 13,532 | 6,813,971 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 57,453 | 6,332,422 | 0.92 | 9.89 | 567,934 | 62,597,258 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 6,294 | 759,325 | 0.84 | 9.89 | 62,217 | 7,506,079 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 14,313 | 6,274,969 | 0.23 | 9.15 | 131,017 | 57,439,184 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,568 | 753,031 | 0.21 | 9.15 | 14,353 | 6,893,020 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 10,123 | 6,260,656 | 0.16 | 9.21 | 93,282 | 57,691,319 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,109 | 751,463 | 0.15 | 9.21 | 10,219 | 6,924,656 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 45,903 | 6,250,533 | 0.74 | 9.08 | 416,602 | 56,727,962 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,029 | 750,354 | 0.67 | 9.08 | 45,642 | 6,809,988 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Comon Stock |
P - Purchase | 1,325 | 12,446,380 | 0.01 | 6.94 | 9,197 | 86,396,547 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Comon Stock |
P - Purchase | 51,370 | 12,445,055 | 0.41 | 6.87 | 352,974 | 85,512,462 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 92,200 | 12,393,685 | 0.75 | 7.12 | 656,750 | 88,281,458 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25,000 | 12,301,485 | 0.20 | 7.49 | 187,332 | 92,178,718 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 175,000 | 12,276,485 | 1.45 | 7.45 | 1,303,890 | 91,469,634 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 47,193 | 6,204,630 | 0.77 | 8.56 | 403,930 | 53,106,049 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,196 | 745,325 | 0.70 | 8.56 | 44,473 | 6,379,311 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,949 | 6,157,437 | 0.08 | 8.95 | 44,308 | 55,126,918 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 545 | 740,129 | 0.07 | 8.95 | 4,879 | 6,626,301 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,279 | 6,152,488 | 0.05 | 8.82 | 28,937 | 54,295,091 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 361 | 739,584 | 0.05 | 8.82 | 3,186 | 6,526,755 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20,851 | 6,149,209 | 0.34 | 8.10 | 168,891 | 49,807,978 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,296 | 739,223 | 0.31 | 8.10 | 18,597 | 5,987,632 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,998 | 6,128,358 | 0.05 | 8.08 | 24,213 | 49,495,071 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 330 | 736,927 | 0.04 | 8.08 | 2,665 | 5,951,717 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12,706 | 6,125,360 | 0.21 | 7.91 | 100,517 | 48,457,723 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,399 | 736,597 | 0.19 | 7.91 | 11,067 | 5,827,219 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 90,550 | 6,112,654 | 1.50 | 8.17 | 739,947 | 49,950,775 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,970 | 735,198 | 1.37 | 8.17 | 81,472 | 6,007,817 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 47,193 | 6,204,630 | 0.77 | 8.56 | 403,930 | 53,106,049 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,196 | 745,325 | 0.70 | 8.56 | 44,473 | 6,379,311 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,949 | 6,157,437 | 0.08 | 8.95 | 44,308 | 55,126,918 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 545 | 740,129 | 0.07 | 8.95 | 4,879 | 6,626,301 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,279 | 6,152,488 | 0.05 | 8.82 | 28,937 | 54,295,091 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 361 | 739,584 | 0.05 | 8.82 | 3,186 | 6,526,755 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20,851 | 6,149,209 | 0.34 | 8.10 | 168,891 | 49,807,978 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,296 | 739,223 | 0.31 | 8.10 | 18,597 | 5,987,632 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,998 | 6,128,358 | 0.05 | 8.08 | 24,213 | 49,495,071 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 330 | 736,927 | 0.04 | 8.08 | 2,665 | 5,951,717 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12,706 | 6,125,360 | 0.21 | 7.91 | 100,517 | 48,457,723 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,399 | 736,597 | 0.19 | 7.91 | 11,067 | 5,827,219 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 90,550 | 6,112,654 | 1.50 | 8.17 | 739,947 | 49,950,775 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,970 | 735,198 | 1.37 | 8.17 | 81,472 | 6,007,817 | |
| 2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,801,161 | 20,278,008 | 9.75 | 29.00 | 52,233,669 | 588,062,232 | |
| 2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785,045 | 2,337,100 | 50.58 | 29.00 | 22,766,305 | 67,775,900 | |
| 2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,801,161 | 20,278,008 | 9.75 | 29.00 | 52,233,669 | 588,062,232 | |
| 2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785,045 | 2,337,100 | 50.58 | 29.00 | 22,766,305 | 67,775,900 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7,082 | 78,885 | 9.86 | 3.00 | 21,246 | 236,655 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7,082 | 78,885 | 9.86 | 3.00 | 21,246 | 236,655 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7,082 | 6,348,612 | 0.11 | 3.00 | 21,246 | 19,045,836 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513,020 | 0.03 | 108.45 | 18,979 | 55,637,019 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513,020 | 0.03 | 108.45 | 18,979 | 55,637,019 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 666,111 | 0.03 | 108.45 | 18,979 | 72,239,738 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308,843 | 0.18 | 35.20 | 19,994 | 10,871,274 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308,843 | 0.18 | 35.20 | 19,994 | 10,871,274 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 482,740 | 0.12 | 35.20 | 19,994 | 16,992,448 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 11,423,179 | 0.00 | 35.20 | 19,994 | 402,095,901 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 196,132 | 0.29 | 35.20 | 19,994 | 6,903,846 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 356,791 | 0.16 | 35.20 | 19,994 | 12,559,043 | |
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-15 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150,000 | 33,428,852 | 0.45 | 44.00 | 6,600,000 | 1,470,869,488 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,647 | 33,278,852 | 0.10 | 43.87 | 1,388,259 | 1,459,843,401 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57,461 | 33,247,205 | 0.17 | 43.93 | 2,524,015 | 1,460,406,753 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 75,612 | 33,189,744 | 0.23 | 43.93 | 3,321,363 | 1,457,905,971 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,000 | 33,114,132 | 0.01 | 43.00 | 172,000 | 1,423,907,676 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,638 | 33,110,132 | 0.03 | 43.84 | 466,321 | 1,451,395,880 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,400 | 33,099,494 | 0.03 | 44.00 | 413,600 | 1,456,377,736 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 800 | 33,090,094 | 0.00 | 43.00 | 34,400 | 1,422,874,042 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 407,800 | 33,089,294 | 1.25 | 43.71 | 17,823,388 | 1,446,207,301 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98,700 | 32,681,494 | 0.30 | 44.00 | 4,342,800 | 1,437,985,736 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 196,490 | 32,582,794 | 0.61 | 41.31 | 8,117,179 | 1,346,024,545 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 221,434 | 32,386,304 | 0.69 | 42.51 | 9,412,318 | 1,376,618,715 | |
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,945 | 71,803 | 10.71 | 3.06 | 21,252 | 219,717 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,945 | 71,803 | 10.71 | 3.06 | 21,252 | 219,717 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,945 | 71,803 | 10.71 | 3.06 | 21,252 | 219,717 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 512,845 | 0.03 | 110.33 | 18,977 | 56,582,189 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 972,118 | 0.02 | 110.33 | 18,977 | 107,253,779 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 16,282,190 | 0.00 | 110.33 | 18,977 | 1,796,414,023 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308,275 | 0.30 | 21.34 | 19,974 | 6,578,588 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308,275 | 0.30 | 21.34 | 19,974 | 6,578,588 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 11,422,611 | 0.01 | 21.34 | 19,974 | 243,758,519 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 1,911,734 | 0.05 | 21.34 | 19,974 | 40,796,404 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 195,564 | 0.48 | 21.34 | 19,974 | 4,173,336 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 356,223 | 0.26 | 21.34 | 19,974 | 7,601,799 | |
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -892,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -31,967,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -7,587,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -65,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -64,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 101,652 | 512,673 | 24.73 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 3,642,962 | 16,128,927 | 29.18 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 864,614 | 2,943,733 | 41.59 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7,406 | 61,049 | 13.81 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7,292 | 58,632 | 14.20 | ||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | 137 | 137 | |||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | 137 | 137 | |||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | -274 | 0 | -100.00 | ||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 139,220 | 2,744,052 | 5.34 | 45.00 | 6,264,900 | 123,482,340 | |
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 10,780 | 170,714 | 6.74 | 45.00 | 485,100 | 7,682,130 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 346,000 | 32,164,870 | 1.09 | 48.44 | 16,761,728 | 1,558,204,612 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50,000 | 31,818,870 | 0.16 | 47.40 | 2,370,000 | 1,508,214,438 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 160,453 | 31,768,870 | 0.51 | 48.60 | 7,798,690 | 1,544,100,511 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,320 | 31,608,417 | 0.11 | 47.98 | 1,598,614 | 1,516,495,987 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,386 | 31,575,097 | 0.05 | 47.54 | 683,847 | 1,500,941,181 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,600 | 31,560,711 | 0.01 | 47.24 | 75,577 | 1,490,798,589 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20,500 | 31,559,111 | 0.06 | 46.31 | 949,351 | 1,461,496,119 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,950 | 31,538,611 | 0.01 | 44.68 | 87,130 | 1,409,201,909 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89,843 | 31,536,661 | 0.29 | 45.28 | 4,067,696 | 1,427,841,249 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 212,983 | 31,446,818 | 0.68 | 46.81 | 9,969,500 | 1,471,990,959 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,818 | 31,233,835 | 0.03 | 46.74 | 458,905 | 1,459,906,929 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,331 | 31,224,017 | 0.01 | 45.63 | 106,368 | 1,424,814,344 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,513 | 31,221,686 | 0.01 | 45.43 | 159,601 | 1,418,448,028 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,897 | 31,218,173 | 0.04 | 45.00 | 625,359 | 1,404,805,298 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,649 | 31,204,276 | 0.13 | 42.14 | 1,713,148 | 1,315,101,092 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,063 | 31,163,627 | 0.03 | 44.40 | 357,971 | 1,383,565,315 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15,391 | 31,155,564 | 0.05 | 40.67 | 625,950 | 1,267,093,672 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 191,321 | 31,140,173 | 0.62 | 41.06 | 7,856,214 | 1,278,708,924 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88,640 | 30,948,852 | 0.29 | 42.44 | 3,761,802 | 1,313,441,425 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 183,073 | 30,860,212 | 0.60 | 43.28 | 7,923,253 | 1,335,605,287 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 274,814 | 30,677,139 | 0.90 | 44.63 | 12,265,553 | 1,369,188,203 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,100 | 30,402,325 | 0.01 | 40.55 | 125,706 | 1,232,823,399 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,300 | 30,399,225 | 0.04 | 41.13 | 464,823 | 1,250,466,041 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,612 | 30,387,925 | 0.14 | 43.60 | 1,901,322 | 1,324,801,095 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,338,927 | 30,344,313 | 12.36 | 41.00 | 136,896,007 | 1,244,116,833 | |
| 2015-09-11 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,213,469 | 6,022,104 | 58.12 | 15.50 | 34,308,770 | 93,342,612 | |
| 2015-09-11 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 266,563 | 725,228 | 58.12 | 15.50 | 4,131,726 | 11,241,034 | |
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
2,260 | ||||||||
| 2015-08-10 | 3/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
2,260 | ||||||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2,329 | 2,329 | |||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6,103,727 | 0.01 | ||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6,103,727 | 0.01 | ||||
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -229,436 | 90,538 | -71.70 | 1.09 | -250,659 | 98,913 | |
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9,411,311 | 3,153,539 | -74.90 | 1.09 | -10,281,857 | 3,445,241 | |
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1,359,253 | 467,436 | -74.41 | 1.09 | -1,484,984 | 510,674 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 307,339 | 0.24 | 27.34 | 19,958 | 8,402,648 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 1,350,721 | 0.05 | 27.34 | 19,958 | 36,928,712 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 481,236 | 0.15 | 27.34 | 19,958 | 13,156,992 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 11,421,675 | 0.01 | 27.34 | 19,958 | 312,268,594 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 194,628 | 0.38 | 27.34 | 19,958 | 5,321,130 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 355,287 | 0.21 | 27.34 | 19,958 | 9,713,547 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 826,200 | 0.02 | 104.21 | 18,966 | 86,098,302 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 411,021 | 0.04 | 104.21 | 18,966 | 42,832,498 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 549,414 | 0.03 | 104.21 | 18,966 | 57,254,433 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,260 | 64,858 | 8.83 | 3.66 | 19,252 | 237,380 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,260 | 64,858 | 8.83 | 3.66 | 19,252 | 237,380 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,260 | 64,858 | 8.83 | 3.66 | 19,252 | 237,380 | |
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 6,103,033 | 6,103,033 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 506,166 | 506,166 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 94,412 | 94,412 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 66,154 | 66,154 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 65,811 | 65,811 | |||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3,000 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3,000 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15,000 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,750 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,750 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,750 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -9,184,771 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -680,187 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -143,462 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -200,526 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15,000 | 0 | -100.00 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 21,196 | 100,003 | 26.90 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -211,614 | 12,250 | -94.53 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 497 | 78,807 | 0.63 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -100,490 | 12,250 | -89.13 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 40,449 | 78,310 | 106.84 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -1,068,128 | 680,187 | -61.09 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 5,543 | 37,861 | 17.15 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -55,479 | 12,250 | -81.91 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 12,500 | 32,318 | 63.07 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -165,213 | 12,250 | -93.10 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 19,318 | 19,818 | 3,863.60 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -206,800 | 12,250 | -94.41 | ||||
| 2015-06-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
| 2015-06-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2015-06-10 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70,000 | 70,000 | |||||
| 2015-05-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198,802 | 27,005,386 | 0.74 | 43.27 | 8,602,242 | 1,168,533,854 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57,202 | 26,816,266 | 0.21 | 43.29 | 2,476,343 | 1,160,908,335 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,300 | 26,759,064 | 0.06 | 43.67 | 711,775 | 1,168,493,400 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90,155 | 26,742,764 | 0.34 | 43.62 | 3,932,723 | 1,166,567,503 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150,000 | 26,652,609 | 0.57 | 42.93 | 6,439,500 | 1,144,196,504 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,200 | 26,492,927 | 0.03 | 40.95 | 376,718 | 1,084,821,778 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 52,381 | 26,483,727 | 0.20 | 41.54 | 2,176,038 | 1,100,200,229 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 139,683 | 26,431,346 | 0.53 | 42.68 | 5,961,908 | 1,128,134,781 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 13,352 | 26,291,663 | 0.05 | 42.97 | 573,749 | 1,129,779,051 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 2,300 | 26,278,311 | 0.01 | 42.15 | 96,949 | 1,107,675,482 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,382 | 26,276,011 | 0.03 | 41.24 | 304,410 | 1,083,538,610 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,500 | 26,268,629 | 0.02 | 41.07 | 184,815 | 1,078,852,593 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89,100 | 26,264,129 | 0.34 | 40.57 | 3,614,475 | 1,065,443,789 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 120,529 | 26,175,029 | 0.46 | 41.09 | 4,951,958 | 1,075,406,301 | |
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 26,054,500 | 0.01 | 39.94 | 147,778 | 1,040,616,730 | |
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 26,054,500 | 0.01 | 39.94 | 147,778 | 1,040,616,730 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 410,839 | 5.12 | 7.68 | 153,600 | 3,155,244 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 410,839 | 5.12 | 7.68 | 153,600 | 3,155,244 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 410,839 | 5.12 | 7.68 | 153,600 | 3,155,244 | |
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 26,050,800 | 0.04 | 5.11 | 51,100 | 133,119,588 | |
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 26,050,800 | 0.04 | 5.11 | 51,100 | 133,119,588 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,100 | 26,040,800 | 0.00 | 37.07 | 40,777 | 965,332,456 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46,617 | 26,039,700 | 0.18 | 37.15 | 1,732,013 | 967,481,618 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,334 | 25,993,083 | 0.03 | 35.85 | 298,745 | 931,761,050 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129,118 | 25,984,749 | 0.50 | 36.40 | 4,700,515 | 945,969,590 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 137,800 | 25,855,631 | 0.54 | 36.25 | 4,995,250 | 937,266,624 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 155,731 | 25,717,831 | 0.61 | 36.67 | 5,710,048 | 942,972,563 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 23,012 | 25,562,100 | 0.09 | 35.91 | 826,437 | 918,019,366 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 354,300 | 25,539,088 | 1.41 | 34.76 | 12,315,078 | 887,710,606 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59,973 | 25,184,788 | 0.24 | 34.61 | 2,075,833 | 871,716,030 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,330 | 25,124,815 | 0.02 | 33.99 | 147,177 | 853,992,462 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90,397 | 25,120,485 | 0.36 | 34.56 | 3,123,949 | 868,116,233 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,952 | 25,030,088 | 0.09 | 34.52 | 757,888 | 864,158,782 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,470 | 59,598 | 10.11 | 3.52 | 19,254 | 209,785 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,470 | 59,598 | 10.11 | 3.52 | 19,254 | 209,785 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,470 | 59,598 | 10.11 | 3.52 | 19,254 | 209,785 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306,609 | 0.21 | 30.43 | 19,962 | 9,330,112 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306,609 | 0.21 | 30.43 | 19,962 | 9,330,112 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,880 | 25,008,136 | 0.01 | 34.72 | 99,986 | 868,217,461 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,439 | 25,005,256 | 0.03 | 34.47 | 221,935 | 861,863,660 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 158,771 | 24,998,817 | 0.64 | 34.69 | 5,507,401 | 867,151,464 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 116,946 | 24,840,046 | 0.47 | 34.62 | 4,049,208 | 860,076,657 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,600 | 24,723,100 | 0.08 | 34.82 | 682,537 | 860,939,928 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,021 | 24,703,500 | 0.02 | 34.79 | 139,882 | 859,380,417 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 213,820 | 24,699,479 | 0.87 | 34.76 | 7,432,169 | 858,529,191 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 211,400 | 24,485,659 | 0.87 | 34.92 | 7,382,532 | 855,090,632 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,000 | 24,274,259 | 0.00 | 35.60 | 35,595 | 864,042,249 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62,650 | 24,273,259 | 0.26 | 34.46 | 2,159,163 | 836,551,171 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 163,054 | 24,210,609 | 0.68 | 33.80 | 5,510,818 | 818,258,058 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,995 | 24,047,555 | 0.02 | 33.60 | 167,830 | 807,985,824 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,416 | 24,042,560 | 0.21 | 33.65 | 1,662,843 | 809,029,740 | |
| 2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,898,409 | 6,323,855 | 343.64 | 3.75 | 18,369,034 | 23,714,456 | |
| 2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 434,924 | 625,495 | 228.22 | 3.75 | 1,630,965 | 2,345,606 | |
| 2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 390,935 | 2,604,832 | 17.66 | 20.00 | 7,818,700 | 52,096,640 | |
| 2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 34,065 | 159,934 | 27.06 | 20.00 | 681,300 | 3,198,680 | |
| 2015-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1,000,000 | 9,184,771 | 12.22 | 94.19 | 94,190,000 | 865,113,580 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21,441 | 345,074 | -5.85 | 3.86 | -82,762 | 1,331,986 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -859,988 | 12,589,950 | -6.39 | 3.86 | -3,319,554 | 48,597,207 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118,571 | 1,851,789 | -6.02 | 3.86 | -457,684 | 7,147,906 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21,548 | 366,515 | -5.55 | 3.81 | -82,130 | 1,396,972 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -863,100 | 13,449,938 | -6.03 | 3.81 | -3,289,706 | 51,264,439 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118,652 | 1,970,360 | -5.68 | 3.81 | -452,242 | 7,510,027 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4,554 | 388,063 | -1.16 | 3.55 | -16,184 | 1,379,059 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -182,454 | 14,313,038 | -1.26 | 3.55 | -648,387 | 50,864,243 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -25,092 | 2,089,012 | -1.19 | 3.55 | -89,169 | 7,423,722 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,927 | 54,128 | 7.82 | 4.90 | 19,242 | 265,227 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,927 | 54,128 | 7.82 | 4.90 | 19,242 | 265,227 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,927 | 1,425,446 | 0.28 | 4.90 | 19,242 | 6,984,685 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 305,953 | 0.20 | 31.97 | 19,949 | 9,781,317 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1,349,335 | 0.05 | 31.97 | 19,949 | 43,138,240 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 11,420,289 | 0.01 | 31.97 | 19,949 | 365,106,639 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1,909,412 | 0.03 | 31.97 | 19,949 | 61,043,902 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 193,242 | 0.32 | 31.97 | 19,949 | 6,177,947 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 353,901 | 0.18 | 31.97 | 19,949 | 11,314,215 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8,415 | 392,617 | -2.10 | 3.65 | -30,711 | 1,432,856 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337,123 | 14,495,492 | -2.27 | 3.65 | -1,230,330 | 52,901,298 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46,362 | 2,114,104 | -2.15 | 3.65 | -169,198 | 7,715,423 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4,746 | 401,032 | -1.17 | 3.68 | -17,447 | 1,474,274 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -190,117 | 14,832,615 | -1.27 | 3.68 | -698,908 | 54,527,659 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -26,137 | 2,160,466 | -1.20 | 3.68 | -96,085 | 7,942,305 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -2,825 | 405,778 | -0.69 | 3.71 | -10,482 | 1,505,680 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -112,855 | 15,022,732 | -0.75 | 3.71 | -418,760 | 55,743,349 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -15,420 | 2,186,603 | -0.70 | 3.71 | -57,217 | 8,113,609 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -16,182 | 408,603 | -3.81 | 4.21 | -68,102 | 1,719,606 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -647,781 | 15,135,587 | -4.10 | 4.21 | -2,726,186 | 63,698,118 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -88,937 | 2,202,023 | -3.88 | 4.21 | -374,291 | 9,267,214 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -3,558 | 424,785 | -0.83 | 4.29 | -15,260 | 1,821,903 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -142,543 | 15,783,368 | -0.90 | 4.29 | -611,367 | 67,694,865 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -19,599 | 2,290,960 | -0.85 | 4.29 | -84,060 | 9,825,927 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -14,753 | 428,343 | -3.33 | 4.31 | -63,571 | 1,845,730 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -590,638 | 15,925,911 | -3.58 | 4.31 | -2,545,059 | 68,624,750 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -81,109 | 2,310,559 | -3.39 | 4.31 | -349,499 | 9,956,199 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,900 | 23,993,144 | 0.02 | 31.97 | 124,679 | 767,036,821 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 500 | 23,989,244 | 0.00 | 30.80 | 15,400 | 738,868,715 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,685 | 23,988,744 | 0.21 | 31.82 | 1,581,096 | 763,379,407 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,855,894 | 23,939,059 | 8.40 | 31.94 | 59,276,698 | 764,606,363 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 597,000 | 22,083,165 | 2.78 | 31.75 | 18,954,631 | 701,136,072 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 305,532 | 21,486,165 | 1.44 | 31.68 | 9,680,415 | 680,763,355 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 70,867 | 21,180,633 | 0.34 | 31.41 | 2,226,244 | 665,376,877 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -6,874 | 443,096 | -1.53 | 4.27 | -29,358 | 1,892,419 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -274,734 | 16,516,549 | -1.64 | 4.27 | -1,173,361 | 70,540,529 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -37,592 | 2,391,668 | -1.55 | 4.27 | -160,552 | 10,214,575 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9,908 | 449,970 | -2.15 | 4.45 | -44,093 | 2,002,456 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -396,496 | 16,791,283 | -2.31 | 4.45 | -1,764,486 | 74,724,568 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -54,396 | 2,429,260 | -2.19 | 4.45 | -242,073 | 10,810,693 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -5,457 | 459,878 | -1.17 | 4.71 | -25,724 | 2,167,865 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -218,383 | 17,187,779 | -1.25 | 4.71 | -1,029,457 | 81,023,190 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -29,960 | 2,483,656 | -1.19 | 4.71 | -141,231 | 11,707,954 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8,429 | 465,335 | -1.78 | 4.62 | -38,907 | 2,147,940 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337,541 | 17,406,162 | -1.90 | 4.62 | -1,558,056 | 80,345,103 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46,383 | 2,513,616 | -1.81 | 4.62 | -214,099 | 11,602,600 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100,000 | 21,109,766 | 0.48 | 34.95 | 3,495,000 | 737,786,322 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 354,000 | 21,009,766 | 1.71 | 34.27 | 12,131,651 | 720,008,883 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,772 | 20,655,766 | 0.07 | 34.53 | 510,114 | 713,295,239 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185,378 | 20,640,994 | 0.91 | 34.33 | 6,364,935 | 708,706,465 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30,507 | 107,504 | 39.62 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30,507 | 3,993,087 | 0.77 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -399,208 | 0 | -100.00 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,500 | 20,455,616 | 0.03 | 33.90 | 186,438 | 693,400,380 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 80,430 | 20,450,116 | 0.39 | 34.64 | 2,786,393 | 708,467,684 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42,500 | 20,369,686 | 0.21 | 33.28 | 1,414,515 | 677,958,148 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185,528 | 20,327,186 | 0.92 | 33.31 | 6,180,420 | 677,151,416 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 216,284 | 20,141,658 | 1.09 | 32.56 | 7,043,267 | 655,911,079 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38,614 | 19,925,374 | 0.19 | 33.00 | 1,274,254 | 657,533,357 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,890 | 19,886,760 | 0.13 | 33.06 | 822,744 | 657,360,829 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -28,086 | 473,764 | -5.60 | 4.55 | -127,671 | 2,153,589 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1,122,584 | 17,743,703 | -5.95 | 4.55 | -5,102,930 | 80,657,551 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -153,618 | 2,559,999 | -5.66 | 4.55 | -698,301 | 11,636,987 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -11,965 | 501,850 | -2.33 | 4.84 | -57,913 | 2,429,054 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -486,800 | 18,866,287 | -2.52 | 4.84 | -2,356,209 | 91,316,602 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -69,153 | 2,713,617 | -2.49 | 4.84 | -334,714 | 13,134,449 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -10,534 | 513,815 | -2.01 | 5.36 | -56,453 | 2,753,586 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -428,583 | 19,353,087 | -2.17 | 5.36 | -2,296,819 | 103,715,129 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -60,883 | 2,782,770 | -2.14 | 5.36 | -326,278 | 14,913,143 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98,076 | 19,861,870 | 0.50 | 36.57 | 3,586,737 | 726,368,448 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,639 | 19,763,794 | 0.05 | 36.75 | 390,999 | 726,349,075 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69,397 | 19,753,155 | 0.35 | 35.88 | 2,490,291 | 708,836,041 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63,137 | 19,683,758 | 0.32 | 36.74 | 2,319,502 | 723,134,028 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,505 | 19,620,621 | 0.13 | 35.91 | 915,851 | 704,550,993 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22,839 | 19,595,116 | 0.12 | 35.55 | 811,963 | 696,637,726 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,116 | 19,572,277 | 0.07 | 35.56 | 466,413 | 696,001,913 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 17,098 | 19,559,161 | 0.09 | 34.91 | 596,816 | 682,724,250 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 104,140 | 19,542,063 | 0.54 | 35.98 | 3,746,947 | 703,121,473 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,006 | 19,437,923 | 0.15 | 35.28 | 1,023,471 | 685,863,225 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,500 | 19,408,917 | 0.07 | 34.26 | 462,530 | 664,978,610 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,769 | 19,395,417 | 0.13 | 34.58 | 890,989 | 670,615,938 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 866,669 | 19,369,648 | 4.68 | 33.79 | 29,287,172 | 654,554,641 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,394 | 18,502,979 | 0.02 | 33.71 | 148,139 | 623,807,584 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38,166 | 18,498,585 | 0.21 | 34.83 | 1,329,390 | 644,339,013 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 252,474 | 18,460,419 | 1.39 | 34.41 | 8,686,949 | 635,173,175 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,914 | 50,201 | 21.59 | 2.16 | 19,254 | 108,434 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,914 | 50,201 | 21.59 | 2.16 | 19,254 | 108,434 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,914 | 1,421,519 | 0.63 | 2.16 | 19,254 | 3,070,481 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305,329 | 0.23 | 28.54 | 19,978 | 8,714,090 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305,329 | 0.23 | 28.54 | 19,978 | 8,714,090 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 1,348,711 | 0.05 | 28.54 | 19,978 | 38,492,212 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 11,419,665 | 0.01 | 28.54 | 19,978 | 325,917,239 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 192,618 | 0.36 | 28.54 | 19,978 | 5,497,318 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 353,277 | 0.20 | 28.54 | 19,978 | 10,082,526 | |
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 7,000 | 7,000 | |||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5,500 | 524,349 | 1.06 | ||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5,500 | 524,349 | 1.06 | ||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5,500 | 524,349 | 1.06 | ||||
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,182 | 41,287 | 17.61 | 2.83 | 17,495 | 116,842 | |
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,182 | 41,287 | 17.61 | 2.83 | 17,495 | 116,842 | |
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,182 | 1,412,605 | 0.44 | 2.83 | 17,495 | 3,997,672 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 304,629 | 0.24 | 27.86 | 19,948 | 8,486,964 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1,348,011 | 0.05 | 27.86 | 19,948 | 37,555,586 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 11,418,965 | 0.01 | 27.86 | 19,948 | 318,132,365 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1,908,088 | 0.04 | 27.86 | 19,948 | 53,159,332 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 191,918 | 0.37 | 27.86 | 19,948 | 5,346,835 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 352,577 | 0.20 | 27.86 | 19,948 | 9,822,795 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 223,864 | 1.94 | 60.45 | 256,912 | 13,532,579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 223,864 | 1.94 | 60.45 | 256,912 | 13,532,579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 223,864 | 1.94 | 60.45 | 256,912 | 13,532,579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 257,722 | 1.68 | 60.45 | 256,912 | 15,579,295 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 1,893,297 | 0.22 | 60.45 | 256,912 | 114,449,804 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 212,711 | 2.04 | 60.45 | 256,912 | 12,858,380 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 322,445 | 1.34 | 60.45 | 256,912 | 19,491,800 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 670 | 416,208 | 0.16 | 39.80 | 26,668 | 16,566,494 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 27,046 | 18,207,945 | 0.15 | 39.80 | 1,076,523 | 724,738,118 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,471 | 415,538 | 0.36 | 39.93 | 58,731 | 16,590,770 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59,400 | 18,180,899 | 0.33 | 39.93 | 2,371,604 | 725,890,573 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,938 | 414,067 | 0.47 | 39.99 | 77,503 | 16,559,036 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78,262 | 18,121,499 | 0.43 | 39.99 | 3,129,791 | 724,700,491 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,155 | 412,129 | 0.28 | 39.84 | 46,021 | 16,421,239 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46,653 | 18,043,237 | 0.26 | 39.84 | 1,858,884 | 718,930,974 | |
| 2014-06-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70,000 | 70,000 | |||||
| 2014-06-10 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
| 2014-06-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,534 | 410,974 | 1.36 | 38.96 | 215,578 | 16,009,574 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 223,466 | 17,996,584 | 1.26 | 38.96 | 8,705,163 | 701,060,529 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 534 | 405,440 | 0.13 | 38.56 | 20,591 | 15,633,847 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,559 | 17,773,118 | 0.12 | 38.56 | 831,319 | 685,334,985 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 477 | 404,906 | 0.12 | 37.52 | 17,895 | 15,190,413 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,223 | 17,751,559 | 0.11 | 37.52 | 721,168 | 665,965,712 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,757 | 404,429 | 0.94 | 37.40 | 140,504 | 15,124,795 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151,530 | 17,732,336 | 0.86 | 37.40 | 5,666,904 | 663,152,128 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,411 | 400,672 | 0.61 | 37.67 | 90,826 | 15,093,995 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97,254 | 17,580,806 | 0.56 | 37.67 | 3,663,724 | 662,298,849 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 496 | 398,261 | 0.12 | 37.63 | 18,667 | 14,988,274 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20,011 | 17,483,552 | 0.11 | 37.63 | 753,100 | 657,981,241 | |
| 2014-06-06 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,534 | 397,765 | 0.39 | 36.04 | 55,281 | 14,334,377 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61,878 | 17,463,541 | 0.36 | 36.04 | 2,229,916 | 629,338,866 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 572 | 396,231 | 0.14 | 36.39 | 20,817 | 14,419,995 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,058 | 17,401,663 | 0.13 | 36.39 | 839,147 | 633,296,981 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 | 395,659 | 0.00 | 35.27 | 670 | 13,956,001 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 781 | 17,378,605 | 0.00 | 35.27 | 27,548 | 612,992,058 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,137 | 395,640 | 0.54 | 34.38 | 73,479 | 13,603,725 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 86,201 | 17,377,824 | 0.50 | 34.38 | 2,963,944 | 597,520,838 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 270 | 393,503 | 0.07 | 35.11 | 9,481 | 13,817,386 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,896 | 17,291,623 | 0.06 | 35.11 | 382,600 | 607,174,592 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,809 | 393,233 | 0.46 | 34.05 | 61,604 | 13,391,196 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,980 | 17,280,727 | 0.42 | 34.05 | 2,485,268 | 588,479,605 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 480 | 391,424 | 0.12 | 34.21 | 16,421 | 13,391,046 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,348 | 17,207,747 | 0.11 | 34.21 | 661,916 | 588,695,953 | |
| 2014-05-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11,600 | 11,600 | |||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 518,849 | 1.65 | ||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 518,849 | 1.65 | ||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 518,849 | 1.65 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 390,839 | 2.63 | 7.02 | 70,200 | 2,743,690 | |
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 390,839 | 2.63 | 7.02 | 70,200 | 2,743,690 | |
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 390,839 | 2.63 | 7.02 | 70,200 | 2,743,690 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,151 | 390,944 | 0.30 | 34.08 | 39,232 | 13,325,287 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46,460 | 17,188,399 | 0.27 | 34.08 | 1,583,584 | 585,864,861 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,921 | 389,793 | 0.76 | 34.03 | 99,415 | 13,266,449 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 117,879 | 17,141,939 | 0.69 | 34.03 | 4,011,965 | 583,419,037 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 386,872 | 0.91 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 386,872 | 0.91 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 17,178,061 | 0.02 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 505 | 383,372 | 0.13 | 34.26 | 17,304 | 13,136,012 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20,395 | 17,020,560 | 0.12 | 34.26 | 698,822 | 583,199,276 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7 | 382,867 | 0.00 | 34.10 | 239 | 13,055,765 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 293 | 17,000,165 | 0.00 | 34.10 | 9,991 | 579,705,626 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 382,860 | 2.68 | 7.26 | 72,600 | 2,779,564 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 382,860 | 2.68 | 7.26 | 72,600 | 2,779,564 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 382,860 | 2.68 | 7.26 | 72,600 | 2,779,564 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372,860 | 0.20 | 34.60 | 25,815 | 12,902,522 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30,122 | 16,989,872 | 0.18 | 34.60 | 1,042,348 | 587,920,929 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372,114 | 0.20 | 33.73 | 24,964 | 12,553,191 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,865 | 16,959,750 | 0.18 | 33.73 | 1,007,490 | 572,133,774 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,069 | 371,374 | 0.29 | 34.31 | 36,673 | 12,740,319 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,131 | 16,929,885 | 0.26 | 34.31 | 1,479,648 | 580,794,942 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370,305 | 0.21 | 33.92 | 26,559 | 12,560,486 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,617 | 16,886,754 | 0.19 | 33.92 | 1,072,427 | 572,786,875 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369,522 | 0.09 | 34.74 | 11,430 | 12,837,564 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,271 | 16,855,137 | 0.08 | 34.74 | 461,048 | 585,564,315 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,933 | 369,193 | 0.80 | 33.77 | 99,060 | 12,469,235 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118,389 | 16,841,866 | 0.71 | 33.77 | 3,998,506 | 568,822,235 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366,260 | 0.23 | 33.72 | 28,295 | 12,352,009 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,868 | 16,723,477 | 0.20 | 34.72 | 1,176,056 | 580,717,722 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,534 | 365,421 | 0.42 | 33.98 | 52,118 | 12,415,252 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61,892 | 16,689,609 | 0.37 | 33.98 | 2,102,793 | 567,032,804 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363,887 | 0.17 | 34.01 | 21,190 | 12,376,779 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,156 | 16,627,717 | 0.15 | 34.01 | 855,623 | 565,553,550 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,228 | 363,264 | 0.34 | 33.40 | 41,020 | 12,134,580 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,553 | 16,602,561 | 0.30 | 33.40 | 1,655,283 | 554,596,928 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362,036 | 0.27 | 33.54 | 33,007 | 12,143,991 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39,710 | 16,553,008 | 0.24 | 33.54 | 1,332,016 | 555,247,479 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372,860 | 0.20 | 34.60 | 25,815 | 12,902,522 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30,122 | 16,989,872 | 0.18 | 34.60 | 1,042,348 | 587,920,929 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372,114 | 0.20 | 33.73 | 24,964 | 12,553,191 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,865 | 16,959,750 | 0.18 | 33.73 | 1,007,490 | 572,133,774 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,069 | 371,374 | 0.29 | 34.31 | 36,673 | 12,740,319 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,131 | 16,929,885 | 0.26 | 34.31 | 1,479,648 | 580,794,942 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370,305 | 0.21 | 33.92 | 26,559 | 12,560,486 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,617 | 16,886,754 | 0.19 | 33.92 | 1,072,427 | 572,786,875 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369,522 | 0.09 | 34.74 | 11,430 | 12,837,564 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,271 | 16,855,137 | 0.08 | 34.74 | 461,048 | 585,564,315 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,933 | 369,193 | 0.80 | 33.77 | 99,060 | 12,469,235 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118,389 | 16,841,866 | 0.71 | 33.77 | 3,998,506 | 568,822,235 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366,260 | 0.23 | 33.72 | 28,295 | 12,352,009 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,868 | 16,723,477 | 0.20 | 34.72 | 1,176,056 | 580,717,722 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,534 | 365,421 | 0.42 | 33.98 | 52,118 | 12,415,252 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61,892 | 16,689,609 | 0.37 | 33.98 | 2,102,793 | 567,032,804 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363,887 | 0.17 | 34.01 | 21,190 | 12,376,779 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,156 | 16,627,717 | 0.15 | 34.01 | 855,623 | 565,553,550 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,228 | 363,264 | 0.34 | 33.40 | 41,020 | 12,134,580 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,553 | 16,602,561 | 0.30 | 33.40 | 1,655,283 | 554,596,928 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362,036 | 0.27 | 33.54 | 33,007 | 12,143,991 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39,710 | 16,553,008 | 0.24 | 33.54 | 1,332,016 | 555,247,479 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 219,614 | 3.78 | 65.10 | 520,800 | 14,296,871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 219,614 | 3.78 | 65.10 | 520,800 | 14,296,871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 219,614 | 3.78 | 65.10 | 520,800 | 14,296,871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 253,472 | 3.26 | 65.10 | 520,800 | 16,501,027 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 1,889,047 | 0.43 | 65.10 | 520,800 | 122,976,960 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 208,461 | 3.99 | 65.10 | 520,800 | 13,570,811 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 318,195 | 2.58 | 65.10 | 520,800 | 20,714,494 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303,913 | 0.25 | 26.57 | 19,981 | 8,074,968 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303,913 | 0.25 | 26.57 | 19,981 | 8,074,968 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1,347,295 | 0.06 | 26.57 | 19,981 | 35,797,628 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 11,418,249 | 0.01 | 26.57 | 19,981 | 303,382,876 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1,907,372 | 0.04 | 26.57 | 19,981 | 50,678,874 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 191,202 | 0.39 | 26.57 | 19,981 | 5,080,237 | |
| 2014-03-19 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 80,000 | 80,000 | |||||
| 2014-03-12 |
|
4 | IDP |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 60,000 | 60,000 | |||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-07 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 9,031 | 211,614 | 4.46 | 105.75 | 955,028 | 22,378,180 | |
| 2014-03-07 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 365,969 | 8,172,521 | 4.69 | 105.75 | 38,701,222 | 864,244,096 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11,738 | 452,540 | 2.66 | 28.50 | 334,533 | 12,897,390 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 475,644 | 18,476,847 | 2.64 | 28.50 | 13,555,854 | 526,590,140 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38,934 | 1,552,055 | 2.57 | 28.50 | 1,109,619 | 44,233,568 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303,161 | 0.23 | 29.27 | 19,962 | 8,873,522 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303,161 | 0.23 | 29.27 | 19,962 | 8,873,522 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 11,243,600 | 0.01 | 29.27 | 19,962 | 329,100,172 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 1,732,723 | 0.04 | 29.27 | 19,962 | 50,716,802 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 16,553 | 4.30 | 29.27 | 19,962 | 484,506 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 177,212 | 0.39 | 29.27 | 19,962 | 5,186,995 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 639 | 361,052 | 0.18 | 39.91 | 25,504 | 14,410,344 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,596 | 16,513,298 | 0.16 | 39.91 | 1,021,590 | 659,080,401 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,280 | 360,413 | 0.36 | 39.92 | 51,100 | 14,388,372 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 51,244 | 16,487,702 | 0.31 | 39.92 | 2,045,758 | 658,220,390 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,063 | 359,133 | 0.30 | 39.65 | 42,153 | 14,241,383 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42,646 | 16,436,458 | 0.26 | 39.65 | 1,691,123 | 651,786,098 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,486 | 358,070 | 0.70 | 39.70 | 98,694 | 14,215,379 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 99,775 | 16,393,812 | 0.61 | 39.70 | 3,961,068 | 650,834,336 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,377 | 355,584 | 0.39 | 39.54 | 54,442 | 14,058,725 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 55,256 | 16,294,037 | 0.34 | 39.54 | 2,184,656 | 644,217,341 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,056 | 354,207 | 0.87 | 39.53 | 120,798 | 14,001,201 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 122,660 | 16,238,781 | 0.76 | 39.53 | 4,848,541 | 641,891,407 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,492 | 351,151 | 1.59 | 43.98 | 241,512 | 15,441,935 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 219,958 | 16,116,121 | 1.38 | 43.98 | 9,672,697 | 708,709,644 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 553 | 345,659 | 0.16 | 44.00 | 24,332 | 15,208,823 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22,147 | 15,896,163 | 0.14 | 44.00 | 974,457 | 699,423,224 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,863 | 345,106 | 0.84 | 44.05 | 126,102 | 15,200,366 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 114,663 | 15,874,016 | 0.73 | 44.05 | 5,050,389 | 699,178,972 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170 | 342,243 | 0.05 | 43.42 | 7,382 | 14,861,800 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,814 | 15,759,353 | 0.04 | 43.42 | 295,896 | 684,345,176 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,512 | 342,073 | 0.74 | 42.95 | 107,883 | 14,691,043 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100,626 | 15,752,539 | 0.64 | 42.95 | 4,321,595 | 676,525,868 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 340 | 339,561 | 0.10 | 43.72 | 14,864 | 14,845,233 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,632 | 15,651,913 | 0.09 | 43.72 | 595,976 | 684,284,419 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,011 | 339,221 | 0.30 | 43.01 | 43,479 | 14,588,403 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,471 | 15,638,281 | 0.26 | 43.01 | 1,740,480 | 672,533,657 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,818 | 338,210 | 0.54 | 43.20 | 78,547 | 14,612,329 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,807 | 15,597,810 | 0.47 | 43.20 | 3,145,619 | 673,901,821 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 455 | 336,392 | 0.14 | 43.64 | 19,858 | 14,681,829 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,232 | 15,525,003 | 0.12 | 43.64 | 795,736 | 677,588,756 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 290 | 335,937 | 0.09 | 42.65 | 12,369 | 14,328,721 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,617 | 15,506,771 | 0.07 | 42.65 | 495,500 | 661,410,303 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,551 | 335,647 | 1.07 | 42.56 | 151,129 | 14,284,968 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 142,220 | 15,495,154 | 0.93 | 42.56 | 6,052,812 | 659,466,007 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,632 | 332,096 | 0.80 | 42.41 | 111,631 | 14,085,188 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 105,414 | 15,352,934 | 0.69 | 42.41 | 4,470,924 | 651,163,990 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,816 | 329,464 | 0.86 | 42.31 | 119,144 | 13,939,556 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 112,797 | 15,247,520 | 0.75 | 42.31 | 4,772,419 | 645,119,522 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -127,000 | 892,000 | -12.46 | 432.60 | -54,940,390 | 385,880,538 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -4,567,000 | 31,967,000 | -12.50 | 432.60 | -1,975,691,050 | 13,828,972,150 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -1,084,000 | 7,587,000 | -12.50 | 432.60 | -468,940,026 | 3,282,147,580 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -2,459,000 | 1,019,000 | -70.70 | 425.88 | -1,047,233,756 | 433,969,580 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -88,153,000 | 36,534,000 | -70.70 | 425.88 | -37,542,414,519 | 15,559,023,199 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -20,922,000 | 8,671,000 | -70.70 | 425.88 | -8,910,217,424 | 3,692,787,271 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 170,000 | 6,050,000 | 2.89 | 104.52 | 17,768,043 | 632,333,295 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 6,830,000 | 243,450,000 | 2.89 | 104.52 | 713,857,257 | 25,444,882,755 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 242,000 | 5,880,000 | 4.29 | 104.25 | 25,228,500 | 612,990,000 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 9,758,000 | 236,620,000 | 4.30 | 104.25 | 1,017,271,500 | 24,667,635,000 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 61,000 | 5,638,000 | 1.09 | 103.75 | 6,328,750 | 584,942,500 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 2,439,000 | 226,862,000 | 1.09 | 103.75 | 253,046,250 | 23,536,932,500 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 121,000 | 5,577,000 | 2.22 | 104.75 | 12,674,750 | 584,190,750 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 4,879,000 | 224,423,000 | 2.22 | 104.75 | 511,075,250 | 23,508,309,250 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5,456,000 | 5,456,000 | 100.00 | 545,600,000 | 545,600,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 5,456,000 | 5,456,000 | 100.00 | 545,600,000 | 545,600,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 219,544,000 | 219,544,000 | 100.00 | 21,954,400,000 | 21,954,400,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 219,544,000 | 219,544,000 | 100.00 | 21,954,400,000 | 21,954,400,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 25,000,000 | 25,000,000 | 100.00 | 2,500,000,000 | 2,500,000,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 25,000,000 | 25,000,000 | 100.00 | 2,500,000,000 | 2,500,000,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 133,000 | 5,674,000 | 2.40 | 104.09 | 13,844,090 | 590,611,767 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5,367,000 | 228,326,000 | 2.41 | 104.09 | 558,655,860 | 23,766,658,833 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 85,000 | 5,541,000 | 1.56 | 104.12 | 8,850,625 | 576,956,625 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 3,415,000 | 222,959,000 | 1.56 | 104.12 | 355,586,875 | 23,215,605,875 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 8,721 | 40,308 | 27.61 | 17.50 | 152,618 | 705,390 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 346,965 | 2,213,897 | 18.58 | 17.50 | 6,071,888 | 38,743,198 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 44,314 | 125,869 | 54.34 | 17.50 | 775,495 | 2,202,708 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 302,479 | 0.22 | 30.33 | 19,957 | 9,174,188 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 11,242,918 | 0.01 | 30.33 | 19,957 | 340,997,703 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 1,732,041 | 0.04 | 30.33 | 19,957 | 52,532,804 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 15,871 | 4.33 | 30.33 | 19,957 | 481,367 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 176,530 | 0.37 | 30.33 | 19,957 | 5,354,155 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 196,794 | 0.34 | 30.33 | 19,957 | 5,968,762 | |
| 2013-09-27 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 25,663 | 202,583 | 14.51 | 56.63 | 1,453,296 | 11,472,275 | |
| 2013-09-27 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1,024,337 | 7,806,552 | 15.10 | 56.63 | 58,008,204 | 442,085,040 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 21,410 | 510,449 | 4.38 | 3.62 | 77,504 | 1,847,825 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 1,854,058 | 19,767,770 | 10.35 | 3.62 | 6,711,690 | 71,559,327 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 882,323 | 2,829,753 | 45.31 | 3.62 | 3,194,009 | 10,243,706 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 21,410 | 510,449 | 4.38 | 3.62 | 77,504 | 1,847,825 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 1,854,058 | 19,767,770 | 10.35 | 3.62 | 6,711,690 | 71,559,327 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 882,323 | 2,829,753 | 45.31 | 3.62 | 3,194,009 | 10,243,706 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,705 | 145,533 | 20.45 | 4.40 | 108,702 | 640,345 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 991,161 | 4,832,285 | 25.80 | 4.40 | 4,361,108 | 21,262,054 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 120,498 | 1,642,513 | 7.92 | 4.40 | 530,191 | 7,227,057 | |
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
81,555 | ||||||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
1,866,932 | ||||||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
31,587 | ||||||||
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301,821 | 0.20 | 32.85 | 19,907 | 9,914,820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301,821 | 0.20 | 32.85 | 19,907 | 9,914,820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301,821 | 0.20 | 32.85 | 19,907 | 9,914,820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 1,731,383 | 0.04 | 32.85 | 19,907 | 56,875,932 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 15,213 | 4.15 | 32.85 | 19,907 | 499,747 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 175,872 | 0.35 | 32.85 | 19,907 | 5,777,395 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 10,000 | -50.00 | 4.44 | -44,400 | 44,400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 10,000 | -50.00 | 4.44 | -44,400 | 44,400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 10,000 | -50.00 | 4.44 | -44,400 | 44,400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 380,839 | 2.70 | 4.44 | 44,400 | 1,690,925 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 380,839 | 2.70 | 4.44 | 44,400 | 1,690,925 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 12,455,783 | 0.08 | 4.44 | 44,400 | 55,303,677 | |
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 5,437 | 440,802 | 1.25 | 14.46 | 78,641 | 6,375,804 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 217,986 | 18,001,203 | 1.23 | 14.46 | 3,152,971 | 260,371,200 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 26,577 | 1,513,121 | 1.79 | 14.46 | 384,412 | 21,885,933 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 3,790 | 435,365 | 0.88 | 14.55 | 55,145 | 6,334,648 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 151,980 | 17,783,217 | 0.86 | 14.55 | 2,211,339 | 258,749,364 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 18,530 | 1,486,544 | 1.26 | 14.55 | 269,615 | 21,629,513 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 4,312 | 431,575 | 1.01 | 14.58 | 62,885 | 6,294,003 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 172,893 | 17,631,237 | 0.99 | 14.58 | 2,521,437 | 257,130,434 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 21,080 | 1,468,014 | 1.46 | 14.58 | 307,427 | 21,409,223 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 5,437 | 427,263 | 1.29 | 14.46 | 78,600 | 6,176,728 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 217,986 | 17,458,344 | 1.26 | 14.46 | 3,151,315 | 252,386,550 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 26,577 | 1,446,934 | 1.87 | 14.46 | 384,210 | 20,917,601 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,775 | 421,826 | 0.66 | 14.42 | 40,004 | 6,081,001 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 111,266 | 17,240,358 | 0.65 | 14.42 | 1,604,000 | 248,535,277 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13,566 | 1,420,357 | 0.96 | 14.42 | 195,566 | 20,475,724 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11,552 | 419,051 | 2.83 | 14.45 | 166,955 | 6,056,335 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 463,197 | 17,129,092 | 2.78 | 14.45 | 6,694,355 | 247,558,202 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 56,475 | 1,406,791 | 4.18 | 14.45 | 816,205 | 20,331,647 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 890 | 407,499 | 0.22 | 14.50 | 12,903 | 5,907,798 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 35,702 | 16,665,895 | 0.21 | 14.50 | 517,597 | 241,617,146 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,353 | 1,350,316 | 0.32 | 14.50 | 63,108 | 19,576,476 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,189 | 406,609 | 1.29 | 14.00 | 72,641 | 5,692,119 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 208,063 | 16,630,193 | 1.27 | 14.00 | 2,912,674 | 232,806,072 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25,368 | 1,345,963 | 1.92 | 14.00 | 355,127 | 18,842,136 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11,511 | 401,420 | 2.95 | 14.08 | 162,100 | 5,652,877 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 461,548 | 16,422,130 | 2.89 | 14.08 | 6,499,611 | 231,259,719 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 56,274 | 1,320,595 | 4.45 | 14.08 | 792,462 | 18,596,883 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,735 | 301,215 | 1.60 | 35.82 | 169,584 | 10,788,015 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 189,886 | 11,241,654 | 1.72 | 35.82 | 6,800,767 | 402,619,838 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23,152 | 1,730,777 | 1.36 | 35.82 | 829,189 | 61,987,778 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,558 | 296,480 | 1.21 | 36.62 | 130,294 | 10,857,098 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 142,702 | 11,051,768 | 1.31 | 36.62 | 5,225,747 | 404,715,744 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17,399 | 1,707,625 | 1.03 | 36.62 | 637,151 | 62,533,228 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,790 | 292,922 | 0.96 | 36.69 | 102,356 | 10,746,400 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 111,907 | 10,909,066 | 1.04 | 36.69 | 4,105,521 | 400,219,813 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13,644 | 1,690,226 | 0.81 | 36.69 | 500,556 | 62,009,152 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,114 | 290,132 | 0.39 | 36.75 | 40,942 | 10,662,989 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 44,627 | 10,797,159 | 0.42 | 36.75 | 1,640,140 | 396,819,347 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,501 | 1,676,582 | 0.33 | 36.75 | 202,174 | 61,618,077 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,021 | 289,018 | 0.35 | 36.82 | 37,595 | 10,642,105 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40,933 | 10,752,532 | 0.38 | 36.82 | 1,507,219 | 395,925,432 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,046 | 1,671,081 | 0.30 | 36.82 | 185,802 | 61,531,876 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,613 | 287,997 | 0.56 | 36.93 | 59,574 | 10,636,852 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 64,679 | 10,711,599 | 0.61 | 36.93 | 2,388,848 | 395,621,126 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,974 | 1,666,035 | 0.48 | 36.93 | 294,511 | 61,533,170 | |
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11,600 | 11,600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11,600 | 11,600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11,600 | 11,600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 489,039 | 1.75 | ||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 489,039 | 1.75 | ||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 1,947,430 | 0.43 | ||||
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,358 | 286,384 | 0.48 | 36.93 | 50,154 | 10,576,877 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 54,399 | 10,646,920 | 0.51 | 36.93 | 2,009,091 | 393,217,373 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6,760 | 1,658,061 | 0.41 | 36.93 | 249,664 | 61,236,338 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 332 | 285,026 | 0.12 | 36.99 | 12,280 | 10,542,371 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13,313 | 10,592,521 | 0.13 | 36.99 | 492,413 | 391,789,811 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,655 | 1,651,301 | 0.10 | 36.99 | 61,214 | 61,077,331 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 35 | 284,694 | 0.01 | 36.18 | 1,266 | 10,300,969 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,392 | 10,579,208 | 0.01 | 36.18 | 50,366 | 382,783,251 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 173 | 1,649,646 | 0.01 | 36.18 | 6,260 | 59,688,481 | |
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 326,648 | 1.08 | ||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 326,648 | 1.08 | ||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 326,648 | 1.08 | ||||
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43,184 | 389,909 | 12.45 | 12.50 | 539,800 | 4,873,862 | |
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,730,970 | 15,960,582 | 12.16 | 12.50 | 21,637,125 | 199,507,275 | |
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218,846 | 1,264,321 | 20.93 | 12.50 | 2,735,575 | 15,804,012 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 418 | 284,659 | 0.15 | 36.54 | 15,273 | 10,401,212 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16,768 | 10,577,816 | 0.16 | 36.54 | 612,689 | 386,504,934 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,120 | 1,649,473 | 0.13 | 36.54 | 77,463 | 60,270,424 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,129 | 284,241 | 0.40 | 36.41 | 41,111 | 10,350,295 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 45,279 | 10,561,048 | 0.43 | 36.41 | 1,648,780 | 384,567,890 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,725 | 1,647,353 | 0.35 | 36.41 | 208,469 | 59,986,383 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 589 | 283,112 | 0.21 | 35.53 | 20,928 | 10,059,507 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23,610 | 10,515,769 | 0.23 | 35.53 | 838,908 | 373,645,253 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,985 | 1,641,628 | 0.18 | 35.53 | 106,063 | 58,330,162 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,516 | 282,523 | 1.26 | 34.02 | 119,609 | 9,610,980 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 140,962 | 10,492,159 | 1.36 | 34.02 | 4,795,302 | 356,926,462 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17,822 | 1,638,643 | 1.10 | 34.02 | 606,276 | 55,744,013 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,104 | 279,007 | 0.40 | 34.74 | 38,358 | 9,694,098 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 44,244 | 10,351,197 | 0.43 | 34.74 | 1,537,258 | 359,652,340 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,594 | 1,620,821 | 0.35 | 34.74 | 194,364 | 56,315,426 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 277,903 | 0.26 | 27.99 | 19,985 | 7,778,505 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 277,903 | 0.26 | 27.99 | 19,985 | 7,778,505 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 10,306,953 | 0.01 | 27.99 | 19,985 | 288,491,614 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 1,615,227 | 0.04 | 27.99 | 19,985 | 45,210,204 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 14,607 | 5.14 | 27.99 | 19,985 | 408,850 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 175,266 | 0.41 | 27.99 | 19,985 | 4,905,695 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 612 | 277,189 | 0.22 | 27.63 | 16,912 | 7,659,813 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24,508 | 10,306,239 | 0.24 | 27.64 | 677,325 | 284,832,497 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,080 | 1,614,513 | 0.19 | 27.64 | 85,122 | 44,620,134 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 453 | 276,577 | 0.16 | 27.97 | 12,672 | 7,736,744 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 18,151 | 10,281,731 | 0.18 | 27.97 | 507,742 | 287,612,918 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,281 | 1,611,433 | 0.14 | 27.97 | 63,807 | 45,076,938 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 758 | 276,124 | 0.28 | 28.43 | 21,551 | 7,850,509 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 30,102 | 10,263,580 | 0.29 | 28.43 | 855,833 | 291,804,869 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,940 | 1,609,152 | 0.25 | 28.43 | 112,019 | 45,749,961 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 375 | 275,366 | 0.14 | 28.58 | 10,718 | 7,870,098 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 14,878 | 10,233,478 | 0.15 | 28.58 | 425,221 | 292,477,918 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,947 | 1,605,212 | 0.12 | 28.58 | 55,646 | 45,877,762 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,742 | 274,991 | 0.64 | 28.23 | 49,180 | 7,763,463 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 69,187 | 10,218,600 | 0.68 | 28.23 | 1,953,267 | 288,488,450 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9,055 | 1,603,265 | 0.57 | 28.23 | 255,638 | 45,262,897 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 788 | 273,249 | 0.29 | 27.96 | 22,033 | 7,640,288 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 31,584 | 10,149,413 | 0.31 | 27.96 | 883,117 | 283,786,722 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,004 | 1,594,210 | 0.25 | 27.96 | 111,955 | 44,575,546 | |
| 2013-01-23 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-01-08 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 20,099 | 176,920 | 12.82 | 47.53 | 955,305 | 8,409,008 | |
| 2013-01-08 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 839,621 | 6,782,215 | 14.13 | 47.53 | 39,907,186 | 322,358,679 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 272,461 | 0.13 | 27.24 | 9,997 | 7,421,838 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 272,461 | 0.13 | 27.24 | 9,997 | 7,421,838 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 10,117,829 | 0.00 | 27.24 | 9,997 | 275,609,662 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 1,590,206 | 0.02 | 27.24 | 9,997 | 43,317,211 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 13,893 | 2.71 | 27.24 | 9,997 | 378,445 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 174,552 | 0.21 | 27.24 | 9,997 | 4,754,796 | |
| 2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
1,045,475 | ||||||||
| 2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
14,229,612 | ||||||||
| 2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
346,725 | ||||||||
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6 | 271,806 | 0.00 | 27.54 | 165 | 7,485,537 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 268 | 10,117,174 | 0.00 | 27.54 | 7,381 | 278,626,972 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 26 | 1,589,551 | 0.00 | 27.54 | 716 | 43,776,235 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,859 | 271,800 | 1.82 | 26.83 | 130,352 | 7,291,551 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 202,311 | 10,116,906 | 2.04 | 26.83 | 5,427,377 | 271,405,226 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 21,830 | 1,589,525 | 1.39 | 26.83 | 585,631 | 42,642,028 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,223 | 266,941 | 0.84 | 27.32 | 60,725 | 7,291,894 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 92,592 | 9,914,595 | 0.94 | 27.32 | 2,529,289 | 270,832,034 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8,352 | 1,567,695 | 0.54 | 27.32 | 228,147 | 42,823,940 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,231 | 264,718 | 0.85 | 27.99 | 62,450 | 7,409,960 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 92,917 | 9,822,003 | 0.96 | 27.99 | 2,600,923 | 274,936,526 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8,691 | 1,559,343 | 0.56 | 27.99 | 243,278 | 43,648,973 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,298 | 262,487 | 1.66 | 27.94 | 120,075 | 7,333,204 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 178,978 | 9,729,086 | 1.87 | 27.94 | 5,000,180 | 271,805,367 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16,724 | 1,550,652 | 1.09 | 27.94 | 467,225 | 43,321,185 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 143 | 258,189 | 0.06 | 27.86 | 3,983 | 7,192,010 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24 | 258,046 | 0.01 | 26.68 | 640 | 6,884,693 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 79 | 258,022 | 0.03 | 27.16 | 2,146 | 7,008,187 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9,905 | 257,943 | 3.99 | 27.84 | 275,793 | 7,182,113 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 651 | 248,038 | 0.26 | 26.91 | 17,516 | 6,673,735 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 324 | 247,387 | 0.13 | 25.83 | 8,367 | 6,388,868 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,972 | 9,550,108 | 0.06 | 27.86 | 166,354 | 266,023,988 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 980 | 9,544,136 | 0.01 | 26.68 | 26,146 | 254,638,503 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,298 | 9,543,156 | 0.03 | 27.16 | 89,578 | 259,203,569 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 412,596 | 9,539,858 | 4.52 | 27.84 | 11,488,241 | 265,625,898 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 27,125 | 9,127,262 | 0.30 | 26.91 | 729,828 | 245,579,024 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13,447 | 9,100,137 | 0.15 | 25.83 | 347,274 | 235,014,678 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 585 | 1,533,928 | 0.04 | 27.86 | 16,296 | 42,728,485 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 96 | 1,533,343 | 0.01 | 26.68 | 2,561 | 40,909,745 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 323 | 1,533,247 | 0.02 | 27.16 | 8,773 | 41,644,828 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40,412 | 1,532,924 | 2.71 | 27.84 | 1,125,224 | 42,682,429 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,657 | 1,492,512 | 0.18 | 26.91 | 71,490 | 40,157,677 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,316 | 1,489,855 | 0.09 | 25.83 | 33,986 | 38,476,101 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 103,608 | 463,839 | 28.76 | 3.00 | 310,824 | 1,391,517 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 4,282,419 | 17,888,512 | 31.47 | 3.00 | 12,847,257 | 53,665,536 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 336,639 | 1,922,230 | 21.23 | 3.00 | 1,009,917 | 5,766,690 | |
| 2012-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 288 | 288 | 35.89 | 10,336 | 10,336 | ||
| 2012-07-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Stock Options (right to buy) |
A - Award | 16,500 | 16,500 | |||||
| 2012-07-13 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 21,082 | 156,821 | 15.53 | 41.20 | 868,578 | 6,461,025 | |
| 2012-07-13 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 864,918 | 5,942,594 | 17.03 | 41.20 | 35,634,622 | 244,834,873 | |
| 2012-06-29 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Stock Option (Right to Buy) |
A - Award | 7,500 | 7,500 | |||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -12,500 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -12,500 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -25,000 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -4,023 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -147,292 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -46,195 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -998 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -205 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -116,454 | 0 | -100.00 | 32.00 | -3,726,528 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -4,922,226 | 0 | -100.00 | 32.00 | -157,511,232 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -1,646,964 | 0 | -100.00 | 32.00 | -52,702,848 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -99,636 | 0 | -100.00 | 32.00 | -3,188,352 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -65,882 | 0 | -100.00 | 32.00 | -2,108,224 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -60,827 | 0 | -100.00 | 32.00 | -1,946,464 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -2,302 | 0 | -100.00 | 32.00 | -73,664 | ||
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 380 | 247,063 | 0.15 | 32.94 | 12,518 | 8,138,922 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17,026 | 9,086,690 | 0.19 | 32.94 | 560,882 | 299,340,103 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,732 | 246,683 | 1.12 | 32.21 | 87,992 | 7,945,166 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 546 | 243,951 | 0.22 | 32.04 | 17,493 | 7,815,922 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 122,268 | 9,069,664 | 1.37 | 32.21 | 3,938,008 | 292,115,738 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24,454 | 8,947,396 | 0.27 | 32.04 | 783,479 | 286,664,726 | |
| 2012-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 17,500 | 17,500 | |||||
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 517 | 243,405 | 0.21 | 34.46 | 17,815 | 8,387,176 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23,104 | 8,922,942 | 0.26 | 34.46 | 796,111 | 307,464,059 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,972 | 242,888 | 0.82 | 34.25 | 67,541 | 8,318,914 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 540 | 240,916 | 0.22 | 33.11 | 17,882 | 7,977,668 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 555 | 240,376 | 0.23 | 34.47 | 19,129 | 8,285,160 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 88,028 | 8,899,838 | 1.00 | 34.25 | 3,014,959 | 304,819,452 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24,136 | 8,811,810 | 0.27 | 33.11 | 799,237 | 291,793,395 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24,769 | 8,787,674 | 0.28 | 34.47 | 853,726 | 302,889,154 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,212 | 239,821 | 1.36 | 33.92 | 108,951 | 8,134,728 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 897 | 236,609 | 0.38 | 33.67 | 30,198 | 7,965,513 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 370 | 235,712 | 0.16 | 32.59 | 12,058 | 7,681,501 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 175 | 235,342 | 0.07 | 31.53 | 5,517 | 7,419,863 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 143,388 | 8,762,905 | 1.66 | 33.92 | 4,863,721 | 297,237,738 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40,073 | 8,619,517 | 0.47 | 33.67 | 1,349,070 | 290,178,626 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16,526 | 8,579,444 | 0.19 | 32.59 | 538,558 | 279,591,211 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,797 | 8,562,918 | 0.09 | 31.53 | 245,824 | 269,971,679 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 627 | 235,167 | 0.27 | 30.22 | 18,946 | 7,105,877 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 26,033 | 8,555,121 | 0.31 | 30.22 | 786,621 | 258,504,103 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 214 | 234,540 | 0.09 | 29.98 | 6,415 | 7,030,829 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8,867 | 8,529,088 | 0.10 | 29.98 | 265,807 | 255,677,324 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,402 | 234,326 | 0.60 | 29.86 | 41,861 | 6,996,599 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 58,198 | 8,520,221 | 0.69 | 29.86 | 1,737,699 | 254,400,167 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 460 | 232,924 | 0.20 | 29.90 | 13,752 | 6,963,379 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 19,087 | 8,462,023 | 0.23 | 29.90 | 570,615 | 252,976,409 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 116 | 232,464 | 0.05 | 28.50 | 3,306 | 6,624,620 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,737 | 232,348 | 0.75 | 28.90 | 50,196 | 6,714,416 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 172 | 230,611 | 0.07 | 28.41 | 4,886 | 6,550,529 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,811 | 8,442,936 | 0.06 | 28.50 | 137,101 | 240,601,724 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 72,073 | 8,438,125 | 0.86 | 28.90 | 2,082,773 | 243,845,780 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,124 | 8,366,052 | 0.09 | 28.41 | 202,358 | 237,638,544 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 536 | 230,439 | 0.23 | 28.28 | 15,159 | 6,517,184 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 754 | 229,903 | 0.33 | 28.25 | 21,300 | 6,494,530 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 22,241 | 8,358,928 | 0.27 | 28.28 | 629,011 | 236,403,858 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 31,273 | 8,336,687 | 0.38 | 28.25 | 883,431 | 235,503,071 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 722 | 1,488,539 | 0.05 | 28.28 | 20,419 | 42,098,265 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,014 | 1,487,817 | 0.07 | 28.25 | 28,644 | 42,029,342 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5 | 229,149 | 0.00 | 28.00 | 140 | 6,416,172 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 369 | 229,144 | 0.16 | 27.99 | 10,330 | 6,414,863 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 935 | 228,775 | 0.41 | 28.03 | 26,208 | 6,412,540 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 188 | 8,305,414 | 0.00 | 28.00 | 5,264 | 232,551,592 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 14,078 | 8,305,226 | 0.17 | 27.99 | 394,112 | 232,503,971 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 35,727 | 8,291,148 | 0.43 | 28.03 | 1,001,424 | 232,400,049 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7 | 1,486,803 | 0.00 | 28.00 | 196 | 41,630,484 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 514 | 1,486,796 | 0.03 | 27.99 | 14,389 | 41,622,705 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,305 | 1,486,282 | 0.09 | 28.03 | 36,579 | 41,660,336 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 910 | 57,704 | 1.60 | 3.01 | 2,735 | 173,429 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 1,482 | 56,794 | 2.68 | 2.99 | 4,430 | 169,763 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 4,186 | 55,312 | 8.19 | 2.96 | 12,383 | 163,618 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 15,076 | 51,126 | 41.82 | 2.55 | 38,444 | 130,371 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 8,628 | 36,050 | 31.46 | 2.34 | 20,186 | 84,343 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 1,170 | 27,422 | 4.46 | 1.87 | 2,188 | 51,279 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 430 | 26,252 | 1.67 | 1.89 | 811 | 49,506 | |
| 2012-03-14 | 3 | TZYM |
TRANZYME INC
Common Stock |
25,822 | ||||||||
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 34,544 | 3,540,015 | 0.99 | 3.01 | 103,822 | 10,639,515 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 56,294 | 3,505,471 | 1.63 | 2.99 | 168,268 | 10,478,203 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 159,015 | 3,449,177 | 4.83 | 2.96 | 470,382 | 10,203,010 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 572,737 | 3,290,162 | 21.08 | 2.55 | 1,460,479 | 8,389,913 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 327,769 | 2,717,425 | 13.72 | 2.34 | 766,848 | 6,357,688 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 44,467 | 2,389,656 | 1.90 | 1.87 | 83,153 | 4,468,657 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 16,326 | 2,345,189 | 0.70 | 1.89 | 30,788 | 4,422,557 | |
| 2012-03-14 | 3 | TZYM |
TRANZYME INC
Common Stock |
2,328,863 | ||||||||
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 4,592 | 232,011 | 2.02 | 3.01 | 13,801 | 697,309 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 7,484 | 227,419 | 3.40 | 2.99 | 22,370 | 679,778 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 15,599 | 219,935 | 7.63 | 2.96 | 46,143 | 650,590 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 56,187 | 204,336 | 37.93 | 2.55 | 143,277 | 521,057 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 32,155 | 148,149 | 27.72 | 2.34 | 75,230 | 346,609 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 4,363 | 115,994 | 3.91 | 1.87 | 8,159 | 216,909 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 1,601 | 111,631 | 1.46 | 1.89 | 3,019 | 210,514 | |
| 2012-03-14 | 3 | TZYM |
TRANZYME INC
Common Stock |
110,030 | ||||||||
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 516 | 227,840 | 0.23 | 30.36 | 15,668 | 6,918,088 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 583 | 227,324 | 0.26 | 29.88 | 17,420 | 6,792,259 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 19,513 | 8,255,421 | 0.24 | 30.36 | 592,489 | 250,665,952 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 22,071 | 8,235,908 | 0.27 | 29.88 | 659,464 | 246,082,342 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,162 | 1,484,977 | 0.15 | 30.36 | 65,647 | 45,089,545 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,346 | 1,482,815 | 0.16 | 29.88 | 70,097 | 44,305,326 | |
| 2012-03-08 | 3 | XOMA |
XOMA Corp
Common Stock |
360,231 | ||||||||
| 2012-03-08 | 3 | XOMA |
XOMA Corp
Common Stock |
1,585,591 | ||||||||
| 2012-03-08 | 3 | XOMA |
XOMA Corp
Common Stock |
13,606,093 | ||||||||
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,845 | 226,741 | 0.82 | 30.07 | 55,477 | 6,817,830 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,254 | 224,896 | 1.01 | 29.96 | 67,521 | 6,737,007 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,419 | 222,642 | 1.10 | 29.52 | 71,410 | 6,572,503 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 405 | 220,223 | 0.18 | 29.47 | 11,936 | 6,490,060 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 69,783 | 8,213,837 | 0.86 | 30.07 | 2,098,291 | 246,980,222 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 85,231 | 8,144,054 | 1.06 | 29.96 | 2,553,188 | 243,964,096 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 91,459 | 8,058,823 | 1.15 | 29.52 | 2,699,915 | 237,900,484 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 15,288 | 7,967,364 | 0.19 | 29.47 | 450,543 | 234,801,404 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8,372 | 1,480,469 | 0.57 | 30.07 | 251,736 | 44,515,926 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10,225 | 1,472,097 | 0.70 | 29.96 | 306,301 | 44,098,285 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10,972 | 1,461,872 | 0.76 | 29.52 | 323,899 | 43,155,192 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,763 | 1,450,900 | 0.12 | 29.47 | 51,956 | 42,758,603 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,149 | 219,818 | 1.92 | 29.06 | 120,562 | 6,387,493 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,353 | 215,669 | 0.63 | 29.11 | 39,384 | 6,277,801 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 974 | 214,316 | 0.46 | 29.03 | 28,276 | 6,221,722 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 156,902 | 7,952,076 | 2.01 | 29.06 | 4,559,274 | 231,072,220 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 51,248 | 7,795,174 | 0.66 | 29.11 | 1,491,752 | 226,905,822 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 36,881 | 7,743,926 | 0.48 | 29.03 | 1,070,678 | 224,810,818 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 19,552 | 1,449,137 | 1.37 | 29.06 | 568,144 | 42,109,168 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,934 | 1,429,585 | 0.42 | 29.11 | 172,730 | 41,613,075 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,270 | 1,423,651 | 0.30 | 29.03 | 123,961 | 41,329,443 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,639 | 213,342 | 0.77 | 28.12 | 46,095 | 5,999,988 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 145 | 211,703 | 0.07 | 27.98 | 4,057 | 5,923,683 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,238 | 211,558 | 0.59 | 27.98 | 34,635 | 5,918,737 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 62,098 | 7,707,045 | 0.81 | 28.12 | 1,746,432 | 216,751,392 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,511 | 7,644,947 | 0.07 | 27.98 | 154,204 | 213,914,027 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 46,909 | 7,639,436 | 0.62 | 27.98 | 1,312,368 | 213,727,737 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,477 | 1,419,381 | 0.53 | 28.12 | 210,282 | 39,918,387 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 638 | 1,411,904 | 0.05 | 27.98 | 17,852 | 39,506,627 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,217 | 1,411,266 | 0.37 | 27.98 | 145,955 | 39,482,848 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,419 | 210,320 | 1.16 | 29.85 | 72,219 | 6,279,062 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,460 | 207,901 | 1.20 | 29.61 | 72,842 | 6,156,073 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10 | 205,441 | 0.00 | 28.96 | 290 | 5,950,085 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 849 | 205,431 | 0.41 | 28.88 | 24,517 | 5,932,272 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,475 | 204,582 | 0.73 | 28.44 | 41,945 | 5,817,698 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 91,543 | 7,592,527 | 1.22 | 29.85 | 2,732,998 | 226,673,375 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 93,088 | 7,500,984 | 1.26 | 29.61 | 2,756,392 | 222,108,637 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 349 | 7,407,896 | 0.00 | 28.96 | 10,108 | 214,551,188 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 32,125 | 7,407,547 | 0.44 | 28.88 | 927,680 | 213,909,216 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 55,804 | 7,375,422 | 0.76 | 28.44 | 1,586,898 | 209,734,875 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10,838 | 1,406,049 | 0.78 | 29.85 | 323,566 | 41,977,312 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 11,021 | 1,395,211 | 0.80 | 29.61 | 326,338 | 41,313,035 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 41 | 1,384,190 | 0.00 | 28.96 | 1,187 | 40,089,603 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,944 | 1,384,149 | 0.29 | 28.88 | 113,892 | 39,970,348 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,341 | 1,380,205 | 0.53 | 28.44 | 208,756 | 39,248,890 | |
| 2012-02-14 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 150,000 | 557,211 | 36.84 | 20.85 | 3,128,040 | 11,619,855 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 753 | 203,107 | 0.37 | 26.52 | 19,967 | 5,385,666 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 492 | 202,354 | 0.24 | 26.62 | 13,098 | 5,387,048 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,980 | 201,862 | 1.50 | 26.60 | 79,278 | 5,370,195 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 102 | 198,882 | 0.05 | 26.24 | 2,676 | 5,217,868 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,312 | 198,780 | 0.66 | 26.33 | 34,540 | 5,233,162 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 64 | 197,468 | 0.03 | 26.27 | 1,681 | 5,187,208 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,594 | 197,404 | 0.81 | 26.26 | 41,851 | 5,182,921 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,585 | 195,810 | 1.87 | 26.18 | 93,840 | 5,125,464 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 161 | 192,225 | 0.08 | 26.17 | 4,213 | 5,029,586 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 28,469 | 7,319,618 | 0.39 | 26.52 | 754,895 | 194,089,919 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 18,628 | 7,291,149 | 0.26 | 26.62 | 495,913 | 194,104,240 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 112,735 | 7,272,521 | 1.57 | 26.60 | 2,999,123 | 193,473,058 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,883 | 7,159,786 | 0.05 | 26.24 | 101,874 | 187,844,145 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 49,670 | 7,155,903 | 0.70 | 26.33 | 1,307,632 | 188,389,165 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,441 | 7,106,233 | 0.03 | 26.27 | 64,122 | 186,670,792 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 60,315 | 7,103,792 | 0.86 | 26.26 | 1,583,594 | 186,512,900 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 135,681 | 7,043,477 | 1.96 | 26.18 | 3,551,545 | 184,367,941 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6,093 | 6,907,796 | 0.09 | 26.17 | 159,424 | 180,743,173 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,378 | 1,372,864 | 0.32 | 26.52 | 116,089 | 36,403,411 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,865 | 1,368,486 | 0.21 | 26.62 | 76,272 | 36,431,697 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17,339 | 1,365,621 | 1.29 | 26.60 | 461,275 | 36,330,025 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 615 | 1,348,282 | 0.05 | 26.24 | 16,135 | 35,373,527 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,858 | 1,347,667 | 0.59 | 26.33 | 206,873 | 35,479,221 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 387 | 1,339,809 | 0.03 | 26.27 | 10,166 | 35,194,907 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9,891 | 1,339,422 | 0.74 | 26.26 | 259,692 | 35,167,060 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 22,251 | 1,329,531 | 1.70 | 26.18 | 582,436 | 34,801,405 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 999 | 1,307,280 | 0.08 | 26.17 | 26,139 | 34,205,112 | |
| 2012-02-03 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
P - Purchase | 23,172 | 116,454 | 24.84 | 17.00 | 393,924 | 1,979,718 | |
| 2012-02-03 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
P - Purchase | 876,828 | 4,922,226 | 21.67 | 17.00 | 14,906,076 | 83,677,842 | |
| 2012-01-31 |
|
4 | DDXS |
diaDexus, Inc.
Common Stock |
S - Sale | -59,340 | 0 | -100.00 | 0.22 | -13,156 | ||
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 12,907 | 407,211 | 3.27 | 17.89 | 230,942 | 7,286,145 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 28,966 | 394,304 | 7.93 | 17.95 | 519,960 | 7,078,033 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 3,018 | 365,338 | 0.83 | 18.43 | 55,629 | 6,734,093 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 18,547 | 362,320 | 5.40 | 18.55 | 343,997 | 6,720,058 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 14,629 | 343,773 | 4.44 | 18.01 | 263,424 | 6,190,320 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 7,926 | 329,144 | 2.47 | 17.86 | 141,534 | 5,877,491 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1,944 | 195,858 | 1.00 | 17.89 | 34,784 | 3,504,448 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 4,360 | 193,914 | 2.30 | 17.95 | 78,265 | 3,480,892 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 454 | 189,554 | 0.24 | 18.43 | 8,368 | 3,493,954 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 2,792 | 189,100 | 1.50 | 18.55 | 51,784 | 3,507,294 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 2,202 | 186,308 | 1.20 | 18.01 | 39,651 | 3,354,848 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1,193 | 184,106 | 0.65 | 17.86 | 21,303 | 3,287,562 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 75,149 | 8,574,445 | 0.88 | 17.89 | 1,344,626 | 153,420,829 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 168,641 | 8,499,296 | 2.02 | 17.95 | 3,027,224 | 152,568,313 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 17,571 | 8,330,655 | 0.21 | 18.43 | 323,877 | 153,554,798 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 107,980 | 8,313,084 | 1.32 | 18.55 | 2,002,737 | 154,185,263 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 85,169 | 8,205,104 | 1.05 | 18.01 | 1,533,638 | 147,749,308 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 46,142 | 8,119,935 | 0.57 | 17.86 | 823,953 | 144,996,867 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 7,925 | 321,218 | 2.53 | 16.84 | 133,456 | 5,409,279 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 12,694 | 313,293 | 4.22 | 16.88 | 214,254 | 5,287,885 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 7,590 | 300,599 | 2.59 | 16.90 | 128,252 | 5,079,372 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -16 | 0 | -100.00 | 1.50 | -24 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -28 | 16 | -63.64 | 1.25 | -35 | 20 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 16 | 44 | 57.14 | 1.50 | 24 | 66 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 1,600 | 293,009 | 0.55 | 15.00 | 24,000 | 4,395,135 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 2,800 | 291,409 | 0.97 | 15.00 | 42,000 | 4,371,135 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 12,041 | 288,609 | 4.35 | 16.44 | 197,940 | 4,744,386 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 31,115 | 276,568 | 12.68 | 16.41 | 510,585 | 4,538,370 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 28 | 28 | 1.25 | 35 | 35 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 426 | 245,453 | 0.17 | 15.81 | 6,735 | 3,880,391 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1,795 | 245,027 | 0.74 | 16.07 | 28,843 | 3,937,241 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 3,839 | 243,232 | 1.60 | 16.07 | 61,686 | 3,908,300 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1,201 | 182,913 | 0.66 | 16.84 | 20,225 | 3,080,237 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1,923 | 181,712 | 1.07 | 16.88 | 32,457 | 3,067,008 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1,149 | 179,789 | 0.64 | 16.90 | 19,415 | 3,037,985 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -2 | 0 | -100.00 | 1.50 | -3 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -5 | 2 | -71.43 | 1.25 | -6 | 2 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 2 | 7 | 40.00 | 1.50 | 3 | 10 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 200 | 178,640 | 0.11 | 15.00 | 3,000 | 2,679,600 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 500 | 178,440 | 0.28 | 15.00 | 7,500 | 2,676,600 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1,824 | 177,940 | 1.04 | 16.44 | 29,984 | 2,925,120 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 4,712 | 176,116 | 2.75 | 16.41 | 77,322 | 2,889,993 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 5 | 5 | 1.25 | 6 | 6 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 66 | 171,404 | 0.04 | 15.81 | 1,043 | 2,709,743 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 278 | 171,338 | 0.16 | 16.07 | 4,467 | 2,753,162 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 594 | 171,060 | 0.35 | 16.07 | 9,545 | 2,748,626 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 45,574 | 8,073,793 | 0.57 | 16.84 | 767,462 | 135,961,867 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 72,997 | 8,028,219 | 0.92 | 16.88 | 1,232,073 | 135,503,492 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 43,644 | 7,955,222 | 0.55 | 16.90 | 737,474 | 134,423,364 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -87 | 0 | -100.00 | 1.50 | -130 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -162 | 87 | -65.06 | 1.25 | -202 | 109 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 87 | 249 | 53.70 | 1.50 | 130 | 373 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 8,700 | 7,911,578 | 0.11 | 15.00 | 130,500 | 118,673,670 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 16,200 | 7,902,878 | 0.21 | 15.00 | 243,000 | 118,543,170 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 69,245 | 7,886,678 | 0.89 | 16.43 | 1,137,958 | 129,608,089 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 178,921 | 7,817,433 | 2.34 | 16.41 | 2,936,022 | 128,280,949 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 162 | 162 | 1.25 | 202 | 202 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 2,449 | 7,638,512 | 0.03 | 15.81 | 38,716 | 120,758,000 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 10,327 | 7,636,063 | 0.14 | 16.07 | 165,940 | 122,700,842 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 22,081 | 7,625,736 | 0.29 | 16.07 | 354,802 | 122,531,851 | |
| 2012-01-20 |
|
4 | DDXS |
diaDexus, Inc.
Common Stock |
S - Sale | -20,000 | 59,340 | -25.21 | 0.20 | -4,000 | 11,868 | |
| 2012-01-20 |
|
4 | DDXS |
diaDexus, Inc.
Common Stock |
S - Sale | -118,800 | 79,340 | -59.96 | 0.21 | -25,233 | 16,852 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,122 | 355,839 | 0.32 | 16.62 | 18,648 | 5,914,115 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,965 | 354,717 | 0.56 | 16.58 | 32,576 | 5,880,463 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,769 | 352,752 | 0.79 | 16.46 | 45,570 | 5,805,345 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5,919 | 349,983 | 1.72 | 16.21 | 95,924 | 5,671,859 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,850 | 344,064 | 0.84 | 16.38 | 46,691 | 5,636,697 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 41,677 | 12,430,783 | 0.34 | 16.62 | 692,680 | 206,602,100 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 72,978 | 12,389,106 | 0.59 | 16.58 | 1,209,822 | 205,385,360 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 102,856 | 12,316,128 | 0.84 | 16.46 | 1,692,732 | 202,690,213 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 219,881 | 12,213,272 | 1.83 | 16.21 | 3,563,413 | 197,929,507 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 105,847 | 11,993,391 | 0.89 | 16.38 | 1,734,060 | 196,484,127 | |
| 2012-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
A - Award | 29,089 | 135,739 | 27.28 | 25.18 | 732,461 | 3,417,908 | |
| 2012-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
A - Award | 1,077,225 | 5,077,676 | 26.93 | 25.18 | 27,124,526 | 127,855,882 | |
| 2012-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
A - Award | 187,576 | 1,736,065 | 12.11 | 25.18 | 4,723,164 | 43,714,117 | |
| 2012-01-05 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Options (Right to Buy) |
A - Award | 12,500 | 12,500 | |||||
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -355,143 | 0 | -100.00 | ||||
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 355,143 | 15,131,223 | 2.40 | 6.25 | 2,219,644 | 94,570,144 | |
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -49,563 | 0 | -100.00 | ||||
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 49,563 | 450,461 | 12.36 | 6.25 | 309,769 | 2,815,381 | |
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -68,006 | 0 | -100.00 | ||||
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 68,006 | 539,130 | 14.43 | 6.25 | 425,038 | 3,369,562 | |
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -339,788 | 0 | -100.00 | ||||
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 339,788 | 4,966,001 | 7.34 | 6.25 | 2,123,675 | 31,037,506 | |
| 2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -186,272 | 0 | -100.00 | 4.25 | -791,656 | ||
| 2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -6,669,338 | 0 | -100.00 | 4.25 | -28,344,686 | ||
| 2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -12,679 | 0 | -100.00 | 4.25 | -53,886 | ||
| 2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -79,054 | 0 | -100.00 | 4.25 | -335,980 | ||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Series A Convertible Preferred Stock |
J - Other | 284,115 | 284,115 | |||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Series A Convertible Preferred Stock |
J - Other | -34,385 | 0 | -100.00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Series A Convertible Preferred Stock |
J - Other | -249,730 | 0 | -100.00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
J - Other | 355,143 | 355,143 | |||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
J - Other | -42,981 | 0 | -100.00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
J - Other | -312,162 | 0 | -100.00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 448,047 | 682,908 | 190.77 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -45,090 | 0 | -100.00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -49,807 | 0 | -100.00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -353,150 | 0 | -100.00 |
